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Legal Disclaimer
The Guidelines for medical fitness to drive Sláinte agus Tiomáint (‘the Guidelines’) have been compiled by the Road Safety 
Authority in conjunction with the National Office for Traffic Medicine* using all reasonable care and are based on expert 
medical opinion and relevant literature at the time of printing. The legal basis for the Guidelines in general is provided 
for in regulations made under the Road Traffic Acts. The Road Traffic (Licensing of Drivers) Regulations 2006 (SI 537 of 
2006) is the substantive legislative instrument underpinning the Guidelines. This has been amended and will continue 
to be amended as EU Directives update medical fitness rules. Medical fitness rules relating to diabetes, epilepsy, vision 
and obstructive sleep apnoea syndrome were developed on foot of recommendations from EU Specialist Working Groups 
and reflected in EU Directives 2009/113/EC and 2014/85/EU. Doctors should be mindful that certain specific and detailed 
elements of the EU Directives have force of law by virtue of being incorporated into Irish regulations, particularly relating 
to diabetes, vision and epilepsy. These aspects are marked with an EU Symbol in the Guidelines. Neither the Road Safety 
Authority nor the National  Office for Traffic Medicine nor the Royal College of Physicians of Ireland to which it is also 
associated accepts responsibility for any consequences arising from their application, including any liability in respect of 
any claim or cause of action arising out of, or in relation to, the use or reliance on the Guidelines.
Health professionals should keep informed of any changes in health care and health technology that may affect their 
assessment of drivers. They should also maintain an awareness of any changes in the law that may affect their legal 
responsibilities.
* The National Office for Traffic Medicine was established as a joint initiative between the Road Safety Authority and the Royal College of Physicians of Ireland in 
2011.
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Foreword
Sláinte agus Tiomáint provides guidance on medical fitness for drivers and highlights the need for all of us to appreciate 
that the state of our health impacts, to a greater or lesser degree, on our ability to drive safely. Driver fitness is governed 
by EU law and regulations made in Ireland under the Road Traffic Acts. Sláinte agus Tiomáint is an interpretation of these 
laws; however, the Directive/regulations form the overriding legal basis for driver medical fitness in Ireland. 
 
One of the objectives of Sláinte agus Tiomáint is to promote mobility and to do this in a way that is consistent with safety 
on our roads. Once a driver is aware of any health aspects that impact on driving and follows the advice of their doctor, 
they can continue to drive in most cases. Included in this edition are driver information leaflets on Cardiac Conditions, 
Diabetes, Alcohol, Obstructive Sleep Apnoea Syndrome and Epilepsy and how these conditions can affect driving. Also 
included is an advisory leaflet for drivers who been treated recently in Hospital Emergency Departments.  
Sláinte agus Tiomáint forms one part of a broader information and communication campaign to increase awareness 
among medical professionals and the wider public about fitness to drive. Sláinte agus Tiomáint was developed by the 
National Office for Traffic Medicine which has been established as a joint initiative between the Road Safety Authority and 
the Royal College of Physicians of Ireland. In developing the Guidelines, the National Office for Traffic Medicine engaged 
widely with stakeholders to ensure that they reflect good practice.
The Office also works to ensure that all doctors, healthcare disciplines, medical professionals, An Garda Síochána 
and transport professionals have training and support for the practical implementation of the guidelines on the ground. 
Sláinte agus Tiomáint is an important addition to the range of initiatives that ensures we can continue to drive safely 
on our roads.
Moyagh Murdock, CEO
Road Safety Authority
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Part A: General information
Chapter 1 
1.0 Introduction
This publication summarises Irish medical guidelines of fitness to drive. The information in these Guidelines is intended to 
assist doctors and other healthcare professionals in advising their patients on fitness to drive, requirements for reporting 
to the National Driver Licence Service (NDLS) and guidance on review of stability, progression or improvement of these 
conditions. It should be used by health professionals when:
• Treating any patient who holds a driver licence whose condition may impact on their ability to drive safely. The majority 
of adults drive, thus a health professional should routinely consider the impact of a patient’s condition on their ability 
to drive safely. Awareness of a patient’s occupation or other driving requirements is also helpful.
• Undertaking an examination at the request of NDLS:
– Assessing a person whose driving the NDLS believes may be unsafe (i.e. ‘for cause’ examinations).
– For licence renewal of an older driver.
This publication focuses on long-term health and disability-related conditions and their associated functional effects 
that may impact on driving. It sets out clear minimum medical requirements for licensing and forms the medical basis 
of decisions made by the NDLS. This publication also provides general guidance with respect to patient management for 
fitness to drive.
This publication is intended for use by any health professional who is involved in assessing a person’s fitness to drive 
including but not confined to: 
• medical practitioners (general practitioners (GPs) and other specialists) 
• optometrists 
• occupational therapists 
• psychologists 
• physiotherapists
• alcohol and drug addiction counsellors
These medical standards refer to Group 1 and Group 2 licence holders. The categories are outlined below.
These Guidelines are a part of a larger project of the National Office for Traffic Medicine, a joint initiative between the 
Road Safety Authority and the Royal College of Physicians of Ireland. This larger project will encompass the annual renewal 
and updating of Group 1 and Group 2 medical fitness to drive guidelines in conjunction with the delivery of education 
and research supports and developments such as conditional or restricted licences. The literature searches underpinning 
the annual review of the guidelines are available on the website of the National Office for Traffic Medicine www.rcpi.ie/
traffic-medicine/
Group 1 Categories A, A1, A2, AM, B, BE, or W i.e. motorcycles, cars and tractors (with or without trailer).
Group 2 Categories C, CE, C1, C1E, D, DE, D1 or D1E i.e. truck and bus (with or without trailer).
The vehicles in Group 2 are regarded as higher-risk vehicles which require a higher standard of physical and mental 
fitness on the part of the driver.
Contact Details for Medical Fitness to Drive
Email: medicalfitness@rsa.ie
Website: www.ndls.ie
telephone no.: 1890406040
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1.1 Traffic medicine and the compilation of the guidelines
Although the first automobile fatality in the world occurred in Ireland in 18591, Traffic Medicine is a relatively new specialism 
embracing all those disciplines, techniques, and methods aimed at reducing the harm traffic crashes inflict on human beings 
(International Traffic Medicine Association, 2009). There is also an enabling/rehabilitative element which tries to ensure 
that transport mobility (an important constituent of well-being and social inclusion) is not hampered, or rendered unsafe, 
by remediable illness or functional loss. 
It involves a wide range of disciplines, with a rapidly increasing research database which encompasses an active process of 
reflection, debate and consensus to maximise safe mobility. The most visible face of Traffic Medicine in most jurisdictions 
is the ‘medical fitness to drive’ aspect of driver licensing. Support for the approach of using evidence based guidelines is 
provided by evidence of a significant drop in crashes among drivers when such guidelines are systematically applied2. 
 
These Guidelines represent a synthesis of current research and clinical practice on medical fitness to drive as interpreted by 
the National Office for Traffic Medicine, a joint initiative of the Road Safety Authority and the Royal College of Physicians of 
Ireland (see Acknowledgements). The contributors to the RCPI Working Group on Traffic Medicine includes virtually every 
medical specialty relevant to medical fitness to drive, as well as associated disciplines, the Irish Patients’ Association, the 
Garda Síochána and the Automobile Association. 
The Guidelines are based on four major sources of knowledge: i) Significant articles in the peer reviewed literature3; ii) 
Position papers by scientific organisations4; iii) National guidelines, particularly those of the UK Driver and Vehicle Licensing 
Agency, Australia’s Austroads, the Canadian Medical Association (CMA), the American Medical Association (AMA) as well 
as the US FMCSA Medical Examiner Handbook Information for Group 25; iv) the ‘grey’ literature including reports from the 
US Transportation Research Board, UK Transport Research Laboratory and other sources6. In addition, some key overview 
reports are used7 and the Directives of the European Union provide a legislative framework for some aspects, particularly 
vision, diabetes, epilepsy and sleep apnoea8. 
Annual syntheses of emerging research from medical databases are prepared each year and distributed to the Working 
Group and its sub-groups to aid in the deliberations on potential revisions of each section. The key search strategy is through 
the Medical SubHeading term “Automobile Driving” in the MedLine database, with allocation of the results to the various 
sections of the guide (see NOTM website for 2016 searches). Given that any one recommendation may affect practice across 
many disciplines, the various aspects of medical fitness to drive are examined by various sub-groups (Vision, Substance 
Abuse, Diabetes, Cardiology, Psychiatry and Rehabilitation) but also by the whole Working Group.
1. Fallon I, O’Neill D. The world’s first automobile fatality. Accid Anal Prev 2005 Jul;37(4):601-3.
2. Redelmeier DA, Yarnell CJ, Thiruchelvam D, Tibshirani RJ. Physicians’ warnings for unfit drivers and the risk of trauma from road crashes.  
N Engl J Med. 2012 Sep 27;367(13):1228-36.
3. e.g. Laberge-Nadeau, Trucks and Diabetes, Diabetes Care, 2000;23:612-7; Hansotia P, Broste SK. The effect of epilepsy or diabetes on the risk of automobile 
accidents. N Eng J Med. 1991;324:22–26.
4. e.g. American Diabetes Association, Lorber D, Anderson J, Arent S, Cox DJ, Frier BM, Greene MA, Griffin JW Jr, Gross G, Hathaway K, Kohrman DB, Marrero DG, 
Songer TJ, Yatvin AL. Diabetes and driving. Diabetes Care. 2013 Jan;36 Suppl 1:S80-5; American Academy of Neurology, American Epilepsy Society, Epilepsy 
Foundation of America. Consensus statements, sample statutory provisions, and model regulations regarding driver licensing and epilepsy. Epilepsia. 
1994;35:696–705; Iverson, D.J., et al., Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards 
Subcommittee of the American Academy of Neurology. Neurology, 2010. 74(16): p. 1316-24. 
5. e.g. DVLA, https://www.gov.uk/government/publications/at-a-glance; Austroads, http://www.austroads.com.au/assessing-fitness-to-drive; / CMA, http:// 
www.cma.ca/ AMA, http://www.ama-assn.org/ama; FMCSA, http://nrcme.fmcsa.dot.gov/mehandbook/part_4_work_ep.aspx;
6. e.g. Medical Conditions and Driving: A Review of the Scientific Literature (1960–2000), Technical Report for the National Highway and Traffic Safety 
Administration and the Association for the Advancement of Automotive Medicine Project, Washington, TRB’s Conference Proceedings 27 -- Transportation in an 
Aging Society: A Decade of Experience. Washington DC, Transportation Research Board, 2004; Tunbridge, RJ,Keigan, M,James, FJ. The incidence of drugs and 
alcohol in road accident fatalities, Crowthorne, Transport Research Laboratory, 2001.
7. Vaa T. (2003) Impairment, Diseases, Age and Their Relative Risks of Accident Involvement: Results from Meta-Analysis, TØI Report 690 for the Institute of 
Transport Economics, Oslo, Norway; Charlton JL, Koppel S, Odell M, Devin A, Langford J, O’Hare M, et al. Influence of chronic illness on crash involvement 
of motor vehicle drivers. 2nd ed. Report 300.Victoria, Australia: Monash University Accident Research Centre; 2010; Available: www.monash.edu.au/miri/
research /reports/muarc300.html (accessed 2012 Oct. 10); Dobbs BM. (2005) DC; Marshall, Shawn C. (2008). The Role of Reduced Fitness to Drive Due to 
Medical Impairments in Explaining Crashes Involving Older Drivers. Traffic Injury Prevention, 9 (4), 291-298.
8. Directive 80/1263/EEC; Directive (91/439/EEC); Directive 2006/126; Directive 2009/113/EC; Directive 2014/85/EU.
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The determination of the guidelines, and their annual review is based on a number of factors, including likelihood of crash 
relating to factors associated with each illness, the importance of personal transport, fit with the practice and working of 
the Irish health services, European Union legislation and interdisciplinary perspectives. 
The perspective of patients as drivers is incorporated through their review of the material processed through the Working 
Group: the incorporation of such perspectives is a topic which is not covered in the research literature on medical fitness to 
drive but thus far has been consensual in the development and review of the Irish guidelines. 
In addition, and consistent with good practice in guideline preparation9, external review of the guidelines is undertaken by an 
international expert in the field. Finally, the NOTM also reviews the utility and applicability of the guidelines with end users10. 
The NOTM is joint-funded by the Road Safety Authority and RCPI: the preparation and review process of these guidelines is 
editorially independent from both bodies. 
We are fortunate to be able to work with, and draw on the experience of, the UK Driver and Vehicle Licensing Authority 
(DVLA). The Irish Guidelines are to a very significant extent based on its At a Glance Guide to the current Medical Standards 
of Fitness to Drive, and some of the specialist contributors to the Guidelines are honorary members of the Advisory Panels 
of the DVLA. These Panels, which meet biannually, consist of doctors and other professionals eminent in the respective of 
cardiology, neurology, diabetes, vision, alcohol/substance misuse and psychiatry together with lay members. Consequently, 
both the Irish and UK standards are reviewed and updated regularly. 
Whilst every effort has been made to ensure the accuracy of the information contained, no guarantees can be given concerning 
the completeness or up-to-date nature of the information provided in these Guidelines, which are only accurate at the time 
of publication. Health Professionals should keep themselves up-to-date with changes in medical knowledge and technology 
that may influence their assessment of drivers, and with legislation that may affect the duties of the health professional or 
the driver. Therefore, neither the Road Safety Authority nor the National Office for Traffic Medicine nor the Royal College of 
Physicians of Ireland accept liability whatsoever arising from errors or omissions in the Guidelines. 
It is also emphasised that the majority of these Guidelines are for use as guidance only, and should be viewed in the context 
of appropriate Continuing Professional Development on the topic of medical fitness to drive, as well as referral for appropriate 
specialist advice. However, the legal basis for the Guidelines in general is provided for in regulations made under the Road 
Traffic Acts. The Road Traffic (Licensing of Drivers) Regulations 2006 (SI 537 of 2006) is the substantive legislative instrument 
underpinning the Guidelines. This has been amended and will continue to be amended as EU Directives update medical fitness 
rules. Medical fitness rules relating to diabetes, epilepsy, vision and obstructive sleep apnoea syndrome were developed 
on foot of recommendations from EU Specialist Working Groups and reflected in EU Directives 2009/113/EC and 2014/85/
EU. Doctors should be mindful that certain specific and detailed elements of the EU Directives have force of law by virtue 
of being incorporated into Irish regulations, particularly relating to diabetes, vision and epilepsy. These aspects are marked 
with an EU Symbol in the Guidelines.
9.  Rapoport MJ, Weegar K, Kadulina Y, Bédard M, Carr D, Charlton J, Dow J, Gillespie I, Hawley C. Koppel S, Molnar F, Murie-Fernandez M, Naglie G, O’Neill D, 
McCullagh S, Shortt S, Simpson C, Tuokko H, Vrkljan B, Marshall S. An international study of the quality of national-level guidelines on driving with medical 
illness. QJM. 2015 Nov; 108(11):859-69.
10.  Kahvedžic A, McFadden R, Cummins G, Carr D, O’Neill D. Impact of new guidelines and educational programme on awareness of medical ftness to driveamong 
general practitioners in Ireland. Traffc Inj Prev. 2015; 16(6):593-8.
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2.0 Roles and responsibilities
Table 1: Roles and responsibilities of drivers, health professionals and National Driver Licence Service
Driver
• To report to the National Driver Licence Service (NDLS) and their insurance provider any long-term or permanent 
injury or illness that may affect their ability to drive without elevated risk: if holding a licence from an EU country 
other than Ireland, or a recognised country for licence exchange, and developing a condition which could elevate 
risk of impairment while driving, the driver must contact the NDLS to arrange for an exchange of their licence.
• To respond truthfully to questions from the health professional regarding their health status and the likely impact 
on their driving ability.
• To adhere to prescribed medical treatment and monitor and manage their condition(s) and any adaptations 
with ongoing consideration of their fitness to drive.
• To comply with requirements of their licence as appropriate, including periodic medical reviews.
Health professional 
• To assess the person’s medical fitness to drive based on the current Sláinte agus Tiomáint medical standards.
• To advise the person regarding the impact of their medical condition or disability on their ability to drive and 
recommend restrictions and ongoing monitoring as required.
• To advise the person of their responsibility to report their condition to the NDLS if their long-term or permanent 
injury or illness may affect their ability to drive.
• To treat, monitor and manage the person’s condition with ongoing consideration of their fitness to drive.
• To report to the NDLS regarding a person’s fitness to drive in the exceptional circumstances where there is a risk 
to the public and the driver cannot or will not cease driving.
National Driver Licence Service (NDLS)
• To make all decisions regarding the licensing of drivers. The NDLS will consider reports provided by health 
professionals.
• To inform the driving public of their responsibility to report any long-term or permanent injury or illness to the 
NDLS if the condition may affect their ability to drive safely.
• Will act on reports of third parties, Gardaí, general public and healthcare workers regarding concerns of public 
safety relating to medical fitness to drive.
2.1 Roles and responsibilities of the NDLS
The responsibility for issuing, renewing, suspending, withdrawing, refusing or cancelling a person’s driving licence lies 
ultimately with the NDLS. Licensing decisions are based on a full consideration of relevant factors relating to the driver’s 
health and driving performance record. In making a licensing decision, the authority will seek input regarding a person’s 
medical fitness to drive, either directly from the driver and/or from a health professional by way of D501 Medical Report. 
Where appropriate, the NDLS will also consider unsolicited reports from health professionals or the police regarding 
a person’s fitness to drive. Payments for health examinations or assessments related to fitness to drive are not the 
responsibility of the NDLS.
An appeals mechanism is available for drivers who have been refused a licence on medical grounds. The NDLS will 
inform drivers of the appeals process when informing them of the licensing decision.
See for further details:
Email: medicalfitness@rsa.ie
Website: http://www.ndls.ie
Telephone: 1890 40 60 40
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2.2 Roles and responsibilities of drivers
A driver should advise the NDLS of any long-term or permanent injury or illness that may elevate risk of impairment 
while driving.
The legal basis for the Guidelines in general is provided for in regulations made under the Road Traffic Acts. The Road 
Traffic (Licensing of Drivers) Regulations 2006 (SI 537 of 2006) is the substantive legislative instrument underpinning 
the Guidelines. This has been amended and will continue to be amended as EU Directives update medical fitness rules. 
Medical fitness rules relating to diabetes, epilepsy, vision and obstructive sleep apnoea syndrome were developed 
on foot of recommendations from EU Specialist Working Groups and reflected in EU Directives 2009/113/EC and 
2014/85/EU. Doctors should be mindful that certain specific and detailed elements of the EU Directives have force 
of law by virtue of being incorporated into Irish regulations, particularly relating to diabetes, vision and epilepsy. 
These aspects are marked with an EU Symbol in the Guidelines.
At licence application and renewal, drivers complete a declaration regarding their health, including whether they have 
any relevant medical conditions from a list of 23 medical conditions. As advised on the Driving Licence Application form 
(D401), when the listed medical conditions are present the NDLS requests that a medical examination is required to confirm 
a driver’s fitness to hold a driver licence. In the case of medical examinations requested by the NDLS, drivers have a duty 
to declare their health status to the examining health professional. Drivers are also required to report to the NDLS when 
they become aware of a health condition that may affect their ability to drive safely.
A driver should not drive while medically unfit to do so and can be convicted of an offence for doing so. Under Sections 
32 and 48 of the Road Traffic Act 1961, drivers should be aware that there may be long-term financial, insurance and 
legal consequences where there is failure to report a medical condition that may impact on their ability to drive safely 
to the NDLS and insurance provider. Drivers must adhere to prescribed medical treatment and monitor and manage their 
condition(s) and any adaptations with ongoing consideration of their fitness to drive.
2.3 Roles and responsibilities of health professionals
Drivers rely on health professionals to advise them if a permanent or long-term injury or illness could elevate risk 
of impairment while driving, and whether it should be reported to the NDLS. The health professional has an ethical 
obligation, and potentially a legal one, to give clear advice to the driver in cases where an illness or injury may elevate 
risk of impairment while driving, and to maximise health and function so as to facilitate ease and driving safety. In the 
case of an incident illness which may affect driving ability, it is the responsibility of the healthcare professional attending 
the patient for the relevant care episode to advise the patient on medical fitness to drive.
There may be options other than complete cessation of driving where a driver presents with a particular condition, the 
NDLS are currently working on introducing a system where a restriction can be noted on a drivers “https://www.ndls.ie/
medical-reports.html” D501 Medical Report coded on the driving licence allowing for safer mobility.
Restrictions which may be indicated on the driver https://www.ndls.ie/medical-reports.html” D501 Medical Report 
will be:- 
• Needs driving to be restricted to certain types of vehicle
• Needs vehicle adaptation(s) fitted to the vehicle
• Limited to day-time driving (one hour after sunrise and one hour before sunset)
• Limited to journeys within a radius of 30km from place of residence
• Limited to a speed not greater than 80km
For full details of these restrictions, please visit the NDLS website: https://www.ndls.ie/medical-reports.htlm
Witnesses to dangerous driving can contact Traffic Watch lo-call number  
1890 205 805
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When what appears to be dangerous driving, possibly related to medical fitness to drive issues, is reported to a healthcare 
professional by a third party, it is a misguided kindness to pursue an exclusively medical approach. Dangerous driving is 
a hazard to the driver and other road users and is a statutory offence so people who witness dangerous driving should 
report it immediately to the Gardaí.  Unless witnessed by the healthcare professional directly, the onus for reporting lies 
with the person witnessing the alleged dangerous driving. The medical issues can be pursued at a later stage. 
Underlying the professional obligation to manage risk and fitness to drive, there is also a professional and moral obligation 
to recognise and support mobility through appropriate diagnosis, treatment and support, as the consequences of driving 
cessation can lead to serious health, mobility and quality of life concerns as well11.
2.3.1 Confidentiality, privacy and reporting to the NDLS
Health professionals have both an ethical and legal duty to maintain patient confidentiality. The ethical duty is generally 
expressed through codes issued by professional bodies. The legal duty is expressed through legislative and administrative 
means, and includes measures to protect personal information about a specific individual. The duty to protect confidentiality 
also applies to the NDLS. The patient–professional relationship is built on a foundation of trust. Patients disclose highly 
personal and sensitive information to health professionals because they trust that the information will remain confidential. 
If such trust is broken, many patients could either forego examination/treatment and/or modify the information they 
give to their health professional, thus placing their health at risk.
Although confidentiality is an essential component of the patient–professional relationship, there are, on rare occasions, 
ethically and/or legally justifiable reasons for breaching confidentiality. With respect to assessing and reporting fitness 
to drive, the duty to maintain confidentiality is legally qualified in certain circumstances in order to protect public safety. 
The Irish Medical Council Guidelines provide for breach of confidentiality if the driver represents a risk to the safety of 
others, refuses or cannot inform the NDLS, fails to stop or adapt driving appropriately, and is not amenable to appropriate 
persuasion and discussion. The health professional should consider reporting directly to the NDLS in situations where 
the driver is:
• Unable or unwilling to appreciate the impact of their condition which is impacting on their fitness to drive;  
and is 
• Unable or unwilling to take notice of the health professional’s recommendations; and
• Continues driving despite appropriate advice and is likely to endanger the public.
If the situation is urgent and rises outside of normal NDLS working hours and in the opinion of the health professional is 
likely to prove a significant threat to the public, consideration should be given to inform the Gardaí.
A positive duty is imposed on health professionals to notify the relevant authority in writing of a belief that a driver is 
physically or mentally unfit to drive, poses a risk to public safety and is not compliant with professional advice to stop 
driving. It is preferable that any action taken in the interests of public safety should be taken with the consent of the 
driver wherever possible and should certainly be undertaken with the driver’s knowledge of the intended action to the 
greatest extent possible. The driver should be fully informed as to why the information needs to be disclosed to the NDLS, 
and be given the opportunity to consider this information. Failure to inform the driver will only exacerbate the driver’s 
(and others’) mistrust in the patient–professional relationship.
It is recognised that there might be an occasion where the health professional feels that informing the driver of the 
disclosure may place the health professional at risk of violence. Under such circumstances, the health professional must 
consider how to appropriately manage such a situation. In making a decision to report directly to the NDLS, it may be 
useful for the health professional to consider:
• The seriousness of the situation (i.e. the immediate risks to public safety).
• The risks associated with disclosure without the individual’s consent or knowledge, balanced against the implications 
of non-disclosure.
• The health professional’s ethical and professional obligations.
• Whether the circumstances indicate a serious and imminent threat to the health, life or safety of any person.
11.  Oxley, J., & Whelan, M. (2008). It cannot be all about safety: the benefits of prolonged mobility. Traffic injury prevention, 9(4), 367-378
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Examinations requested by the NDLS 
When a driver presents for a medical examination at the request of the NDLS, the situation is different with respect to 
confidentiality. The driver will present with a form or letter from the NDLS, requesting an examination for the purposes of 
licence application or renewal. In the future the completed form will generally be returned by the driver to the NDLS, thus 
there is no risk of breaching confidentiality or privacy, provided only information relevant to the driver’s driving ability is 
included on the form, and a copy of the form/report should be retained by the assessing clinician.
Privacy legislation
All health professionals and the NDLS should be aware of data protection and other applicable legislation when collecting 
and managing patient information and when forwarding such information to third parties.
2.3.2 Patient–health professional relationship
It is expected that the health professional will be able to act objectively in assessing a patient’s fitness to drive. If this 
cannot be achieved, for example, where there may be the possibility of the patient ceasing contact or avoiding all medical 
management of their condition, health professionals should be prepared to disqualify themselves and refer their patient 
to another practitioner.
2.3.3 Adverse patient reaction towards the health professional
Sometimes patients feel affronted by the possibility of restrictions to their driving or withdrawal of their licence, and may 
be hostile towards their treating health professionals. In such circumstances, the health professional may elect to refer the 
driver to another practitioner or may refer them directly to the NDLS without a recommendation regarding fitness to drive 
with the former being the preference of the NDLS, as a completed D501 Medical Report is required in such cases to inform 
the licensing decision. The NDLS recognise that it is their role to enforce the laws on driver licensing and road safety and 
will not place pressure on health professionals that might needlessly expose them to risk of harassment or intimidation. 
In addition guidelines of the medical council on hostile and violent behaviour i.e. Guide to professional conduct and 
ethics for registered medical practitioners, s.14.1, should be considered. In addition, particularly for conditions such as 
dementia where insight may be reduced, helpful guides are available for the manner in which such conversations may be 
managed by doctors, families and patients from the Hartford Foundation At the Crossroads: Family Conversations about 
Alzheimer’s Disease, Dementia and Driving) and the Alzheimer Society of Ireland (Driving with Dementia).
2.3.4 Dealing with individuals that are not regular patients
Care should be taken when health professionals are dealing with drivers who are not regular patients. Some drivers may 
seek to deceive health professionals about their medical history and health status, and may ‘doctor shop’ for a desirable 
opinion. If a health professional has doubts about an individual’s reason for seeking a consultation, they should consider:
• Asking permission from the individual to request their medical file from their regular health professional.
• Conducting a more thorough examination of the individual than would usually be undertaken.
2.4 Role of the consultant including specialist occupational physician
In most circumstances, medical assessments of drivers can be conducted by a GP. However, if doubt exists about a patient’s 
fitness to drive or if the patient’s particular condition or circumstances are not covered specifically by the standards, 
review by a consultant experienced in the management of the particular condition is warranted and the GP should refer 
the patient to such a specialist.
If in doubt about the patient’s suitability to drive, referral to a further specialist and associated multi-disciplinary team 
(i.e. physiotherapy, occupational therapy, psychology, optometry) and/or on-road assessment with a driving assessor 
qualified to assess driving among those with disabilities may be of assistance. 
The consultant or specialist occupational physician  should advise the driver’s GP on the fitness to drive or otherwise 
relating to their specialist area of expertise. This would enable the GP to complete the D501 Medical Report based on 
their assessment of the overall health of the driver, as well as incorporating the specialist opinion.
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The D501 Medical Report is the form in general use for all medical conditions: the D502 Eyesight Report is used at original 
licence application, and if through medical or surgical intervention the driver’s vision improves to the point that corrective 
lenses, previously specified on a driving licence application, are no longer needed.
2.4.1 Documentation
Clear documentation of the assessment results and communication with the driver and NDLS is important, as well as 
maintenance of a record of decisions and advice given to the driver. The D501 Medical Reports or D502 Eyesight Reports 
are only accepted by NDLS if printed and signed as double-sided documents. The D501 Medical Report and D502 Eyesight 
Report forms are available for download at  “http://www.ndls.ie/ and  “http://www.rsa.ie/”. Where there is any doubt 
about how to complete the D501 Medical Report or D502 Eyesight Report forms please review the guide on our websites.
To aid the documentation of the assessment process, a discretionary but useful Driver Advisory Form is available on the 
RSA and NDLS website. This form provides written information that can be given to the patient and where used it is also 
advisable to keep this form on file.
3.0 General considerations for assessing fitness to drive
The aim of determining fitness to drive is to achieve a balance between minimising any driving-related road safety risks 
for the individual and the community posed by the driver’s permanent or long-term injury or illness, and maintaining 
the driver’s lifestyle and employment-related mobility independence. Indeed, for many conditions, remediation and 
rehabilitation may improve driver comfort and safety.
The following pages outline the general principles and considerations for assessing driver fitness. Also included in this 
section is a summary of the assessment process. These principles should be considered in conjunction with the specific 
standards outlined in Part B of this publication.
3.1 Considerations for Group 2 licensing
The assignment of medical standards for vehicle drivers is based on an evaluation of the driver, passenger and public 
safety risk, where risk equals likelihood of the event x severity of consequences. 
Group 2 vehicle crashes may present a severe threat to passengers, other road users (including pedestrians and cyclists) 
and residents adjacent to the road. Such crashes present potential threats in terms of weight and height, spillage of 
chemicals, fire and other significant property damage. 
Group 2 vehicle drivers generally spend considerable time on the road, thus increasing the likelihood of a motor vehicle 
crash. Crashes involving Group 1 drivers are likely to have less severe consequences. 
Therefore, to ensure that the risk to the public is similar for Group 1 and Group 2 vehicle drivers, the medical fitness 
requirements for the latter must be more stringent. This is required in order to reduce to a minimum the risk of crash due 
to long-term injuries or illnesses. The standards outlined in this publication reflect these differences. 
In developing the standards, a number of approaches have been adopted to manage the increased risk associated with 
driving a Group 2 vehicle. These approaches include:
• There are generally longer non-driving periods prescribed for Group 2 vehicle drivers compared with private vehicles, 
for example, after a seizure or heart attack.
• Some medical conditions may preclude a person from driving a Group 2 vehicle but they may still be eligible to hold 
a full or short period licence for 1-3 years for a Group 1 , for example, implanted cardiac defibrillator.
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Note:
In such cases, both sets of standards may need to be consulted. The standards are intended for application to drivers who 
drive within the ambit of ordinary road laws. Drivers who are permitted to exceed these laws, such as emergency service 
vehicle drivers, should have a risk assessment and an appropriate level of medical standard applied, as determined by 
the relevant occupational health service.
The review period for a short period licence for a Group 2 vehicle driver is 1, 3 or a maximum period of 5 years.
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of driving and other tasks encountered in the course of employment.
3.2 Requirements of the driving task
Consideration of the requirements of the driving task is fundamental to assessing a person’s medical fitness to drive. The 
driving task involves a complex and rapidly repeating cycle that requires a level of skill and the ability to interact with both 
the vehicle and the external environment at the same time. Information about the road environment is obtained via the 
visual and auditory senses. The information is operated on by many cognitive and behavioural processes including short 
and long-term memory and judgement, which leads to decisions being made about driving. Decisions are put into effect 
via the musculoskeletal system, which acts on the steering, gears and brakes to alter the vehicle in relation to the road.
The overall process is co-ordinated via a complex process involving behaviour, strategic and tactical abilities and personality12 
and adaptive strategies are important in maintaining the normal parameters of driving safety in the face of illness and 
disability13. This repeating sequence depends, among other elements, on:
• vision
• visuospatial perception
• hearing
• attention and concentration
• memory
• insight
• judgement
• adaptive strategies
• reaction time
• planning/organisation
• ability to self monitor
• sensation
• muscle power
• co-ordination
Given these requirements, it follows that many body systems need to be functional in order to ensure safe and timely 
execution of the skills required for driving.
12. Fuller R. Towards a general theory of driver behaviour. Accid Anal Prev 2005;37(3):461-72.
13. Langford J, Braitman K, Charlton J, Eberhard J, O’Neill D, Staplin L, Stutts J. TRB Workshop 2007: Licensing authorities’ options  
for managing older driver safety practical advice from the researchers. Traffic Inj Prev 2008;9(4):278-81.
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Table 2: Environmental factors affecting driving performance
Driving tasks occur within a dynamic system influenced by complex driver, vehicle, task, organisational and 
external road environment factors including:
• The driver’s experience, training and attitude.
• The driver’s physical, mental and emotional health, including fatigue and the effect of prescription and non 
prescription (over the counter) medicines.
• The driver’s insight, self-regulation of health and driving, and prudence
• The road system, for example, signs, other road users, traffic characteristics and road layout.
• Legal requirements, for example, speed limits and blood alcohol concentration.
• The natural environment, for example, night, extremes of weather and glare.
• Vehicle and equipment characteristics, for example type of vehicle, braking performance and maintenance.
• Personal requirements, trip purpose, destination, appointments, time pressures etc.
• Passengers and their potential to distract the driver.
• If the Group 2 driver is employed by a company, it may be helpful for the assessing doctor to ask the driver 
for a copy of the specifics of driving task and its nature and extent as identified and evaluated under his/her 
employer’s risk assessment process.
3.3 Medical conditions likely to affect fitness to drive
Given the many causal factors in motor vehicle crashes, the extent to which medical conditions contribute is difficult to 
assess. There is, however, recognition of the potential for certain conditions to cause serious impairments. 
In general, this can occur through three different pathways: 
• Suddenly disabling events
- i.e., syncope, epilepsy, ICDs…
• Physical constraints 
- i.e., Parkinsonism, hemiplegia, vision…
• Impairment of self-regulation
- i.e., imprudence, psychiatric illness, cognitive impairment…
And a driver may present with a condition or conditions relevant to these pathways due to conditions such as:
• blackouts
• cardiovascular diseases
• diabetes
• musculoskeletal conditions
• neurological conditions such as epilepsy, dementia and cognitive impairment due to other causes
• psychiatric conditions
• substance misuse/dependency
• sleep disorders
• vision problems
Treatments for medical conditions (including drug treatments and others) can also affect driving ability positively or 
negatively.
Drivers may present to treating health professionals with a range of conditions, some that affect driving temporarily, or 
may affect the driver’s ability to drive at some time in the future, or that are complicated by the presence of multiple 
conditions. The content of this publication focuses on common conditions known to affect fitness to drive and, in particular, 
on determining the risk of a driver’s involvement in a serious vehicle crash caused by loss of control of the vehicle.
It is accepted that other medical conditions or combinations of conditions may also be relevant and that it is not 
possible to define all clinical situations where an individual’s overall function would compromise public safety. A degree 
of professional judgement, with more extensive assessment or specialist opinion as required, is therefore required in 
assessing fitness to drive.
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Should a clinician require further assessment of a driver (for example, occupational therapy specialist opinion or
on-road assessment), the doctor in charge of their care should be able to advise the driver whether or not it is appropriate 
for them to continue to drive during the period until these further assessments have been completed. Drivers may be 
reminded that if they choose to ignore medical advice to cease driving, there could be consequences with respect to 
their insurance cover.
3.4 Temporary conditions
There is a wide range of conditions that temporarily affect the ability to drive safely. These include conditions such as 
post major surgery, severe migraine, or injuries to limbs. These conditions are self-limiting and hence do not impact 
on licence status; therefore, the NDLS need not be informed. However, the treating health professional should provide 
suitable advice to such driver’s regarding driving safely. Such advice should be based on consideration of the likely 
impact of the driver’s condition and their specific circumstances on the driving task as well as their specific driving 
requirements. Table 3 provides guidance on some common conditions that may temporarily impact on driving ability. 
Note: this publication does not attempt to address every condition or situation that might temporarily affect safe 
driving ability. For conditions not specifically mentioned relevant clinical specialist advice may need to be invoked. 
See following table for examples of management of temporary conditions.
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Condition and impact on driving
Anaesthesia
Physical and mental capacity may be impaired for some 
time post anaesthesia (including both general and local 
anaesthesia). The effects of general anaesthesia will 
depend on factors such as duration of anaesthesia, the 
drugs administered and the surgery performed. The effect 
of local anaesthesia will depend on dosage and the region 
of administration. The use of analgesics and sedatives 
should also be considered.
Post surgery
Surgery will impact on driving ability to varying degrees 
depending on the location, nature and extent of the 
procedure.
Pregnancy
Under normal circumstances pregnancy should not be 
considered a barrier to driving. However, conditions that 
may be associated with some pregnancies should be 
considered when advising drivers. These include:
• Fainting or light-headedness.
• Hyperemesis gravidarum.
• Hypertension of pregnancy.
• Post caesarean section.
Temporary or short-term vision impairments
A number of conditions and treatments may impair vision 
in the short term, for example, temporary patching of 
an eye, use of mydriatics or other drugs known to impair 
vision, or eye surgery. For long-term vision problems, refer 
to Part B, Chapter 7, Vision and eye disorders.
Deep vein thrombosis and pulmonary embolism 
While deep vein thrombosis may lead to an acute pulmonary 
embolus there is little evidence that such an event causes 
crashes. Therefore there is no licensing standard applied to 
either condition. Non-driving periods are advised.
Management guidelines
In cases of recovery following surgery or procedures under 
general or local anaesthesia, it is the responsibility of the 
surgeon/dentist and anaesthetist to advise drivers not 
to drive until physical and mental recovery is compatible 
with driving safety.
• Following minor procedures under local anaesthesia 
without sedation (e.g. dental block), driving may be 
acceptable immediately after the procedure.
• Following brief surgery or procedures with short- 
acting anaesthetic drugs, the driver may be fit to 
drive after a normal night’s sleep.
• After longer surgery or procedures requiring general 
anaesthesia, it may not be safe to drive for 24 hours 
or more.
The non-driving period post surgery should be determined 
by the treating health professionals.
A caution regarding driving may be required depending 
on the severity of symptoms and the expected effects 
of medication.
People whose vision is temporarily impaired by a short-
term eye condition or an eye treatment should be advised 
not to drive for an appropriate period.
The non-driving period after stable on anticoagulation 
should be determined by the treating health professionals. 
Table 3: Examples of management of temporary conditions
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3.5 Undifferentiated conditions
A driver may present with symptoms that could have implications for their licence status but the diagnosis is not clear. 
Investigation of the symptoms will mean there is a period of uncertainty before a definitive diagnosis is made and before 
the licensing requirements can be confidently applied.
Each situation will need to be assessed individually, with due consideration being given to the probability of a serious 
disease or long-term or permanent injury or illness that may affect driving, and to the circumstances in which driving is 
required. However, patients presenting with symptoms of a potentially serious nature, for example, chest pains, dizzy 
spells or black-outs, or delusional states should be advised not to drive until their condition can be adequately assessed. 
During this interim period, in the case of private vehicle drivers, no formal communication with the NDLS is required. After 
a diagnosis is firmly established and the standards applied, normal notification procedures apply, if needed. The health 
professional should consider the impact on the driver’s livelihood and investigate the condition as quickly as possible.
3.6 Multiple conditions and age-related change
Where a vehicle driver has multiple conditions or a condition that affects multiple body systems, there may be an additive 
or a compounding detrimental effect on driving abilities, for example, in:
• Congenital disabilities such as cerebral palsy, spina bifida and various syndromes.
• Multiple trauma causing orthopaedic and neurological injuries as well as psychiatric sequelae.
• Multi-system diseases such as diabetes, connective tissue disease and HIV.
• Dual diagnoses involving psychiatric illness and drug or alcohol addiction.
• Ageing-related changes in motor, cognitive and sensory abilities together with degenerative disease.
• Fatigue related to cancer and neurological conditions.
Although these medical standards are designed principally around individual conditions, clinical judgement is needed 
to integrate and consider the effects on safe driving of any medical conditions and disabilities that a driver may present 
with. For example, glaucoma may cause a slight loss of peripheral vision. If combined with cervical spondylosis and low 
insight, there is likely to be a substantial reduction in the driver’s visual fields and possibly their perceptual abilities, thus 
increasing the risks of missing important visual information when driving.
Advanced age, in itself, is not a barrier to driving, and older drivers in general have an admirable safety record14. Functional 
ability rather than chronological age should be the criterion used in assessing the fitness to drive of older people, although 
physicians should be mindful that multi- morbidity increases with age15. Age-related physical and mental changes vary 
greatly between individuals but will eventually affect the ability to drive safely. Professional judgement must determine 
what is acceptable decline (compensated by the driver’s long experience and self-imposed limitations on when and where 
they drive) and what is irreversible, hazardous deterioration in driving-related skills, requiring reporting to the NDLS. This 
may require careful consideration and specialist referral: options include specialist medical referral, occupational therapy 
assessment, and an on-road assessment.
As all possible combinations of disabilities are too numerous to detail here, the following guidelines provide a general 
approach to assessing these drivers:
The driving task: 
First, consider the ergonomics of the driving task. How might the various impairments (sensory, cognitive and 
musculoskeletal), disabilities and general fitness levels impact on function required to complete driving-related tasks?
General functionality:
Consider to what extent the person is currently able to function with regard to domestic or occupational requirements 
and what compensatory or coping strategies may have been developed. Information gained from relatives or carers is 
also likely to be important in this regard. Individuals may be likely to cope better with congenital or slow-onset conditions 
compared with traumatic or rapidly developing conditions.
14.     O’Neill D. Transport, driving and ageing. Reviews in Clinical Gerontology 2015;25(2):147-158.
15.    Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical educa-
tion: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43.
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Clinical assessment:
The key considerations are:
• Behaviour including risk-taking and prudence.
• Cognition (including attention, concentration, presence of hallucinations and delusions, insight, judgement, memory, 
problem-solving skills, thought processing and visuospatial skills).
• Motor function (including joint movements, strength and co-ordination).
• Sensory (in particular visual acuity and visual fields but also cutaneous, muscle and joint sensation).
It may be necessary for the health professional to consider medical standards for each condition. However, it is insufficient 
simply to apply the medical standards contained in this publication for each condition separately, as a driver may have 
several minor impairments that alone may not affect driving but when taken together may make risks associated with 
driving unacceptable. It will, therefore, be necessary to integrate all clinical information, bearing in mind the additive or 
compounding effect of each condition on the overall capacity of the driver to control the vehicle, and to act and react in 
an appropriate and timely way to emergent traffic and road conditions.
Capacity to learn to drive: 
Young people with multiple disabilities may seek the opportunity to gain a driving licence. In order to ensure they receive 
informed advice and reasonable opportunities for training, it is helpful if they are trained by a driving instructor with 
experience in the area of teaching drivers with disabilities.
Occupational therapy assessment:
A referral for an assessment by a generalist occupational therapist may be useful. It could request an evaluation of overall 
functioning (personal, mobility, community and work activities) as well as seek an opinion on general capacity for driving.
On-road driving assessment:
An on-road assessment may also be helpful.
The National Office for Traffic Medicine is currently working to develop guidelines for competencies and training for on-
road assessment based on the outline from the European PORTARE project. In the interim there a number of agencies and 
providers of on-road driving assessment outlined in the NOTM newsletter of July 2016 On-Road Driving Assessor Information 
although the NOTM cannot as yet endorse any particular provider of on-road assessments. Clinicians whose practice is 
likely to involve a significant number of on-road assessments should ideally develop a linkage with a specific provider or 
providers so as to allow for ready exchange of information and audit as indicated.
On-road driving assessment may be conducted by the on-road driving assessor in isolation, or may involve an OT as well 
in some cases if indicated. 
The final decision on medical certification rests with the referring doctor, who should make a synthesis based on all of the 
assessments: clinical, off-road and on-road assessments, as occasionally the clinical evidence (ie, an informant history of 
a consistent pattern of dangerous driving) may over-rule a single successful on-road assessment.
In light of the information given above, the health professional may advise the driver regarding their fitness to drive and 
provide advice to the NDLS. The key question is: Is there a likelihood the person will be unable to control the vehicle and 
act or react appropriately to the driving environment in a safe, consistent and timely manner?
Where one or more conditions are progressive, it may be important to reduce driving exposure and ensure ongoing monitoring 
of the driver. The requirement for periodic reviews can be included as recommendations. This is also important for drivers 
with conditions likely to be associated with future reductions in insight and self-regulation. If lack of insight may become 
an issue in the future, it is important to advise the driver to report the condition(s) to the NDLS.
A new driver licence Medical Report Form (D501) has been introduced where it will be possible to recommend a restricted 
licence in terms of daylight driving, driving within a specific distance from home, etc., and this may be a useful aid in 
maintaining safe driving.16.
16.    O’Byrne, C., A. Naughton, and D. O’Neill. “Is driver licensing restriction for age-related medical conditions an effective mechanism to improve driver safety 
without unduly impairing mobility?.” European Geriatric Medicine 2015;6(6):541-544.
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3.7 Progressive disorders
Often diagnoses of progressive disorders are made well before there is any need to question whether the driver remains 
safe to drive (e.g. multiple sclerosis). However, it is advantageous to raise issues relating to the likely effects of these 
disorders on personal independent mobility early in the management process so as to facilitate future planning, and 
possible eventual driving cessation and sourcing of alternative transportation.
In a mobile society, people frequently make choices about employment, place of residence and recreational and social 
activities based on the assumption of continued access to a car. Changing jobs, home and social contacts takes a great 
deal of time and places substantial emotional demands on drivers and their families.
It is, therefore, recommended that the driver be advised appropriately where a progressive condition is diagnosed that 
may result in future restrictions on driving. It is important to give the driver as much lead time as possible to make the 
lifestyle changes that may later be required. Assistance from an occupational therapist may be valuable in such instances.
3.8 Congenital conditions
People with congenital or childhood conditions may have developed coping strategies that enable safe driving despite their 
impairment. They will require individual assessment by a Specialist and may need tutoring prior to a practical assessment. 
While they may require specific vehicle modifications, if the condition is static they may not require periodic reviews.
3.9 Medications and driving
The definition of prescription medications for the purpose of these Guidelines is recommended as: Licensed medical 
product for human use requiring to be used in accordance with a prescription or medical product for human use 
requiring it to be used in accordance with prescription or medical or healthcarer (including pharmacist) advice.
Any medication that acts on the central nervous system has the potential to adversely affect driving skills.  Conversely, it is 
recognized  that many medications, such as medications for attention-deficit and hyperactivity disorder17, antiparkinsonian 
medications, anti-inflammatory agents and antidepressants, may actually make driving safer and more comfortable and 
due compliance is an important aspect of MFTD in such cases18.
Central nervous system depressants, for example, may reduce vigilance, increase reaction times and impair decision making 
in a very similar manner to alcohol. In addition, medications that affect behaviour may exaggerate adverse behavioural 
traits and introduce risk-taking behaviours. Group 2 drivers need to be mindful that such effects may be considered to be 
included in the Safety, Health and Welfare at Work Act (2005) s.13 (b) which stipulates that “employees must...ensure…
that he or she is not under the influence of an intoxicant to the extent that he or she is in such a state as to endanger his 
or her own safety, health or welfare at work or that of any other person.”
Acute impairment due to alcohol or drugs (including illicit, prescription and over-the-counter drugs) is managed through 
specific road safety legislation that prohibits driving over a certain blood alcohol concentration (BAC) or when impaired by 
drugs. This is a separate consideration to long-term medical fitness to drive and licensing, thus specific medical requirements 
are not provided in this publication. Dependency and substance misuse, including chronic misuse of prescription drugs, 
is a licensing issue and standards are outlined in Chapter 6. 
Where medication is relevant to the overall assessment of fitness to drive in the management of specific conditions, 
such as diabetes, epilepsy and psychiatric conditions, this is covered in the respective chapters. Prescribing doctors and 
pharmacists do however, need to be mindful of the potential effects of all prescribed and over-the-counter medicines and 
to advise drivers accordingly. General guidance is provided below.
17. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on 
driving performance. J Safety Res. 2007;38(1):113-28.
18.  Chang Z, Lichtenstein P, D’Onofrio BM, et al. Serious transport accidents in adults with  attention-deficit/hyperactivity disorder and the effect of medication a 
population-based study. JAMA Psychiatry 2014;71:319–25.
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3.9.1 General guidance for prescription medicine and driving
While many medicines have effects on the central nervous system most, with the exception of benzodiazepines, tend not to 
pose a significantly increased crash risk when the medicines are used as prescribed, and once the driver is stabilised on the 
treatment. This may also relate to drivers’ self-regulating their driving behaviour. When advising patients and considering 
their general fitness to drive, whether in the short or longer term, health professionals should consider the following:
• The balance between potential impairment due to the medicine and the driver’s improvement in health on safe 
driving ability.
• The individual response of the patient - some individuals are more affected than others.
• The type of licence held and the nature of the driving task, i.e. Group 2 vehicle driver assessments should be more 
stringent.
• The added risks of combining two or more medicines capable of causing impairment, including alcohol.
• The added risks of sleep deprivation on fatigue while driving, which is particularly relevant to Group 2 vehicle drivers.
• The potential impact of changing medications or changing dosage.
• The cumulative effects of medications.
• The presence of other medical conditions that may combine to adversely affect driving ability.
• Other factors that may exacerbate risks, such as known history of alcohol or drug misuse.
For individual medicinal products, the summary of product characteristics (SmPC) and patient information leaflet (PIL) 
may be a useful source of information on the impact of these products on driving safety. SmPCs and PILs can be found 
on the HPRA website: www.hpra.ie.
Liaison between prescribing doctors and pharmacists is encouraged in the consideration of advice given to drivers taking 
medications which may impact on driving safety. 
3.9.2 The effects of specific medicine classes
For the following psychoactive medications, the driver should be advised about concerns over sedation while initiating 
and changing treatment, and that driving should cease if such signs are noted: resumption should only recommence 
when such sedating side-effects have ceased. Helpful background information can be obtained from the deliberations of 
the EU-FP6 funded project “Driving under the Influence of Drugs, Alcohol and Medicines” (DRUID)19,20.
Benzodiazepines
Benzodiazepines, particularly long-acting benzodiazepines, increase the risk of a crash. In many of these studies, 
benzodiazepines were used without prescription, at supra-therapeutic doses,  or in combination with other impairing 
and/or illicit substances. If a hypnotic is needed, ashorter-acting medicine is preferred. Tolerance to the sedative effects 
of the longer-acting benzodiazepines used in the treatment of anxiety gradually reduces their adverse impact on driving 
skills. Particular caution should be exercised with Group 2 drivers and benzodiazepines21, avoiding benzodiazepines to the 
greatest extent possible, and if any doubt persists about their impact on driving, a second opinion from a psychiatrist or 
occupational physician should be sought.
Antidepressants
Although antidepressants are one of the more commonly detected drug groups in fatally injured drivers, this tends to 
reflect their wide use in the community. The ability to impair is greater with sedating tricyclic antidepressants, such as 
amitriptyline and dosulepin, than with less sedating serotonin reuptake inhibitors, such as fluoxetine and sertraline, and 
the mixed reuptake inhibitors. However, antidepressants can reduce the psychomotor and cognitive impairment caused 
by depression and return mood towards normal. This can improve driving performance.
Antipsychotics
This diverse class of drugs can improve performance if substantial psychotic-related cognitive deficits are present. However, 
most antipsychotics are sedating and have the potential to adversely affect driving skills through blockade of central 
dopaminergic and other receptors. Older drugs such as chlorpromazine are very sedating due to their additional actions 
on the cholinergic and histamine receptors. Some newer drugs are also sedating, such as clozapine, olanzapine and 
quetiapine, while others such as aripiprazole, risperidone and ziprasidone are less sedating. Sedation may be a particular 
problem early in treatment and at higher doses.
19. Rudisill TM, Zhu M, Kelley GA, Pilkerton C, Rudisill BR. Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review. 
Accid. Anal. Prev. 2016 Nov;96:255-70.
20. http://www.druid-project.eu/Druid/EN/deliverales-list/downloads/Deliverable_4_4_1.pdf?__blob=publicationFile&v=1.
21. Federal Motor Carrier Safety Administration. https://www.fmcsa.dot.gov/sitehttps://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/Medical-Expert-
Panel-Psychiatric-Psychiatric-MEP-Panel-Opin.pdf 
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Opioids
There is little direct evidence that opioid analgesics such as hydromorphone, morphine or oxycodone have direct adverse 
effects on driving behaviour22. Cognitive performance is reduced early in treatment, largely due to their sedative effects, 
but neuroadaptation is rapidly established. This means that drivers on a stable dose of an opioid may not have a higher 
risk of a crash. This includes drivers on buprenorphine and methadone for their opioid dependency, providing the dose 
has been stabilised over some weeks and they are not abusing other impairing drugs. Driving at night may be a problem 
due to the persistent miotic effects of these drugs reducing peripheral vision.
Medicinal Cannabis
The Health Products Regulatory Authority (successor to the Irish Medicines Board) authorised, in July 2014, by issue of a 
product license, an approved human medicine containing the active ingredients of cannabis which may be prescribed as 
treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS). 
The therapeutic indication is for patients with MS who have not responded adequately to other anti-spasticity medication 
and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy. 
Medicinal cannabis may impair judgment and performance of skilled tasks. Research however suggests that drivers adapted 
to their medicinal dose generally, but not always, maintain their driving ability23. Drivers should be advised about potential 
effects of the medication on their driving and also advised to self-monitor accordingly for any indications of impairment 
of driving particularly when they first start to take the medication and until they are established on a stable daily dose.
4.0 The legal basis for the medical standards
Since January 2013 the Road Safety Authority is the licensing authority with the responsibility of ensuring that all licence holders 
are fit to drive. The legal basis for the Guidelines in general is provided for in regulations made under the Road Traffic Acts. 
The Road Traffic (Licensing of Drivers) Regulations 2006 (SI 537 of 2006) is the substantive legislative instrument underpinning 
the Guidelines. This has been amended and will continue to be amended as EU Directives update medical fitness rules. 
National Driver Licence Service or NDLS, is the name given to the new, dedicated service which receives applications for 
learner permits and driver licences, see Table 4 below.
Table 4: Legal considerations for licensing
• NDLS processes following medical advice
 Driving licences are issued or maintained by the NDLS on the basis that the driver has not been advised to cease 
driving by a doctor or healthcare professional on the basis of clinical assessment and the advice contained within 
these Guidelines. Should a driver be advised to cease driving by a doctor or healthcare professional on the basis 
of clinical assessment and the advice contained within these Guidelines, he/she should inform the NDLS if so 
indicated in these Guidelines. It is then a matter for the NDLS to take appropriate action.
• Appeals
 Decisions about the granting of a driving licence are a matter for the NDLS and arrangements concerning the 
review or appeal against such decisions should be taken up with the NDLS.
• Age limits
 Group1 Licences are normally issued for a 10 year period subject to expiry at age 70 years, unless restricted to a 
shorter duration for medical reasons. There is no upper limit but after age 70 renewal is necessary every 3 years, 
or every year if medical assessment so indicates. All licence applications after 70 currently require a medical 
report furnished by the applicant. Group 2 licences are issued for a maximum of 5 years up to the age of 70.
• Garda/Army driver licensing
 Responsibility for determining the standards, including medical requirements, to be applied to Garda/Army 
vehicle drivers, rests with the Garda Commissioner/Army Director of Services.
• Taxi drivers
 The provision of driving licences for small public service vehicles is the responsibility of An Garda Síochána. 
Responsibility for determining the standards, including medical requirements, to be applied to taxi drivers, 
over and above the Group 1 driving licence requirements, rests with the National Transport Authority, who are 
required to consult with the Garda Commissioner in relation to such proposals.
22. Mailis-Gagnon A, Lakha SF, Furlan A, Nicholson K, Yegneswaran B, Sabatowski R. Systematic review of the quality and generalizability of studies on the effect-
sof opioids on driving and cognitive/psychomotor performance. Clin J Pain. 2012 Jul;28(6):542-55.
23. Freidel, M, Tiel-Wilck, K., Schreiber, H., Prechtl, A., Essner, U. & Lang, M. Drug-resitant MS spacticity treatment with Sativex (®) add-on and driving ability. Acta 
Neurol Scand. 2015 Jan;131(1):9-16. doi: 10.1111/ane.12287. 
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Part B: Medical fitness to drive  
Chapter 2
Neurological disorders24
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of the driving tasks encountered in the course of employment.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Epilepsy
Epileptic attacks are the most 
frequent medical cause of 
collapse at the wheel.
N.B. If within a 24 hour period 
more than one epileptic attack 
occurs, these are treated as a 
“single event” for the purpose of 
applying the epilepsy standards. 
Epilepsy includes all events: 
major, minor and auras.
The epilepsy standards apply. 
Provided a licence holder/
applicant is able to satisfy the 
standards, a 3 year licence 
will be issued normally by the 
NDLS. Before age 70 a person 
must be seizure-free for 5 
years to qualify for a 10 year 
licence in the absence of any 
other disqualifying condition. 
Fit to drive if seizure-free for 
5 years since the last attack, 
with medication if necessary 
in the absence of any other 
disqualifying condition. 
(See appendix to this chapter  
for full standards). 
Driver must notify NDLS.
Standards require a driver to remain 
seizure-free for 10 years since the 
last attack without antiepileptic 
medication.
The applicant should:
• be without anti-epileptic 
medication for the required 
period of seizure freedom. 
• have appropriate medical 
follow-up completed. 
• after extensive neurological 
investigation, have no 
relevant cerebral pathology 
established and there is no 
epileptiform activity on the 
electroencephalogram (EEG). 
• have an EEG and an appropriate 
neurological assessment should 
be performed after the acute 
episode. 
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
24. Helpful recent reviews include: Devlin, A, et al. (2012). Epilepsy and driving: Current status of research. Epilepsy Research, 102, 135— 152.  
Classen, S., et al., (2009). Traumatic brain injury and driving assessment: an evidence-based literature review [Review]. American Journal of Occupational 
Therapy, 63(5), 580-591.Klimkeit, E.I, et al., (2009). Driving ability in Parkinson’s Disease: Current status of research. Neuroscience & Biobehavioral Reviews, 33, 
223-231.Breen DA, Breen DP, Moore JW, Breen PA, O’Neill D. Driving and dementia. BMJ 2007 Jun 30;334(7608):1365-9.Peeters SY, Hoek AE, Mollink SM, Huff JS. 
Syncope: risk stratification andclinical decision making. Emerg Med Pract. 2014 Apr;16(4):1-22
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
First unprovoked seizure 6 months off driving from 
the date of the seizure unless 
there are clinical factors or 
investigation results which, 
in the opinion of the treating 
consultant suggest an 
unacceptably high risk of a 
further seizure, i.e. 20% or 
greater per annum.
Driver must notify NDLS.
5 years off driving from the date of 
the seizure if the licence holder has 
undergone recent assessment by a 
neurologist and there are no clinical 
factors or investigation results (e.g. 
EEG, brain scan) which indicate 
that the risk of a further seizure is 
greater than 2% per annum. They 
should have taken no antiepileptic 
medication throughout the 5 year 
period immediately prior to the 
granting of the licence.
Driver must notify NDLS.
If risk of further seizure is greater 
than 2% per annum Group 2 
epilepsy standards apply.
The following features are consistent with a person having a good prognosis:
• No relevant structural abnormality of the brain on imaging;
• No definite epileptiform activity on EEG;
• Clinical evaluation of the neurologist;
• Seizure risk considered to be 2% or less per annum for Group 2 licensing and 20% or less per annum for 
ordinary driving licensing.
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Epilepsy/epileptic seizures
General guidance for all 
neurosurgical conditions if 
associated with epilepsy or 
epileptic seizures.
In all cases where epilepsy has 
been diagnosed, the epilepsy 
standards apply. These cases will 
include all cases of single seizure 
where a primary cerebral cause 
is present and the liability to 
recurrence cannot be excluded. 
An exception may be made when 
seizures occur at the time of an 
acute head injury or intracranial 
surgery. 
When seizures occur at the 
time of intracranial venous 
thrombosis, 6 months is 
required, free from attacks, 
before resuming driving.
Driver must notify NDLS.
In all cases where a “liability to 
epileptic seizures” either primary or 
secondary has been diagnosed, the 
specific epilepsy standard for this 
group applies. The only exception 
is a seizure occurring immediately 
at the time of an acute head injury 
or intracranial surgery, and not 
thereafter and/or where no liability 
to seizure has been demonstrated. 
Following head injury or intracranial 
surgery, the risk of seizure must 
have fallen to no greater than 2% 
per annum before returning to 
Group 2 driving.
Driver must notify NDLS.
Withdrawal of antiepileptic 
medication and driving
(See Appendix to this chapter  
for full standards).
Standards require a driver to remain 
seizure-free for 10 years since the 
last attack without antiepileptic 
medication.
(See epilepsy standards).
Provoked seizures 
(Apart from alcohol or  
illicit drug misuse)
(See Appendix to this chapter  
for full standards).
Standards require a driver to remain 
seizure-free for 10 years since the 
last attack without antiepileptic 
medication.
(See epilepsy standards).
Non Epileptic seizure attacks Can be considered once 
attacks have been satisfactorily 
controlled and there are no 
relevant mental health issues.
Can be considered once attacks have 
been satisfactorily controlled and 
there are no relevant mental health 
issues.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
1. Reflex Vasovagal Syncope 
Definite provocational factors 
with associated prodromal 
symptoms and which are 
unlikely to occur whilst sitting or 
lying. Benign in nature.
No driving restrictions. No driving restrictions.
If recurrent, will need to 
check the “3 Ps” apply on 
each occasion (provocation/
prodrome/postural). 
(If not see Number 6 below).
NDLS need not be informed. NDLS need not be notified.
N.B. Cough Syncope see Chapter 9
2. Solitary loss of consciousness/
loss of or altered awareness 
likely to be unexplained syncope 
but with a high probability of 
reflex vasovagal syncope.
These have no clinical evidence 
of structural heart disease and a 
normal ECG.
No driving restrictions.
NDLS need not be informed.
Can drive 3 months after the event if 
no further recurrence.
N.B. Cough Syncope see Chapter 9
See Appendix at end of this chapter for epilepsy standards.
Loss of consciousness/loss of or altered awareness25
Excluding Cough Syncope (See Chapter 9)
 
A full history is imperative to include pre-morbid history, prodromal symptoms, period of time unconscious, degree of 
amnesia and confusion on recovery. A neurological cause, for example, epilepsy, subarachnoid haemorrhage, can often 
be identified by the history, examination and the appropriate referral made. The relevant Sláinte agus Tiomáint guidelines 
will then apply. In 80% of all cases there is a cardiovascular cause and again, these can also be determined by history, 
examination and ECG. Investigate and treat accordingly and use the relevant Sláinte agus Tiomáint guidelines.
The remaining cases can be classified under five categories in the following table:
25. Guzman JC, Morillo CA. Syncope and Driving. Cardiol Clin. 2015, Aug;33(3):465-71.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
3. Solitary loss of consciousness/ 
loss of or altered awareness 
likely to be cardiovascular in 
origin (Excluding 1 or 2 directly 
preceding).
Factors indicating high risk: 
A. Abnormal ECG.
B. Clinical evidence of 
structural heart disease.
C. Syncope causing injury, 
occurring at the wheel or 
whilst sitting or lying.
D. More than one episode in 
previous 6 months.
Further investigations such 
as ambulatory ECG (48hrs), 
echocardiography and exercise 
testing may be indicated after 
consultant opinion has been 
sought.
**For Pacemakers see Chapter 3
No driving for 6 months if no 
cause identified.
Can drive 4 weeks after 
the event if the cause has 
been identified and treated 
satisfactorily.
Driver must notify NDLS.
No driving for 12 months if no cause 
identified.
Can drive 3 months after the event 
if the cause has been identified and 
treated satisfactorily.
Driver must notify NDLS.
4. Solitary loss of consciousness/
loss of or altered awareness 
with seizure markers.
This category is for those 
where there is a strong clinical 
suspicion of a seizure but no 
definite evidence.
Factors to be considered:
• Without reliable prodromal 
symptoms.
• Unconsciousness for more 
than 5 minutes.
• Amnesia longer than 5 
minutes.
• Injury.
• Tongue biting.
• Incontinence.
• Remain conscious but with 
confused behavior.
• Headache post attack.
6 months off driving from the 
date of an episode of loss of 
consciousness/loss of or altered 
awareness. However, if a person 
has a previous history of epilepsy 
or a solitary seizure, 12 months’ 
freedom from any further 
episode of loss of consciousness 
with seizure markers must be 
attained.
If a person suffers recurrent 
episodes of loss of consciousness 
with seizure markers, 12 
months’ freedom from such 
episodes must be attained.
Driver must notify NDLS.
5 years off driving from the date 
of an episode if the licence holder 
has undergone assessment by an 
appropriate consultant and no 
relevant abnormality has been 
identified on investigation, for 
example EEG and brain scan, where 
indicated.
Driver must notify NDLS.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
5. Solitary loss of consciousness/
loss of or altered awareness 
with no clinical pointers.
This category will have had 
appropriate neurological 
and cardiac opinion and 
investigations but with no 
abnormality detected.
No driving for 6 months.
Driver must notify NDLS.
No driving for 1 year if no further 
recurrence.
Driver must notify NDLS.
6. Two or more episodes of 
loss of consciousness/loss of 
or altered awareness without 
reliable prodromal symptoms.
No driving for 12 months or until 
the risk has been reduced to 
< 20% per annum.
Driver must notify NDLS.
No driving for 5 years 
or until the risk has been reduced to 
< 2% per annum. 
Driver must notify NDLS.
Primary/Central Hypersomnias
Including Narcoleptic syndromes
Cease driving on diagnosis.
Fit to drive when there has 
been a period of between 3 and 
6 months satisfactory control 
of symptoms with appropriate 
treatment. If not requiring 
treatment, relicensing may be 
considered after satisfactory 
objective assessment of 
maintained wakefulness, such as 
the Osler test26.    
Driver must notify NDLS if 
driving cessation is going to be 6 
months or greater.
Cease driving on diagnosis. 
Fit to drive subject to consultant 
assessment and a satisfactory 
objective assessment of 
maintained wakefulness. 
Driver must notify NDLS if driving 
cessation is going to be 6 months or 
greater.
See Appendix at end of this chapter for epilepsy standards.
26. Pizza F, Jaussent I, Lopez R, Pesenti C, Plazzi G, Drouot X, Leu-Semenescu S, Beziat S, Arnulf I, Dauvilliers Y. Car Crashes and Central Disorders of 
Hypersomnolence: A French Study. PLoS One. 2015 Jun 8;10(6):e0129386.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Neurological Disorders
E.g. Multiple sclerosis, motor 
neurone disease, myopathy etc., 
which may affect vehicle control 
because of impairment of co-
ordination and muscle power.
See section: Drivers with 
disabilities, Chapter 10.
Providing medical assessment 
confirms that driving 
performance is not impaired, 
can drive. 
1 or 3 year licence may be 
advised. Should the driver 
require a restriction to certain 
controls, the law requires this to 
be specified on the licence. Due 
consideration should be given to 
functional status, rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment.
Driver must notify NDLS.
May not drive if condition is 
progressive or disabling. If driving 
would not be impaired and 
condition stable, can be considered 
for licensing subject to satisfactory 
consultant assessment and annual 
review.
Driver must notify NDLS.
Parkinson’s disease and other 
forms of Parkinsonism 
Should not drive if condition or 
functional status is sufficiently 
impaired so as to impair driving 
safety and/or there is clinically 
significant variability in motor 
function. Due consideration 
should be given to medication 
review (with due attention 
to tendency to drowsiness/ 
sleepiness), rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. If driving safety not 
impaired, can continue driving 
subject to satisfactory reports. 
Fitness to drive is subject to 
regular review.
Driver must notify NDLS.
Should not drive if condition is 
disabling and/or there is clinically 
significant variability in motor 
function. If driving would not be 
impaired, can be considered for 
licensing subject to individual 
assessment by a consultant.
Licence may be issued subject to 
annual review.
Driver must notify NDLS.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Liability to sudden attacks of 
unprovoked or
unprecipitated disabling 
dizziness or vestibular symptoms
Cease driving on diagnosis. 
Driving will be permitted 
when satisfactory control of 
symptoms achieved. If remains 
asymptomatic a 10 year licence 
or if over 60 a licence expiring 
at age 70, can be issued. After 
age 70 a one or 3 year licence, 
subject to medical report, can 
be issued.
Driver must notify NDLS.
Cease driving on diagnosis.  
Consider underlying diagnosis 
and if likely to cause recurrent 
attacks, must be symptom- free and 
completely controlled for 1 year 
from last attack before resuming.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Stroke/TIA TIA
NO need to notify NDLS.
Must not drive for 4 weeks.
Stroke
Must not drive for 4 weeks. 
May resume driving after this 
period if the clinical recovery is 
satisfactory. There is no need 
to notify NDLS unless there is 
significant residual neurological 
deficit 4 weeks after the episode; 
of particular importance are 
visual field defects, cognitive 
defects including visual neglect 
and inattention and impaired 
limb function. Minor limb 
weakness alone will not require 
notification unless restriction 
to certain types of vehicle or 
vehicles with adapted controls 
is needed. Due consideration 
should be given to risk of 
reoccurrence, rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment.
Seizures occurring at the time 
of a stroke/TIA or in the ensuing 
24 hours may be treated as 
provoked for licensing purposes 
in the absence of any previous 
seizure history or previous 
cerebral pathology. 
TIA
Must not drive for at least 3 months 
following a TIA. 
Stroke
Must not drive for at least 3 months 
following a stroke.
Further driving requires annual 
medical review:
May drive after at least 3 months 
and subject to at least annual review 
taking into account:
• the nature of the driving task 
(e.g. petrol tanker v light van).
• information provided by an 
appropriate consultant regarding 
the level of impairment of any 
of the following: visuospatial 
perception, insight, judgement, 
attention, reaction time, 
memory, sensation, muscle 
power, coordination, vision 
(including visual fields) and the 
likely impact on driving ability.
• the results of a practical driver 
assessment if required. 
• the risk of recurrence.
• if intra-cerebral haemorrhage, 
that the risk of seizure is 2% or 
less per annum, as judged by 
competent specialist. 
Mild Cognitive Impairment (MCI)
 Or Dementia or any Organic
Brain Syndrome
See Chapter 5, Psychiatric 
disorders.
See Chapter 5, Psychiatric disorders.
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Acute Encephalitic Illnesses 
Including Limbic Encephalitis 
associated with seizures.
1. If no seizure(s), may resume 
driving when clinical 
recovery is complete. (The 
Driver must notify NDLS only 
if there is significant residual 
disability).
2. If associated with seizures 
during acute febrile illness, 
no driving for 6 months from 
the date of seizure(s). Driver 
must notify NDLS.
3. If associated with any 
seizure(s) early or late during 
or after convalescence, will 
be required to meet current 
epilepsy standards.
1. As for Group 1 provided no 
residual disabling symptoms, 
and clinical recovery is complete 
as assessed by a neurologist. 
(The Driver must notify NDLS 
only if there is significant 
residual disability).
2. If associated with seizures 
during acute febrile illness  
must stop driving and Driver 
must notify NDLS.
(a) Encephalitis – there have been 
no further seizures for at 
least 12 months without use 
of antiepileptic medication 
assessment by neurologist 
required.
3.  If associated with any seizure(s) 
early or late during or after 
convalescence, must stop 
driving, driver must notify NDLS 
and meet current epilepsy 
standards before driving 
resumes.
See Appendix to this Chapter  
for full standards.
Transient Global Amnesia Provided epilepsy, any sequelae 
from head injury and other 
causes of altered awareness 
have been excluded, no 
restriction on driving. 
NDLS need not be notified. 
A single confirmed episode does not 
require cessation of driving. If two or 
more episodes occur, driving should 
cease and Driver must notify NDLS. 
Consultant assessment required to 
exclude all other causes of acute 
transient memory loss.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Arachnoid Cysts
Asymptomatic and untreated.
No restriction. No restriction.
Colloid Cysts
Asymptomatic and untreated.
No restriction. No restriction unless prescribed 
prophylactic medication for seizures 
when there should be individual 
assessment.
Driver must notify NDLS.
Craniotomy and/or  
Endoscopic Treatment.
6 months off driving.
Driver must notify NDLS.
Can drive 2 years after treatment, 
provided that there is no debarring 
residual impairment likely to affect 
driving safety.
Driver must notify NDLS.
Pituitary Tumour Provided no visual field defect.
If visual field loss:-
See section: Visual Disorders 
Chapter 7.
Provided no visual field defect 
If visual field loss:-
See section: Visual Disorders  
Chapter 7.
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Craniotomy 6 months off driving.
Driver must notify NDLS.
2 years off driving.
Driver must notify NDLS.
Transphenoidal surgery/ 
other treatment 
(E.g. Drugs, Radiotherapy) or 
Untreated
Drive on recovery. Can drive when there is no debarring 
residual impairment likely to affect 
driving safety.
Benign Supratentorial Tumour
E.g. WHO Grade 1 Meningiomas 
Treatment by Craniotomy 6 months off driving when there 
is no debarring 
residual impairment likely to 
affect safe driving. 
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s).
Not fit to drive. 
In the absence of any seizures, 
a short period licence can be 
considered 5 years after surgery, 
with evidence of complete removal. 
If tumour is associated with 
seizures, 10 years freedom from 
seizures without antiepileptic drugs 
following surgery and consultant 
assessment is required.
Driver must notify NDLS.
Treatment with  
Stereotactic Radiosurgery 
4 weeks off driving; thereafter 
can drive when there is no 
debarring residual impairment 
likely to affect driving safety. 
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s).
3 years after the completion of the 
primary treatment of the tumour the 
driver can be considered fit to drive, 
provided that there is evidence 
on imaging of stability. If tumour 
association with seizure(s), 10 years’ 
freedom from seizures without 
antiepileptic drugs following surgery 
and consultant assessment is 
required.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
Sláinte agus Tiomáint  |  Medical Fitness To Drive Guidelines  |  (Group 1 and Group 2 Drivers)    29 
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Treatment with  
Fractionated Radiotherapy
Can drive on completion of 
treatment, provided that 
there is no debarring residual 
impairment likely to affect safe 
driving. 
Epilepsy standards apply if 
relevant history of seizure(s).
3 years after the completion of the 
primary treatment of the tumour the 
driver can be considered fit to drive, 
provided that there is evidence 
on imaging of stability. If tumour 
association with seizure(s), 10 years’ 
freedom from seizures without 
antiepileptic drugs following surgery 
and consultant assessment is 
required.
Driver must notify NDLS.
WHO Grade II Meningiomas 
treated by Craniotomy  
and/or Radiosurgery and/or 
Radiotherapy
Requires 1 year off driving, 
dating from the completion of 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s). 
Not fit to drive. 
Driver must notify NDLS. 
In the absence of any seizures, 
return to driving can considered 5 
years after surgery, with evidence 
of complete removal. If tumour is 
associated with seizure(s), 10 years 
freedom from seizures without 
antiepileptic drugs following surgery 
is required. Consultant assessment 
may be required.
Asymptomatic, incidental 
meningiomas: Untreated
Continue driving. Requires cessation of driving until 
two scans 12 months apart showing 
no growth. If growth, consultant 
assessment with 1 year short period 
licence and review.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Benign Infratentorial Tumours 
E.g. Meningioma with surgery 
by craniotomy with or without 
radiotherapy.
Drive on recovery. As for Group 1 provided that there 
is no debarring residual impairment 
likely to affect driving safety.
Acoustic Neuroma/Schwannoma Need not notify NDLS unless 
sudden and disabling vestibular 
symptoms.
Need not notify NDLS unless 
accompanied by disabling vestibular 
symptoms and/or the condition is 
bilateral.
Malignant Tumours (including 
metastatic deposits) 
and Gliomas
Supratentorial 
Gliomas Grades I and II 
1 year off driving, from time 
of completion of the primary 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety. 
Driver must notify NDLS.
Not fit to drive. (Pineocytoma, Grade 
I, can be considered on an individual 
basis 2 years post primary treatment 
if satisfactory MRI). 
Driver must notify NDLS.
WHO Grade III Meningioma 2 years off driving from time 
of completion of primary 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive. (Pineocytoma, Grade 
I, can be considered on an individual 
basis 2 years post primary treatment 
if satisfactory MRI). 
Driver must notify NDLS.
Gliomas Grade III and IV and 
Metastatic Deposit(s).
At least 2 years off driving from 
time of completion of primary 
treatment;thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Solitary Metastatic Deposit If totally excised, can be 
considered for recommending 1 
year licence after completion of 
primary treatment if free from 
recurrence and no evidence of 
secondary spread elsewhere in 
the body; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
Infratentorial Tumours
Gliomas Grade I 
As for benign tumours: i.e. drive 
on recovery.
Individual assessment. 
Gliomas Grade II, III & IV As for Supratentorial tumour. Not fit to drive.
Driver must notify NDLS.
Medulloblastoma or Low Grade 
Ependymoma
If totally excised, can be 
considered for 1 year licence 
after primary treatment, if free 
from recurrence.
If entirely infratentorial, may be 
considered for driving when disease-
free for 5 years after treatment.
High Grade Ependymomas,  
Other Primary Malignant  
Brain Tumours and Primary CNS 
Lymphomas
Normally, a period of 2 years 
off driving is required following 
treatment.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
Metastatic deposits Can be considered for driving 
on a 1 year licence after 
completion of primary treatment 
if otherwise well.
Driver must notify NDLS.
May drive 5 years from the date of 
completion of the primary treatment 
if asymptomatic and subject to 
annual consultant review.
Driver must notify NDLS.
Malignant Intracranial Tumours 
in children who survive to adult 
life without recurrence
Normally, till 70 licence is 
issued/maintained.
Individual assessment: see above as 
for “Benign Supratentorial Tumour”.
When a low grade glioma is an incidental finding and asymptomatic, the case may be considered on an 
individual basis for Group 1.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Traumatic brain injury Usually requires 6-12 months 
off driving depending on 
features such as seizures, post-
traumatic amnesia, dural tear, 
haematoma and contusions. 
There will need to have been 
a satisfactory clinical recovery 
and in particular no visual 
field defect, or cognitive or 
behavioural impairment likely 
to affect driving safety. Due 
consideration should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment.
Driver must notify NDLS.
Not fit to drive if the person has had 
head injury producing significant 
impairment of any of the following: 
visuospatial perception, insight, 
judgement, attention, reaction time, 
memory, sensation, muscle power, 
coordination, vision (including visual 
fields).
May be able to return to driving when 
the risk of seizure has fallen to no 
greater than 2% per annum, and with 
no debarring residual impairment 
likely to affect driving safety.
Periodic review is not required if the 
condition is static.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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car, motorcycle and tractor
Group 2 Entitlement ODL
Spontaneous Acute Subdural 
Haematoma
(Treated by Craniotomy)
6 months off driving if no 
significant residual disability. 
If significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. 
Driver must notify NDLS.
At least 6 months off driving, 
with an individual assessment by 
consultant as to fitness to return to 
driving.
Driver must notify NDLS.
Chronic Subdural Haematoma
(Treated surgically)
Resume driving on recovery if 
no significant residual disability. 
If significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, overcome, 
relevant cognitive and physical 
impairment.
Driver must notify NDLS.
6 months –1 year off driving, with an 
individual assessment by consultant 
as to fitness to return to driving.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Subarachnoid Haemorrhage 
1. No cause found
Provided comprehensive 
cerebral angiography normal, 
may resume driving following 
recovery if no significant 
residual disability. If significant 
residual disability, due 
consideration should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment.
Driver must notify NDLS.
Continued on next page
Provided comprehensive cerebral 
angiography normal, 6 months off 
driving and may regain licence if no 
debarring residual impairment likely 
to affect driving safety.
Driver must notify NDLS.
Continued on next page
See Appendix at end of this chapter for epilepsy standards.
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Modified Rankin Scale (mRS)
Neurological 
Disorders
Group 1 Entitlement ODL car, 
motorcycle and tractor
Group 2 Entitlement ODL
Craniotomy Non 
Middle Cerebral 
Artery Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
12 months off 
driving.
mRS 2 or > at 2 
months 24 months 
off driving, there 
should be no residual 
impairment likely to 
affect driving.
Craniotomy Middle 
Cerebral Artery 
Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
24 months off 
driving.
mRS 2 or > at 2 
months. Refusal or 
Revocation. See* 
below.
Endovascular 
Treatment Non 
Middle Cerebral 
Artery Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
6 months off driving
mRS 2 or > at 2 
months 24 months 
off driving, there 
should be no residual 
impairment likely to 
affect driving.
Endovascular 
Treatment Middle 
Cerebral Artery 
Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
24 months off 
driving.
mRS 2 or > at 2 
months Refusal or 
Revocation. See* 
below.
* Consultant assessment required, seizure risk should be 2% per annum or less and there should be no residual 
impairment likely to affect driving.
Subarachnoid Haemorrhage 
2A. Associated with Intracranial Aneurysm
N.B. If any other procedure is undertaken e.g. V.P. shunt, craniotomy for a haematoma etc. then the standards for that 
procedure shall apply.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Subarachnoid Haemorrhage 
2B. No Treatment 
i.e. Aneurysm responsible for 
SAH but no intervention. 
6 months off driving. Not fit to drive.
Subarachnoid Haemorrhage 
2C. Truly Incidental Findings of 
Intracranial Aneurysm (aneurysm 
has not been responsible for 
subarachnoid haemorrhage) 
No Treatment
Drive on clinical recovery. To be acceptable for licensing, 
anterior circulation aneurysms 
(excluding cavernous carotid) must 
be < 13mm in diameter. Posterior 
circulation aneurysms must be < 
7mm diameter.
Surgery Craniotomy Drive on clinical recovery. 1 year off driving. 
Endovascular Treatment Drive on clinical recovery. Cease driving until clinical recovery 
unless there are complications from 
the procedure as determined by 
treating consultant.
N.B. The above is independent of the 
standard for ruptured aneurysm in 
section 2A.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Arteriovenous Malformation
N.B. If any other procedure is undertaken e.g. V.P. shunt, craniotomy for a haematoma etc. then the standards for 
that procedure shall apply. 
Arteriovenous Malformation Supratemtorial AVMS
Intracerebral Haemorrhage due to Supratemtorial AVM
A. Craniotomy 6 months off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving. If 
significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. 
Driver must notify NDLS.
Requires cessation of driving until 
lesion is completely removed or 
ablated and 10 years seizure-free 
from last definitive treatment. 
There must be no debarring residual 
impairment likely to affect driving.
Driver must notify NDLS.
B. Other treatment (embolisation 
or stereotactic radiotherapy)
4 weeks off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving.
Requires cessation of driving until 
lesion is completely removed or 
ablated and 10 years seizure-free 
from last definitive treatment. 
There must be no debarring residual 
impairment likely to affect driving.
Driver must notify NDLS.
C. No treatment 4 weeks off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Incidental finding of a supratentorial AVM
(no history of intracranial bleed)
A. No treatment No restriction. Not fit to drive.
Driver must notify NDLS.
B. Surgical or other treatment See above: as for AVM with 
Intracranial Haemorrhage.
Not fit to drive until lesion is 
completely removed or ablated 
and 10 years seizure-free from last 
definitive treatment. There must be 
no debarring residual impairment 
likely to affect driving.
Driver must notify NDLS.
Infratentorial AVMs Intracranial haemorrhage due to AVM:
A. Treated by Craniotomy Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
B. Embolisation/Stereotactic 
Radiotherapy
Can drive when there is no 
debarring residual
impairment likely to affect 
driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
C. No treatment Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Incidental finding of an infratentorial AVM
A. No treatment No restriction. Not fit to drive. 
Driver must notify NDLS.
B. Surgical or other treatment Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
Dural AV Fistula Continued driving subject to 
individual assessment.
Driving may continue subject 
to individual assessment by 
appropriate consultant. 
Driver must notify NDLS.
Cavernous Malformation Supratentorial
A. Incidental, no surgical 
treatment
No restriction. No restriction subject to individual 
assessment by appropriate 
consultant.
B. Seizure, no surgical treatment Epilepsy standards apply if 
history of seizure(s).
Epilepsy standards apply if history of 
seizure(s).
C. Haemorrhage and/or focal 
neurological deficit, no surgical 
treatment
Can drive when there is no 
debarring residual impairment 
likely to affect driving. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
D. Treated by Surgical Excision
(Craniotomy)
Can drive when there is no 
debarring residual
impairment likely to affect 
driving. If significant residual 
disability, due consideration 
should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment. 
Driver must notify NDLS. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive until 10 years 
post-obliteration of the lesion and 
epilepsy standards apply.
Driver must notify NDLS.
E. Treated by radiosurgery
(I). Incidental No restriction. Not fit to drive.
Driver must notify NDLS.
(II). Symptomatic Can drive when there is no 
debarring residual impairment 
likely to affect driving. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Infratentorial
A. Incidental No restriction. Can drive subject to specialist 
assessment by appropriate 
consultant. 
Driver must notify NDLS.
B. With focal Neurological 
Deficit or Haemorrhage whether 
treated surgically or not
Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Epilepsy standards apply if 
history of seizure(s).
Can drive when there is no debarring 
residual impairment likely to affect 
driving.
Epilepsy standards apply if history  
of seizure(s). 
Driver must notify NDLS.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Intracerebral Abscess/ 
Subdural Empyema
One year off driving. 
Driver must notify NDLS.
Not fit to drive. Very high 
prospective risk of seizure(s). May 
consider licensing if 10 years seizure-
free from treatment.
Driver must notify NDLS.
Hydrocephalus If uncomplicated, can be 
recommended for continued 
driving.
Can be issued with a licence if 
uncomplicated and no associated 
neurological problems.
Intraventricular Shunt or 
Extraventricular Drain
Insertion or revision of upper 
end of ventricular shunt or extra-
ventricular drain
6 months off driving. Can be 
recommended for continued 
driving thereafter when there is 
no debarring residual impairment 
likely to affect driving safety.
Driver must notify NDLS.
Minimum 6 months off and then 
licensing shall be dependent upon 
the individual assessment of the 
underlying condition.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
N.B. Multiple Cavernoma: no firm evidence of increased morbidity. Size is not an issue
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Neuroendoscopic procedures 
E.g. IIIrd ventriculostomy
6 months off driving. Can be 
recommended for continued 
driving thereafter when 
there is no debarring residual 
impairment likely to affect safe 
driving.
Driver must notify NDLS.
Minimum 6 months off and then 
licensing shall be dependent upon 
the individual assessment of the 
underlying condition.
Driver must notify NDLS.
Intracranial Pressure  
Monitoring Device
Inserted by Burr hole surgery
The prospective risk from the 
underlying condition must be 
considered.
The prospective risk from the 
underlying condition must be 
considered.
Implanted Electrodes
Deep brain stimulation for 
movement disorder or pain 
If no complications from surgery 
and seizure, can drive when 
there is no debarring residual 
impairment likely to affect 
driving safety.
Driver must notify NDLS.
If no complications from surgery, 
seizure free and underlying condition 
non-progressive, can drive when there 
is no debarring residual impairment 
likely to affect driving safety.
Driver must notify NDLS.
Implanted Motor Cortex 
stimulator for pain relief
If aetiology of pain is non-
cerebral e.g. trigeminal 
neuralgia, 6 months off driving. 
If the aetiology is cerebral e.g. 
stroke, 12 months off driving. 
Can then drive when there is no 
debarring residual impairment 
likely to affect driving safety.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Appendix — Chapter 2
Epilepsy standards for Group 1 and 2
Group 1
This means that:
1. A person who has suffered an epileptic attack whilst awake must refrain from driving for at least one year from the 
date of the attack: driving cannot resume until the driver has had no further seizures while awake for a 12-month 
period.
2. A person who has experienced seizures exclusively while asleep may be considered for a one year licence despite 
continuing seizures only during sleep, and subject to at least annual review, taking into account information provided 
by the treating doctor (with appropriate expertise and due consultation with a consultant neurologist) as to whether 
the following criteria are met:
• There have been no previous seizures while awake; and 
• The first sleep-only seizure was at least 12 months ago; and 
• The person follows medical advice, including adherence to medication if prescribed. 
 or
• There have been previous seizures while awake but not in the preceding one year; and 
• Sleep-only seizures have been occurring for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
and in both cases
3. I. So far as practicable, the person complies with advised treatment and check-ups for epilepsy,
 AND
 II. The driving of a vehicle by such a person should not be likely to cause danger to the public. 
A specific exception to these are seizures a judged by the treating consultant neurologist as not impairing consciousness 
or driving ability at any time. An annual licence may be granted by the National Driver Licence Service (NDLS) subject to 
at least annual review, taking into account information provided by the treating consultant as to whether the following 
criteria are met:
• Seizures as judged not impairing consciousness or driving ability at any time have been present for at least one year; and 
• There have been no seizures of other type for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
Group 2
This means that:
During the period of 10 years immediately preceding the date when the licence is granted the applicant/licence holder 
should:
1) be free from any epileptic attack
 AND
2) have not taken medication to treat epilepsy
 AND
3) not otherwise be a source of danger whilst driving.
In addition, someone with a structural intracranial lesion who has an increased risk of seizures will not be able to drive 
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vehicles of this group until the risk of a seizure has fallen to no greater than 2% per annum, which permits compliance 
with the standards.
Guidance for clinicians advising patients to cease driving in the case of  
break-through seizures in those with established epilepsy for Group 1 Drivers:
In the event of a seizure, the driver must be advised not to drive unless they are able to meet the conditions of the asleep 
concessions. The driver must be advised to notify the NDLS. In exceptional cases (e.g. seizure secondary to prescribing 
error), a consultant may advise a return after a shorter period.
Guidance for withdrawal of antiepileptic medication being withdrawn on specific  
medical advice for Group 1 Drivers: 
(N.B. This advice only relates to treatment for epilepsy) 
From a medico-legal point of view, the risk of further epileptic seizures occurring during this therapeutic procedure should 
be noted. If an epileptic seizure does occur, the driver will need to satisfy driving licence standards before resuming driving 
and will need to be counselled accordingly. The current epilepsy standards require a period of at least one year free of 
any manifestation of epileptic seizure or attacks whilst awake from the date of the last attack; special consideration is 
given where attacks have occurred only whilst asleep.
It is clearly recognised that withdrawal of antiepileptic medication is associated with a risk of seizure recurrence. A number 
of studies have shown this, including the randomised study of antiepilepsy drug withdrawal in patients in remission, 
conducted by the UK Medical Research Council Anti-epileptic Drug Withdrawal Study Group in the UK27. This study shows 
a 30% risk of seizure in the first year of withdrawal ofmedication compared with those who continued on treatment.
Patients who are drivers undergoing withdrawal or reduction of antiepilepsy medications should be warned of the risk 
they run, both of needing to cease driving and also of having a seizure which could result in a road traffic accident. 
There is a difference between reducing the number of antiepileptic medications to a lesser number and the complete 
withdrawal of antiepileptic medications. Neurologist opinion is required for Group 1 drivers as to whether the risk of 
seizure within the next year is >20%, and a number of clinical factors may help the specialist in this decision. 
The highest risk of seizure is for complete cessation of antiepileptic medications, and driving should cease during the 
period of withdrawal and for at least 3 months thereafter, or a longer period as considered appropriate by the neurologist.
If there is a withdrawal-associated seizure, driving should cease for at least 3 months once previously effective therapy 
is reinstated.
For reduction of numbers of medications from a greater to a lesser number, clinical judgment should exercised by a 
neurologist on an individual basis.
This advice may not be appropriate in every case. One specific example is withdrawal of antiepileptic medication when there 
is a well-established history of seizures only while asleep. In such cases, any restriction in driving is best determined by the 
consultant concerned, after considering the history. It is up to the driver to comply with such advice.
27. Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: 
further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1328-33.
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Provoked seizures
Provoked or acute symptomatic seizures may be dealt with on an individual basis if there is no previous seizure history. 
Seizures associated with alcohol or drug misuse, sleep deprivation or a structural abnormality is not considered provoked 
for licensing purposes. Similarly, reports of seizures as a side-effect of prescribed medication do not automatically imply 
that such events should be considered as provoked. For seizure(s) with alcohol or illicit drugs, please see Chapter 6 in 
these Guidelines.
Doctors may wish to advise drivers that the period of time likely to be recommended off driving will be influenced inter 
alia by:
A. Whether it is clear that the seizure had been provoked by a stimulus which does not convey any risk of recurrence 
and does not represent an unmasking of an underlying liability; 
 AND
B.  Whether the stimulus had been successfully/appropriately treated or is unlikely to occur at the wheel.
In the absence of any previous seizure history or previous cerebral pathology, the following seizures may also be treated 
as provoked: 
• Eclamptic seizures.
• Convulsive syncope. 
• Seizure in first week following a head injury (see head injury section) at the time of a Stroke/TIA or within the ensuing 
24 hours.
• During intracranial surgery or in the ensuing 24 hours.
The D501 Medical Report form provides provision for the assessing doctor to signal that any driver he/she considers fit to 
drive less than 12 months after a seizure that this is because the seizure was a) a first seizure, b) a provoked seizure, c) seizure 
exclusively while asleep, and d) seizure not affecting consciousness of driving ability, e) seizure related to withdrawal or 
reduction of antiepileptic medication, as adjudicated by a consultant neurologist.
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To view or download driver information leaflets visit www.rsa.ie or www.ndls.ie
Epilepsy, Seizures
and Driving
This is an overview of driving with epilepsy. The complete 
standards are published in Sláinte agus Tiomáint: 
Medical Fitness to Drive (MFTD) Guidelines.
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After that, if you do not have any other medical 
condition(s) relevant to driving:
n	 a 1-3 year licence may be issued; and
n	 a 10-year licence may be issued if you have not had a 
seizure for 5 years.
If you have seizures only when you are asleep, you can 
find advice later in this leaflet on page 7.
Group 2 drivers – driving a bus or truck
You must stop driving until you have been seizure free for 
10 years without using anti-epileptic medication.
If you are a Group 1 or Group 2 driver and you have been 
diagnosed with epilepsy, you must stop driving until 
your treating consultant is satisfied that your medical 
results show that you are medically fit to drive, and until 
the minimum seizure-free period as outlined above has 
passed.
I’m a Group 2 driver (driving a bus or truck) 
– why are the health standards higher  
for me?
The standards set for you are higher because your job 
carries extra responsibilities, including:
n	 the time you spend driving,
n	 the weight and size of the vehicle you drive,
n	 your responsibility for passengers, and
n	 the type of cargo you transport.
First unprovoked seizure
How does a first unprovoked seizure affect 
my driving licence?
A first unprovoked seizure is not necessarily epilepsy, 
unless you suffer a further seizure within 5 years. 
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Be a responsible driver
It is your responsibility as a driver to:
n	 follow your doctor’s advice, take your prescribed 
medication, and monitor and manage your medical 
condition(s);
n	 tell the National Driver Licence Service (NDLS) and 
your insurance provider if you have a long-term or 
permanent injury or illness that may affect your 
ability to drive safely. This includes a diagnosis of 
epilepsy;
n	 complete the question on page 1 of your D501 
Medical Report Form signed by your doctor asking 
you to tell the NDLS of the date of your last seizure, 
and whether you have suffered in the past or 
currently suffer from epilepsy. (The date of the first 
‘unprovoked’ seizure should not be included. An 
unprovoked seizure is defined later in this leaflet.);
n	 comply with the requirements of your licence, 
including periodic medical reviews; and
n	 get professional medical advice on your medical 
fitness to drive if you develop a medical condition, 
or your condition changes, during the term of your 
licence.
This leaflet covers medical fitness to drive relating to 
epilepsy, first seizures and provoked seizures. These 
terms are defined below.
What is epilepsy?
Epilepsy is a medical condition characterised by frequent 
seizures, sometimes referred to as ‘epileptic fits’. Seizures 
cause abnormal electrical activity in the brain which 
can affect movement and behaviour. There are different 
types of epilepsy and seizures. In most cases, seizures are 
controlled by medication.
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If you are a Group 1 or Group 2 driver and have a first 
unprovoked seizure, you must stop driving until your 
treating consultant is satisfied that your medical results 
show that you are medically fit to drive. You can’t just 
start driving after the minimum seizure-free period as 
outlined below has passed.
Group 1 drivers – driving a car, motor cycle 
or tractor
You must stop driving until you have been seizure free for 
6 months.
After that, if you do not have any other medical 
condition(s) relevant to driving:
n	 a 1-3 year licence may be issued; and
n	 a 10-year licence may be issued if you have not had a 
seizure for 5 years.
Group 2 drivers – driving a bus or truck
You must stop driving until you have been seizure free for 
5 years without using anti- epileptic medication.
Exceptional cases for Group 1 
drivers only
A Group 1 driver can be declared as an exceptional  
case if:
1. they have a provoked seizure;
2. the seizures only happen when they are asleep;
3. the seizure pattern does not affect consciousness or 
the ability to act at any time;
4. the seizures are as a result of withdrawal from anti-
epileptic medication.
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What are ‘provoked’ and ‘unprovoked’ 
seizures?
A provoked seizure is one where the cause can usually 
be identified – for example, a head trauma or low blood 
sugar. An unprovoked seizure has no cause that can be 
identified.
Why is health important for 
drivers?
Your health is important, as driving any motor vehicle 
requires:
n	 constant attention;
n	 good judgement;
n	 appropriate responsiveness;
n	 reasonable perception and physical capability; and
n	 good senses – for example, sight and hearing.
All of these can be affected by a driver’s physical and 
psychological health. In someone with epilepsy, these 
abilities can also be altered before, during and after a 
seizure.
Epilepsy
How does being diagnosed with epilepsy 
affect my driver’s licence?
A diagnosis of epilepsy is usually made if you have had 
two or more seizures less than five years apart.
Group 1 drivers – driving a car, motor cycle 
or tractor
You must stop driving until you have been seizure free for 
12 months.
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The table below provides more detail on each of these 
exceptions.
1. Provoked seizure - exception
A seizure which has recognisable cause and is, 
therefore, avoidable, and where you have no previous 
history of epileptic seizure.
Examples are seizures that happen:
n during pregnancy;
n collapse or twitching due to lack of oxygen;
n in first week following a head injury;
n at the time of a stroke or within 24 hours of a 
stroke;
n during brain surgery or within 24 hours of brain 
surgery.
Group 1 drivers – driving a car, motor cycle or tractor
You must stop driving until your doctor has assessed 
you and is satisfied that your medical results show 
that you are medically fit to drive.
If your doctor is satisfied that your seizure meets the 
description given above for provoked seizures, they 
can make an individual assessment as to when you 
are medically fit to drive.
What are not considered provoked seizures? 
Seizures that occur as a result of:
n alcohol or drug misuse;
n sleep deprivation;
n structural abnormality in the brain.
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2. Seizures happen only when asleep - exception
Your treating consultant must be satisfied that you 
have an established pattern of sleep seizures with no 
history of seizures while you are awake.
Group 1 drivers – driving a car, motor cycle or tractor
You must stop driving until this pattern of exclusive 
sleep seizures has been established for the minimum 
period of 12 months.
After that, if you do not have any other medical 
condition(s) relevant to driving:
n a 1-3 year licence may be issued.
3. Seizures that do not affect consciousness or ability 
to act at any time - exception
Your treating consultant will review your seizure 
history and other clinical factors to determine that 
your seizures do not affect your consciousness and 
your ability to act and function normally at any time.
Group 1 drivers – driving a car, motor cycle or tractor
You must stop driving until a seizure pattern has been 
established for 12 months.
After this pattern has been established for 12 months, 
your treating consultant must be satisfied that:
n your seizures do not impair consciousness or 
driving ability at any time;
n you have not had any other seizures types for at 
least one year; and
n you follow medical advice, including taking any 
prescribed medication as directed.
After that, if you do not have any other medical 
condition(s) relevant to driving:
n a 1-year licence may be issued subject to at least a 
yearly review.
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Further information sources:
n Your doctor or nurse
n Epilepsy Ireland is a valuable source of support:
Web:  www.epilepsy.ie/
Helpline:  (0)1 455 7500
Email:  info@epilepsy.ie
Sláinte agus Tiomáint: Medical Fitness to Drive 
Guidelines is available on www.ndls.ie
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4. Seizures resulting from withdrawal of anti-epileptic 
medication – exception
You should be aware that you are at risk of a seizure 
once you reduce or stop your epilepsy medication, 
even when you do so under medical supervision.
Group 1 drivers – driving a car, motor cycle or tractor
You must stop driving from the date you begin 
reducing your anti-epileptic medication. Once you 
have stopped taking all anti-epileptic medication, you 
must not drive for a minimum period of 6 months. 
After that, you must get medical fitness to drive 
certification from your treating consultant.
What will happen if I continue  
to drive?
It is important to strike a balance between mobility and 
safety. If you continue to drive against medical advice, 
and evidence is found of this, it will affect your insurance. 
Also, the NDLS and the Gardaí will take action to revoke 
(cancel) your licence.
General advice
If you experience seizures, blackouts or episodes of 
memory loss, you should see a doctor so that the risk 
of further episodes and the need for treatment can be 
determined.
Get a correct diagnosis of epilepsy or your seizure type. It 
means the right treatment is started, and your ability to 
drive safely can be assessed.
Some seizure types are not epilepsy, but they are related 
to other medical conditions. You should get advice from 
your doctor on your seizure type and your driving.
6372 RSA Epilepsy Seizures & Driving DL leaflet.indd   8 20/04/2017   16:51
NDLS
N
D
LS
April 2017
6372 RSA Epilepsy Seizures & Driving DL leaflet.indd   12 19/04/2017   15:11
8 9
If I need to, how do I inform  
the NDLS?
If, following consultation with your doctor, your medical 
condition is one that needs to be noted on your driver 
record (but does not change your licence entitlement), 
or if your licence needs to be changed – for example, 
valid for a shorter period – you must notify the NDLS. 
You need to complete forms (1) and (2) listed below and 
return them in person to any NDLS centre along with 
your current licence and proof of your PPS number. These 
forms are available on www.ndls.ie.
Checklist of what you need to bring:
1) a completed Driver Licence Application Form;
2) a Medical Report Form (D501) completed by your 
doctor (a letter from your doctor is not accepted);
3) proof of PPSN; and
4) your current licence.
You will then, within a specified time frame, be issued 
with a new, updated licence.
Please see www.ndls.ie for locations of offices, bookings 
and forms.
If you have more questions, please email 
medicalfitness@rsa.ie or telephone 1890 40 60 40.
Please note if you have supplied a medical report form to 
obtain your existing licence or permit and the terms of 
licence or permit are not being changed, you may submit 
your new application together with your medical report 
form by post to:
National Driver Licence Service 
PO Box 858 
Southside Delivery Office 
Co Cork
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Chapter 3
Cardiovascular disorders28
A licence holder or applicant must meet the standards for cardiovascular disorders outlined below, and if there is reason 
to doubt that these are met, the applicant or licence holder should undergo a more detailed examination by a consultant 
cardiologist — see Appendix to this chapter. 
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of the driving tasks encountered in the course of employment. 
Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Angina Driving must cease when 
symptoms occur at rest, with 
emotion, or at the wheel.
Driving may recommence when 
satisfactory symptom control is 
achieved. 
NDLS need not be notified.
Refusal or revocation with 
continuing symptoms (treated  
and/or untreated).
Driving may recommence  
thereafter provided:
• Free from angina for at least  
4 weeks.
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
28. Helpful recent reviews include: Sorajja D, Shen WK. Driving guidelines and restrictions in patients with ahistory of cardiac arrhythmias, syncope,or implantable 
devices. Curr Treat Options Cardiovasc Med. 2010 Oct;12(5):443-56.
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acute Coronary Syndromes  
(ACS) defined as:
1. Unstable angina (symptoms at 
rest with ECG changes).
2. Non STEMI with at least two 
of the following criteria:
• Symptoms at rest
• Raised serum Troponin
• ECG changes
3. STEMI symptoms with ST 
elevation on ECG.
If successfully treated by 
coronary angioplasty, driving 
may recommence after 1 week 
provided:
• No other URGENT 
revascularisation is planned. 
(URGENT refers to within 4 
weeks from acute event).
• Left Ventricular Ejection 
Fraction (LVEF) is at least 
35% prior to hospital 
discharge.
• There is no other 
disqualifying condition.  
If not successfully treated by 
coronary angioplasty, driving 
may recommence after 4 
weeks provided:
• There is no other 
disqualifying condition.
All Acute Coronary Syndromes 
disqualify the licence holder from 
driving for at least 4 weeks.
Driving may recommence thereafter 
provided:
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Percutaneous Coronary 
Intervention
(Angioplasty ± stent)
Elective
Driving must cease for at least 
2 days.
Driving may recommence 
thereafter provided there is no 
other disqualifying condition. 
NDLS need not be notified.
Driving must cease for at least  
4 weeks.
Driving may recommence thereafter 
provided:
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
Cardiac Surgery CABG including 
valve or replacement or repair
Driving must cease for at least 4 
weeks.
Driving may recommence 
thereafter provided there is no 
other disqualifying condition. 
NDLS need not be notified.
Disqualifies from driving for at least 
3 months.
Driving may recommence thereafter 
provided:
• There is no evidence of 
significant impairment of  
left ventricular function i.e.  
LVEF is ≥ 35%.
• The exercise or other functional 
test requirements can be met 
3 months or more post operatively.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Arrhythmia 
Sinoatrial disease
Significant atrio-ventricular 
conduction defect
Atrial flutter/fibrillation
Narrow or broad complex 
tachycardia
(See also following Sections 
- Pacemakers are considered 
separately). N.B. Transient 
Arrhythmias occurring during 
acute coronary syndromes do 
not require assessment under 
this section.
Driving must cease if the 
arrhythmia has caused or is 
likely to cause incapacity.
Driving may be permitted when 
underlying cause has been 
identified and controlled for at 
least 4 weeks.
NDLS need not be notified unless 
there are distracting/disabling 
symptoms.
Not fit to drive if the arrhythmia 
has caused or is likely to cause 
incapacity.
Driving may be permitted when:
• The arrhythmia is controlled for 
at least 3 months.
• The LVEF is ≥ 35%. 
• There is no other disqualifying 
condition.
NDLS need not be notified unless 
there are distracting/disabling 
symptoms.
Successful Catheter Ablation Driving must cease for at  
least 2 days.
Driving may be permitted 
thereafter provided there is no 
other disqualifying condition.
NDLS need not be notified.
Following successful catheter 
ablation for an arrhythmia that has 
caused or would likely have caused 
incapacity, driving should cease for 
6 weeks. Driving may recommence 
thereafter provided there is no other 
disqualifying condition.
When the arrhythmia has not 
caused nor would likely have caused 
incapacity, driving may recommence 
after 1 week provided there is no 
other disqualifying condition.
Pacemaker Implant
Includes box change
Driving must cease for at least 
1 week.
Driving may be permitted 
thereafter provided there is no 
other disqualifying condition.
Disqualifies from driving for  
4 weeks.
Driving may be permitted thereafter 
provided there is no other 
disqualifying condition.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Unpaced Congenital Complete 
Heart Block
May drive if asymptomatic. Not fit to drive whether 
symptomatic or asymptomatic.
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for ventricular 
arrhythmia associated with 
incapacity
Drivers with ICDs implanted 
for sustained ventricular 
arrhythmias should not drive for:
1. A period of 6 months after 
the first implant.
2. A further 6 months after 
any shock therapy and/or 
symptomatic antitachycardia 
pacing (see 3A below). 
3A. A period of 2 years if any 
therapy following device 
implantation has been 
accompanied by incapacity 
(whether caused by the 
device or arrhythmia), 
except as in 3B and 3C.
3B. If therapy was delivered due 
to an inappropriate cause, 
i.e. atrial fibrillation or 
programming issues, then 
fit to drive 4 weeks after 
this has been completely 
controlled to the satisfaction 
of the cardiologist.
NDLS need not be notified.
Continued on next page
Not fit to drive.
Driver must notify NDLS.
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car, motorcycle and tractor
Group 2 Entitlement ODL
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for ventricular 
arrhythmia associated with 
incapacity
Continued from previous page
3C. If the incapacitating shock 
was appropriate (i.e. for 
sustained VT or VF) and 
steps have been taken 
to prevent recurrence, 
(e.g., introduction of anti-
arrhythmic drugs or ablation 
procedure) fit to drive after 
6 months in the absence of 
further symptomatic therapy. 
For 2 and 3A/3C, if the driver 
has been re-licensed prior to the 
event, Driver must notify NDLS.
4. A period of 4 weeks off 
driving must occur following 
any revision of the electrodes 
or alteration of anti-
arrhythmic drug treatment.
5. A period of 1 week off 
driving is required after a 
defibrillator box change.
Return to driving requires that:
1. The device is subject to 
regular review with 
interrogation.
2. There is no other disqualifying 
condition.
See appendix at end of this chapter
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car, motorcycle and tractor
Group 2 Entitlement ODL
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for sustained 
ventricular arrhythmia which did 
not cause incapacity
If the driver presents with a 
non-disqualifying cardiac event, 
i.e. haemodynamically stable 
non-incapacitating sustained 
ventricular tachycardia, the 
patient can drive 4 weeks after 
ICD implantation providing all 
of the following conditions are 
met:
• LVEF is ≥ 35%.
• No fast VT induced on 
electrophysiological study 
(RR < 250 msec).
• Any induced VT could be pace-
terminated by the ICD twice, 
without acceleration, during 
the post implantation study.
NDLS need not be notified.
Should the ICD subsequently 
deliver ATP and/or shock therapy 
(except during normal clinical 
testing) then the licensing criteria 
on the previous page applies and 
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
See appendix at end of this chapter
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car, motorcycle and tractor
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Prophylactic ICD Implant Asymptomatic individuals with 
high risk of significant arrhythmia. 
Driving should cease for 4 weeks. 
NDLS need not be notified.
Should the ICD subsequently 
deliver ATP and/or shock 
therapy (except during normal 
clinical testing) then the 
licensing criteria on previous 
page for ICD applies and  
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
Ascending/Descending Thoracic 
and Abdominal Aortic Aneurysm
Driver must notify NDLS of any 
aneurysm of 6cm in diameter, 
despite treatment. Licensing  
will be permitted subject to 
annual review. 
Driving may continue after 
satisfactory medical (blood 
pressure control) or surgical 
treatment, without evidence 
of further enlargement. There 
should be no other disqualifying 
condition. An aortic diameter of 
6.5cm or more not fit to drive.
Not fit to drive if the aortic diameter 
is > 5.5cm. Driving may continue 
after satisfactory medical or 
surgical treatment, unless other 
disqualifying condition.
N.B. The exercise or other functional 
test requirements will apply to 
abdominal aortic aneurysm.
Driver must notify NDLS if aortic 
diameter is > 5.5cm.
See appendix at end of this chapter
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car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Aortic Dissection Driving may continue after 
satisfactory medical (blood 
pressure control) or surgical 
treatment, unless other 
disqualifying condition. 
NDLS need not be notified.
Driving may be permitted when ALL 
of the following criteria can be met:
• The maximum transverse 
diameter of the aorta, including 
false lumen/thrombosed 
segment, does not exceed 
5.5cm.
• There is complete thrombosis of 
the false lumen.
• The BP is well controlled*.
* NOTE “well controlled” refers to 
clinical, standard.
Hypertension Driving may continue unless 
treatment causes unacceptable 
side effects.
NDLS need not be notified.
Not fit to drive if resting BP 
consistently 180 mm Hg systolic  
or more and/or 100 mm Hg  
diastolic or more.
Driving may be permitted when 
controlled provided that treatment 
does not cause side effects which 
may interfere with driving.
See appendix at end of this chapter
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Hypertrophic 
Cardiomyopathy (H.C.M.)
(See also arrhythmia, pacemaker 
and ICD sections)
Driving may continue provided 
no other disqualifying condition.
NDLS need not be notified.
Not fit to drive if symptomatic.
Driving may only be permitted 
when at least three of the following 
criteria are met:
• There is no family history in a 
first degree relative of sudden 
premature death from presumed 
HCM.
• The cardiologist can confirm that 
the HCM is not anatomically 
severe. The maximum wall 
thickness does not exceed 3cm.
• There is no serious abnormality 
of heart rhythm demonstrated; 
e.g. ventricular tachy-arrhythmia 
excluding isolated ventricular 
pre excitation beats.
• There is at least a 25mm Hg 
increase in systolic blood 
pressure during exercise testing 
- (exercise testing to be repeated 
every 3 years).
See Appendix to this Chapter  
for full details.
Driver must notify NDLS.
Dilated Cardiomyopathy
(See also arrhythmia, 
pacemaker, I.C.D. and heart 
failure sections etc.)
Driving may continue provided 
no other disqualifying condition.
NDLS need not be notified.
Not fit to drive if symptomatic.
Driving may be permitted provided 
that there is no other disqualifying 
condition. NDLS need not be 
notified.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Heart Failure Driving may continue provided 
there are no symptoms that may 
distract the driver’s attention.
NDLS need not be notified.
Disqualifies from driving  
if symptomatic.
Driving may be permitted provided:
• The LVEF is ≥ 35%. 
• There is no other disqualifying 
condition.
Exercise or other functional testing 
may be required depending on the 
likely cause for the heart failure.
Cardiac Resynchronisation 
Therapy (CRT)
CRT-P
Driving must cease for at least 1 
week following implantation.
Driving may continue provided 
there are no symptoms relevant 
to driving.
There is no other disqualifying 
condition.
Disqualifies from driving  
for 4 weeks. 
Following Implantation.
Driving may be permitted provided:
• The heart failure requirements 
are met.
• There is no other disqualifying 
condition.
CRT-D Driving may be permitted 
provided the ICD requirements 
are met. There is no other 
disqualifying condition.
Not fit to Drive.
Driver must notify NDLS.
See appendix at end of this chapter
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car, motorcycle and tractor
Group 2 Entitlement ODL
Congenital Heart Disease Driving may continue provided 
there is no other disqualifying 
condition.
Following a first licence 
application or identification of 
such a condition, consultant 
assessment may be required 
before a licence is (re)issued. 
Certain conditions will require 
licence review every 1, 3 years, 
in this instance Driver must 
notify NDLS.
Disqualifies from driving when 
complex or severe disorder(s)  
is (are) present.
Following a first licence application 
or identification of such a condition, 
consultant cardiologist assessment 
may be required before a licence is 
(re)issued. Those with minor disease 
and others who have had successful 
repair of defects or relief of valvular 
problems, fistulae etc. may be 
licensed provided there is no other 
disqualifying condition.
Certain conditions will require 
licence review every 1, 3 years, in 
this instance Driver must notify 
NDLS.
Syncope 
N.B. Cough Syncope see  
Chapter 9
See section entitled “Loss of 
Consciousness” Chapter 2.
See section entitled “Loss of 
Consciousness” Chapter 2.
ECG Abnormality 
Suspected myocardial infarction
Driving may continue unless 
other disqualifying condition. 
NDLS need not be notified.
Driving may be permitted provided:
• There is no other disqualifying 
condition.
• The exercise or other functional 
test requirements can be met.
See appendix at end of this chapter
60    Sláinte agus Tiomáint  |  Medical Fitness To Drive Guidelines  |  (Group 1 and Group 2 Drivers)
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Appendix — Chapter 3 Cardiovascular Disorders
Group 1 and 2 entitlements
Medication
If drug treatment for any cardiovascular condition is required, any patient experiencing an adverse effect which is likely 
to affect driver performance is not fit to drive. 
 
Group 2 entitlements only 
Licence Duration 
An applicant or driver who has, after cardiac assessment, (usually for ischaemic or untreated heart valve disease) been 
permitted to hold either a Group 2 licence will usually be issued with a short term licence (maximum duration 3 years) 
renewable on receipt of satisfactory D501 Medical Report.
Exercise testing
Exercise evaluation shall be performed on a treadmill. Drivers should be able to achieve 90% of age predicted heart rate of 
standard Bruce protocol or equivalent safely, without antianginal* medication for 48 hours and should remain free from 
signs of cardiovascular dysfunction, viz. angina pectoris, syncope, hypotension, sustained ventricular tachycardia, and/
or electrocardiographic ST segment shift which accredited medical opinion interprets as being indicative of myocardial 
ischaemia (usually > 2mm horizontal or down-sloping) during exercise or the recovery period. In the presence of established 
coronary heart disease, exercise evaluation shall be required at regular intervals not to exceed 3 years.
* Antianginal medication refers to the use of nitrates, beta-blockers, calcium channel blockers, nicorandil, ivabradine and 
ranolazine prescribed for antianginal purposes or for other reasons e.g. cardio-protection.
N.B. When any of the above drugs are being prescribed purely for the control of hypertension or an arrhythmiathen 
discontinuation prior to exercise testing is not required.
Should atrial fibrillation develop de novo during exercise testing, provided the individual meets all the NDLS exercise 
tolerance test criteria, the individual will be required to undergo an echocardiogram and meet the licensing criteria, just 
as any individual with a pre-existing atrial fibrillation.
Chest pain of uncertain cause
Exercise testing should be carried out as above. Those with a locomotor disability who cannot comply will require either 
a gated myocardial perfusion scan, stress echo study and/or specialised cardiological opinion.
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Stress Myocardial Perfusion Scan/Stress Echocardiography
The licensing standard requires that:
1. The LVEF is ≥ 35% 
2A) No more than 10% of the myocardium is affected by reversible ischaemic change on myocardial perfusion imaging.
 or
2B) No more than one segment is affected by reversible ischaemic change on stress echocardiography.
N.B. Full details of NDLS protocol requirements for such tests can be obtained on request.
Coronary Angiography
The functional implication of coronary heart disease is considered to be more predictive for licensing purposes than the 
anatomical findings. For this reason the exercise tolerance test and where necessary, myocardial perfusion imaging or 
stress echocardiography are the investigations of relevance for licensing purposes and it is the normal requirement that 
the standard of one or other of these must be met. Angiography is therefore not commissioned for (re-) licensing purposes. 
When there remains conflict between the outcome of a functional test and the results of recent angiography, such cases 
can be considered on an individual basis. However, (re-) licensing will not normally be considered unless the coronary 
arteries are unobstructed or the stenosis is not flow limiting and the LVEF is ≥ 35%. 
‘Predictive’ refers to the risk of an infarct within 1 year. Grafts are considered as ‘Coronary Arteries’.
ETT and Hypertrophic Cardiomyopathy
For the purpose of assessment of hypertrophic cardiomyopathy (HCM) cases, an exercise test falling short of exercise 
target above would be acceptable provided:
1. 90% of age-predicted heart rate.
2. There is no obvious cardiac cause for stopping the test prematurely. 
3. There is at least a 25mm Hg rise in systolic blood pressure during exercise testing.
4. Meets all other requirements as mentioned in HCM section.
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Cardiac	Conditions	
and	Driving
This	is	an	overview	of	driving	with	cardiology	(heart)	
conditions.	The	complete	standards	are	published	in	
Sláinte	agus	Tiomáint:	Medical	Fitness	to	Drive	(MFTD)	
Guidelines	available	at	www.ndls.ie	
NDLS
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Be a responsible driver
It is your responsibility as a driver to: 
n	 take	any	prescribed	medication	and	manage	your	
condition(s);
n	 stop	driving	if	any	of	the	medications	you	are	taking	for	
your	heart	have	side	effects	that	affect	your	ability	to	
drive	–	for	example	drowsiness;
n	 tell	the	National	Driver	Licence	Service	(NDLS)	and	
your	insurance	provider	of	any	long-term	or	permanent	
injury	or	illness	that	may	affect	your	ability	to	drive	
safely;
n	 comply	with	requirements	of	your	licence	as	
appropriate,	including	periodic	medical	reviews;
n	 get	professional	advice	on	your	medical	fitness	to	drive	
if	you	develop	a	medical	condition	during	the	term	of	
your	licence.	
Note: You	are	committing	an	offence	if	you	carry	on	driving	
after	you	become	aware	that	you	are	not	fit	to	do	so.	
‘Awareness’	can	be	your	own	awareness	–	that	is,	things	
you	notice	yourself	without	being	diagnosed	by	a	doctor.	For	
example,	dizziness,	fainting	and	so	on.	Awareness	can	also	
be	as	a	result	of	a	warning	not	to	drive	from	your	doctor.	
Tell the NDLS about your condition
You	need	to	declare	certain	heart	conditions	on	your	
Application	or	Renewal	Form	for	a	Driving	Licence,	under	
Part 5: Driver Fitness.	Return	your	completed	application	
with	a	D501 Medical Report Form	completed	by	your	
doctor.	(Please	see	www.ndls.ie	for	this	and	other	forms.)
Driving a car, motor cycle or tractor 
(Group 1) Driver Guidelines
If	you	develop	a	heart	condition	during	the	term	of	your	
licence,	your	doctor	will	advise	you	on	when	you	can	
resume	driving	and	whether	you	need	to	contact	the	NDLS.	
The	following	pages	set	out	some	of	the	standards	given	in	
the	Medical	Fitness	to	Drive	guidelines.
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Driving a car, motor cycle or tractor (Group 1)
Driver Guidelines
If you have this 
cardiac condition:
These are the guidelines to follow:
a heart attack 
(acute	myocardial	
infarction)	
If	you	are	successfully	treated	with	
angioplasty,	you	must	stop	driving	for	
at	least	1	–	4	weeks,	and	your	doctor	
will	advise	you	on	when	you	can	resume	
driving.
angina You	must	stop	driving	if	you	experience	
symptoms	when	you	are	at	rest,	with	
emotion,	or	at	the	wheel.	Driving	may	
be	resumed	when	your	symptoms	are	
satisfactorily	under	control.	
elective 
angioplasty and/
or stent
You	should	not	drive	for	2	days	after	
angioplasty/stent.
atrial fibrillation/
arrhythmia 
You	should	not	drive	after	an	acute	
episode	that	caused	dizziness	or	fainting.	
You	may	resume	driving	when	the	
underlying	cause	has	been	identified	
and	controlled	for	at	least	4	weeks.	NDLS	
need	not	be	notified	unless	there	are	
distracting	or	disabling	symptoms.
cardiomyopathy You	may	drive	if	you	don’t	have	
symptoms	when	you	moderately	exert	
yourself.	This	is	provided	you	don’t	have	
any	other	disqualifying	condition.
an Implantable 
Cardioverter 
Defibrillator (ICD)
You	should	not	drive	until	your	doctor	
clears	you	to	do	so.	The	standards	and	
period	of	recovery	time	required	for	a	
return	to	driving	are	set	out	the	Medical	
Fitness	to	drive	(MFTD)	Guidelines.	Your	
doctor	will	advise	you	if	you	need	to	
notify	NDLS.
a cardiac 
pacemaker
You	should	not	drive	for	1	week	after	
having	a	pacemaker	inserted.
open heart 
surgery (CABG)
You	must	stop	driving	for	at	least		
4	weeks.	After	that,	you	can		
resume	driving	if	you	have	no		
other	disqualifying	condition.	
successful 
catheter ablation
You	should	not	drive	for	at	least	2	days.
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To view or download driver information leaflets visit www.rsa.ie or www.ndls.ie
Driving a bus or truck (Group 2) 
Driver guidelines
Generally,	Group	2	drivers	with	cardiac	conditions	must	
stop	driving	for	longer	periods	than	Group	1	drivers	–		
for	example,	after	a	seizure	or	a	heart	attack.	
If	you	develop	a	heart	condition	during	the	term	of	your	
licence,	your	doctor	will	advise	you	on	when	you	can	
resume	driving	and	whether	you	need	to	contact	the	
NDLS.	Below	are	some	of	the	standards	given	in	the	
Medical	Fitness	to	Drive	guidelines.
Driving a bus or truck (Group 2)
Driver Guidelines
If you have this 
cardiac condition:
These are the guidelines to follow:
a	heart attack	
(acute	myocardial	
infarction)	
You	must	stop	driving	for	at	least	4	
weeks,	and	your	doctor	will	advise	you	
on	when	you	can	resume	driving.	You 
must notify NDLS.
angina If	you	have	any	symptoms	–	whether	
they	are	being	treated	or	not	–	you	
must	stop	driving.	You	should	not	
resume	driving	until:
•	 you	are	free	from	angina	symptoms	
for	at	least	4	weeks;	
•	 you	can	satisfy	the	exercise	or	
other	functional	test	requirements;	
and
•	 you	have	no	other	disqualifying	
condition.
You must notify NDLS.
elective 
angioplasty and/
or stent
You	must	stop	driving	for	at	least	4	
weeks.	After	that,	you	may	resume	
driving	if	you	can	satisfy	the	exercise	
or	other	functional	test	requirements	
and	you	have	no	other	disqualifying	
condition.	You must notify NDLS.
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Driver guidelines
Generally,	Group	2	drivers	with	cardiac	conditions	must	
stop	driving	for	longer	periods	than	Group	1	drivers	–		
for	example,	after	a	seizure	or	a	heart	attack.	
If	you	develop	a	heart	condition	during	the	term	of	your	
licence,	your	doctor	will	advise	you	on	when	you	can	
resume	driving	and	whether	you	need	to	contact	the	
NDLS.	Below	are	some	of	the	standards	given	in	the	
Medical	Fitness	to	Drive	guidelines.
Driving a bus or truck (Group 2)
Driver Guidelines
If you have this 
cardiac condition:
These are the guidelines to follow:
a	heart attack	
(acute	myocardial	
infarction)	
You	must	stop	driving	for	at	least	4	
weeks,	and	your	doctor	will	advise	you	
on	when	you	can	resume	driving.	You 
must notify NDLS.
angina If	you	have	any	symptoms	–	whether	
they	are	being	treated	or	not	–	you	
must	stop	driving.	You	should	not	
resume	driving	until:
•	 you	are	free	from	angina	symptoms	
for	at	least	4	weeks;	
•	 you	can	satisfy	the	exercise	or	
other	functional	test	requirements;	
and
•	 you	have	no	other	disqualifying	
condition.
You must notify NDLS.
elective 
angioplasty and/
or stent
You	must	stop	driving	for	at	least	4	
weeks.	After	that,	you	may	resume	
driving	if	you	can	satisfy	the	exercise	
or	other	functional	test	requirements	
and	you	have	no	other	disqualifying	
condition.	You must notify NDLS.
Driving a bus or truck (Group 2)
Driver Guidelines
If you have this 
cardiac condition:
These are the guidelines to follow:
atrial fibrillation, 
cardiac 
arrhythmia
You	must	not	drive	if	the	arrhythmia	
has	caused	or	is	likely	to	cause	
incapacity.	You	may	resume	driving	
when	the	arrhythmia	is	controlled	
for	at	least	3	months	and	you	have	
no	other	disqualifying	condition.	
You do not have to notify the NDLS 
unless there are distracting/disabling 
symptoms.
cardiomyopathy You	must	not	drive	if	you	have	any	
symptoms	for	example	shortness	of	
breath,	extreme	fatigue,	dizziness,	
lightheadedness,	fainting,	chest	
pain	and	pressure	(angina),	heart	
palpitations,	swelling	in	the	legs	and	
feet	(edema)	and	abdomen	(tummy).	
You	can	only	resume	driving	when	your	
doctor	is	satisfied	that	you	meet	the	
criteria	set	out	in	the	Medical	Fitness	
to	Drive	Guidelines.	You	must	have	
exercise	testing	every	3	years.	You 
must notify NDLS.
an Implantable 
Cardioverter 
Defibrillator (ICD)
You	must	not	drive.	You must notify 
NDLS and surrender your Group 2 
licence.
a cardiac 
pacemaker
You	should	not	drive	for	4	weeks	after	
a	pacemaker	is	inserted.	You	may	
resume	driving	after	that	provided	you	
have	no	other	disqualifying	condition.
open heart 
surgery (CABG)
You	must	stop	driving	for	at	least	3	
months.	You	may	resume	driving	after	
that	provided	your	doctor(s)	is	satisfied	
that	you	meet	the	criteria	set	out	in	
the	MFTD	Guidelines.	You must notify 
NDLS.
successful 
catheter ablation 
for an arrhythmia 
that has caused or 
would likely have 
caused incapacity
You	should	not	drive	for	6	weeks.
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Tips about resuming driving
n	 If	you	are	in	any	doubt	about	your	fitness	to	drive,	
please	consult	your	doctor.
n	 When	you	resume	driving,	take	it	in	easy	stages.
n	 Driving	with	a	passenger	can	be	helpful.
n	 Avoid	heavy	traffic	and	motorways	until	you	know	
you	can	cope.
n	 Give	yourself	plenty	of	time	for	your	journey.
n	 Do	not	drive	for	longer	than	2	hours	without	a	break.
n	 Try	to	keep	calm	and	relaxed.	If	you	find	driving	
stressful,	leave	it	for	a	while	until	you	feel	a	bit	
better.
Know when to stop
You should stop driving if you experience:
n	 central	chest	pain,	tightness	or	pressure	that	may	
spread	to	your	jaw	or	arms,
n	 shortness	of	breath,
n	 excessive	fatigue,
n	 dizziness,	fainting,	nausea	or	sweatiness.
If you experience any of these symptoms, it is your legal 
responsibility as a driver to stop driving and consult 
with your doctor who will try to help you manage your 
symptoms. 
What if I don’t agree that I should 
stop driving?
If	your	doctor	tells	you	to	stop	driving	and	you	disagree,	
you	can	get	a	second	opinion.	You	must	stop	driving	until	
the	opinion	has	been	completed	and	you	get	permission	
to	drive	again.	
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What will happen if I still drive? 
It	is	important	to	strike	a	balance	between	mobility	and	
safety.	If	you	continue	to	drive	against	medical	advice	or	
ignore	early	warning	symptoms,	and	evidence	is	found	
of	this,	it	will	affect	your	insurance,	and	the	NDLS	and	
Gardaí	will	take	action	to	remove	your	licence.
How do I inform the NDLS?
If,	following	consultation	with	your	GP,	your	medical	
condition	is	one	that	needs	to	be	notified	to	the	NDLS,	
you	need	to	complete	forms	(1)	and	(2)	below	and	return	
in	person	to	any	NDLS	centre.
You need to bring:
1)		 a	completed	Driver	Licence	Application	Form;
2)		 a	Medical	Report	Form	(D501)	completed	by	your	
doctor	(a	letter	from	your	doctor	is	not	accepted);
3)		 proof	of	your	PPSN;	and
4)		 your	current	licence.	
You	will	then,	within	a	specified	time	frame,	be	issued	
with	a	new,	updated	licence.
Please	see	www.ndls.ie	for	locations/bookings	and	
forms.
If	you	have	more	questions,	please	email	
medicalfitness@rsa.ie	or	telephone	1890 40 60 40.
Please	note	if	you	have	supplied	a	medical	report	form	to	
obtain	your	existing	licence	or	permit	and	the	terms	of	
licence	or	permit	are	not	being	altered,	you	may	submit	
your	new	application	together	with	your	medical	report	
form	by	post	to:		
National	Driver	Licence	Service,	PO	Box	858,	Southside	
Delivery	Office,	Co	Cork.
Further information sources:
n	 Your	GP	or	nurse
n	 HSE	Web:	infoline1@hse.ie
n	 HSE	Helpline:	1850	24	1850
n	 IHF	Web:	http://www.irishheart.ie
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Chapter 4
Diabetes Mellitus29
Failure to meet these standards or the presence of any progressive neurological disorder requires the applicant or licence 
holder to inform the NDLS unless stated otherwise in the text. Group 2 standards are minimum standards and do not preclude 
employers setting higher standards in terms of the demands of the driving tasks encountered in the course of employment.
Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Insulin-Treated 
See Appendix to this chapter for 
advice to drivers.
• Has appropriate awareness 
of hypoglycaemia at 
appropriate glucose level. 
• Must not have had more 
than one episode of severe 
hypoglycaemia requiring the 
assistance of another person 
in the preceding twelve 
months.
• There must be appropriate 
blood glucose monitoring.
• Must not be regarded as a 
likely source of danger to the 
public while driving.
• The visual standards for 
acuity and visual field must 
be met.
Must not have impaired 
awareness of hypoglycaemia  
is defined as, ‘an inability 
to detect the onset of 
hypoglycaemia because of 
a total absence of warning 
symptoms’. 
If meets the medical standard 
a 1 or 3 year licence may be 
issued. 
Driver must notify NDLS.
May apply for any Group 2 licence. 
Must satisfy the following criteria:
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level. 
Impaired awareness of 
hypoglycaemia is defined as, ‘an 
inability to detect the onset of 
hypoglycaemia because of a total 
absence of warning symptoms’. 
• Regularly monitors blood 
glucose at least twice daily and 
at times relevant to driving 
using a glucose meter with a 
memory function to measure 
and record blood glucose levels. 
At the annual examination by 
a consultant endocrinologist, 
3 months of blood glucose 
readings must be available. 
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not obliged 
to provide a medical report on fitness 
to drive: in this case, the driver 
should be advised to seek a separate 
consultant endocrinologist for a 
medical report on fitness to drive.
Driver must notify NDLS.
29. Helpful recent reviews include: American Diabetes Association, Lorber D, Anderson J, Arent S, Cox DJ, Frier BM, Greene MA, Griffin J Jr, Gross G, Hathaway K, 
Hirsch I, Kohrman DB, Marrero DG, Songer TJ, Yatvin AL. Diabetes and driving. Diabetes Care. 2014 Jan;37 Suppl 1:S97-103.
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Temporary Insulin Treatment 
E.g. Post-Myocardial Infarction, 
participants in Oral/Inhaled 
Insulin Trials.
Provided they are under medical 
supervision, has appropriate 
awareness of hypoglycaemia at 
appropriate glucose level and 
have not been advised by their 
doctor that they are at risk of 
disabling hypoglycaemia, need 
not notify NDLS. If experiencing 
disabling hypoglycaemia, Driver 
must notify NDLS. 
Notify NDLS if treatment 
continues for more than 3 
months or for more than 3 
months after delivery for 
gestational diabetes.
May apply for any Group 2 licence. 
Must satisfy the following criteria 
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level.
Impaired awareness of 
hypoglycaemia is defined as, ‘an 
inability to detect the onset of 
hypoglycaemia because of a total 
absence of warning symptoms’. 
• Regularly monitors blood 
glucose at least twice daily and 
at times relevant to driving 
using a glucose meter with a 
memory function to measure 
and record blood glucose levels. 
At the annual examination by 
a consultant endocrinologist, 
3 months of blood glucose 
readings must be available. 
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not obliged 
to provide a medical report on fitness 
to drive: in this case, the patient 
should be advised to seek a separate 
consultant endocrinologist for a 
medical report on fitness to drive. 
Driver must notify NDLS.
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Managed by tablets which 
carry a risk of Inducing 
Hypoglycaemia. This includes 
Sulphonylureas and Glinides.
See Appendix to this chapter for 
advice to drivers. 
Must not have had more than 
one episode of hypoglycaemia 
requiring the assistance of 
another person within the 
preceding 12 months. It may be 
appropriate to monitor blood 
glucose regularly and driver 
should monitor blood glucose 
at times relevant to driving 
to enable the detection of 
hypoglycaemia. Has appropriate 
awareness of hypoglycaemia at 
appropriate glucose level. Must 
be under regular medical review. 
If however there has been a 
hypoglycaemic event in the 
preceding 12 months, Driver 
must notify NDLS.
If meets the medical standard 
a 1 or 3 year licence may be 
issued.
Must satisfy the following criteria:
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level.
• Must show adequate control 
of condition by regularly 
monitoring blood glucose at 
least twice daily and at times 
relevant to driving.
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not 
obliged to provide a medical report 
on fitness to drive: in this case, the 
patient should be advised to seek a 
separate consultant endocrinologist 
for a medical report on fitness to 
drive.
Driver must notify NDLS.
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Providing the drivers diabetes is 
managed only by:
• tablets other than those 
mentioned above 
or by 
• non-insulin injectable 
medication
See Appendix to this chapter for 
advice to drivers. 
Need not notify NDLS unless 
develop associated conditions 
which are relevant to driving. 
E.g. Diabetic eye problems 
affecting visual acuity or visual 
field or if insulin required.
Need not notify the NDLS unless 
they develop relevant disabilities 
e.g. diabetic eye problems affecting 
visual acuity or visual fields, in 
which case not fit to drive or or 
short period licence.
Drivers are advised to monitor their 
blood glucose regularly and at times 
relevant to driving. They must be 
under regular medical review.
Managed by diet alone Need not notify NDLS unless 
development of associated 
conditions which are relevant 
to driving e.g. diabetic eye 
problems affecting visual acuity 
or visual field or if insulin 
required.
Need not notify NDLS unless 
development of relevant disabilities 
e.g. diabetic eye problems affecting 
visual acuity or visual field or if 
insulin required.
Impaired awareness of 
Hypoglycaemia 
If confirmed, driving must 
stop. Fit to drive provided 
reports show awareness of 
hypoglycaemia has been 
regained, confirmed by 
consultant/GP report.
Not fit to drive. 
Driver must notify NDLS.
Continuous Glucose Monitoring 
Systems (CGMS)
Drivers must continue to 
produce all required blood 
glucose results stated elsewhere 
in this document by non 
CGMS means regardless of any 
additional use of CGMS.
Drivers must continue to produce 
all required blood glucose results 
stated elsewhere in this document 
by non CGMS means regardless of 
any additional use of CGMS.
Eyesight Complications (affecting 
visual acuity or fields)
See section: Visual Disorders 
Chapter 7.
See previous page for insulin  
treated and See section:  
Visual Disorders Chapter 7
Renal Disorders See section: Renal Disorders 
Chapter 8.
See section: Renal Disorders  
Chapter 8.
Limb Disability
E.g. Peripheral Neuropathy 
See section: Drivers with 
disabilities Chapter 10.
See section: Disabled Drivers  
Chapter 10.
68    Sláinte agus Tiomáint  |  Medical Fitness To Drive Guidelines  |  (Group 1 and Group 2 Drivers)
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
To view or download driver information leaflets visit www.rsa.ie or www.ndls.ie
Diabetes	
and	Driving
This	is	an	overview	of	driving	with	diabetes.	The	
complete	standards	are	published	in	Sláinte	agus	
Tiomáint:	Medical	Fitness	to	Drive	(MFTD)	Guidelines.
NDLS
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Be a responsible driver
It is your responsibility as a driver to:
n	 take	any	prescribed	medication,	monitor	and	manage	
your	condition(s);
n	 tell	the	National	Driver	Licence	Service	(NDLS)	
and	your	insurance	provider	of	any	long-term	or	
permanent	injury	or	illness	that	may	affect	your	
ability	to	drive	safely;
n	 comply	with	requirements	of	your	licence	as	
appropriate,	including	periodic	medical	reviews;	and
n	 get	professional	advice	on	your	medical	fitness	to	
drive	if	you	develop	a	medical	condition	during	the	
term	of	your	licence.
What is Diabetes?
Diabetes mellitus is a lifelong condition caused by 
a lack of insulin in your body. Insulin is a hormone 
that regulates blood glucose (sugar). If some of the 
treatments for diabetes (particularly insulin and certain 
types of the tablets) are not managed properly, this can 
cause ‘hypoglycaemia’ – low blood sugar levels. An 
episode of hypoglycaemia is sometimes called ‘a hypo’.
Hypoglycaemia	makes	you	feel	unwell	and	can	affect	
your	ability	to	drive	safely.	If	you	suffer	a	severe	hypo,	
it	means	you	need	someone	to	help	you	–	you	could	
become	dizzy	or	drowsy	and	you	need	to	get	your	sugar	
levels	under	control.	In	severe	cases,	you	could	lose	
consciousness.	The	risk	of	a	hypo	is	the	main	danger	to	
safe	driving	for	people	with	diabetes.	The	risk	increases	
the	longer	you	are	on	insulin	treatment.
If you get warning symptoms of a hypo whilst driving, 
you must always stop as soon as it is possible to do so 
safely. Do not ignore the warning symptoms.
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Note:	You	are	committing	an	offence	if	you	carry	on	
driving	after	you	become	aware	that	you	are	not	fit	to	
do	so.	‘Awareness’	can	be	your	own	awareness	–	that	is,	
things	you	notice	yourself	without	being	diagnosed	by	
a	doctor.	Awareness	can	also	be	as	a	result	of	a	warning	
not	to	drive	from	your	doctor.
What are the early warning 
symptoms of Hypoglycaemia?
The	early	symptoms	include:
n	 sweating
n	 shakiness	or	trembling
n	 feeling	weak	or	hungry
n	 fast	pulse	or	palpitations
n	 anxiety
n	 tingling	lips
If	you	do	not	get	treatment	for	these	early	signs,	you	may	
experience	more	severe	symptoms	such	as:
n	 slurred	speech
n	 difficulty	concentrating
n	 confusion
n	 disorderly	or	irrational	behaviour,	which	may	be	
mistaken	for	drunkenness
If	left	untreated,	you	could	lose	consciousness.
Drivers with insulin-treated diabetes are advised to take 
the following precautions to manage their condition  
and drive safely.
Carry
Always	carry	your	glucose	meter	and	blood	glucose	strips	
with	you.	You	must	check	your	blood	glucose	before	
driving	and	every	two	hours	whilst	driving.	Also,	always	
carry	personal identification	to	show	that	you	have	
diabetes	in	case	of	injury	in	a	road	traffic	accident.
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Measure
Blood	glucose	is	measured	in	‘millimoles	per	litre’	and	is	
written	as	mmol/l.	If	your	blood	glucose	is	5.0	mmol/l	or	
less,	have	a	snack.	If	it	is	less	than	4.0	mmol/l	or	you	feel	
hypoglycaemic,	do	not	drive.	Take	appropriate	action.	
Retest	to	ensure	your	blood	glucose	is	above	5.1	mmol/l.
Stop
If	you	develop	hypoglycaemia	while	driving,	stop	your	
vehicle	as	soon	as	possible.
Wait
Switch	off	the	engine,	take	the	keys	out	of	the	ignition,	
and	move	from	the	driver’s	seat.	Do not drive again until 
45 minutes after your blood glucose level has returned to 
normal.	It	takes	up	to	45	minutes	for	the	brain	to	recover	
fully.
Keep
Keep	an	emergency	supply	of	fast-acting	carbohydrate,	
such	as	glucose	tablets	or	sweets,	within	easy	reach	in	
your	vehicle.
Take
Always	take	regular	meals,	snacks	and	rest	periods	at	
least	every	two	hours	on	long	journeys.
Avoid
Always	avoid	alcohol.
IMPORTANT
Please	make	sure	that	your	meter	displays	the	correct	
time	and	date	so	that	you	have	a	record.
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Driver Guidelines
Group 1 – Driving a car, motor cycle or 
tractor
If you are a Group 1 driver, you must inform NDLS if:
n	 you	suffer	more	than	one	episode	of	severe	
hypoglycaemia	(where	you	need	someone	to	help	
you)	within	the	last	12	months.
Group 2 – Driving a bus or truck
If you are a Group 2 driver, you must inform NDLS if:
n	 you	suffer	one	episode	of	severe	hypoglycaemia;
n	 your	medical	team	feels	you	are	at	high	risk	of	
developing	hypoglycaemia;
n	 you	begin	to	have	difficulty	in	recognising	warning	
symptoms	of	low	blood	sugar	(impaired	awareness		
of	hypoglycaemia);
n	 you	suffer	severe	hypoglycaemia	while	driving;
n	 an	existing	medical	condition	gets	worse,	or	you	
develop	any	other	condition	that	may	affect	safe	
driving.
If	you	are	a	Group	1	or	Group	2	driver	applying	for,	or	
renewing	your	licence,	or	if	you	have	been	diagnosed	
with	diabetes,	you must inform NDLS if:
n	 you	are	treated	by	insulin,	or	if	your	diabetes	is	
managed	by	tablets	which	carry	a	risk	of	inducing	
hypoglycaemia	(bringing	on	a	hypo	attack),	for	
example	sulphonylureas.	(Ask	your	doctor	whether	
you	are	on	sulphonylureas	or	other	medications	
which	carry	a	risk	of	inducing	hypoglycaemia.)
n	 you	develop	any	problems	with	your	circulation	
or	sensation	in	your	legs	or	feet	which	makes	it	
necessary	for	you	to	drive	certain	types	of	vehicles	
only	(for	example,	automatic	vehicles	or	adapted	
vehicles).
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If	you	are	on	temporary	insulin	treatment,	you	should	
consult	with	your	doctor	as	to	whether	or	not	you	must	
notify	the	NDLS.
There	is	no	need	to	notify	the	NDLS	if	your	diabetes	is	
managed	by	diet	alone,	or	only	by	medications	which		
do	not	carry	a	risk	of	inducing	hypoglycaemia.
Diabetes and eyesight
n	 Diabetes	may	affect	your	eyesight.	You	should	have	
an	eye	test	at	least	every	year	carried	out	by	a	doctor	
or	optometrist	or	orthoptist.	They	might	recommend	
that	you	have	more	frequent	tests	at	regular	
intervals.	These	tests	should	be	a	full	examination	
including	the	back	of	the	eye.
What will happen if I still drive?
It	is	important	to	strike	a	balance	between	mobility	and	
safety.	If	you	continue	to	drive	against	medical	advice	or	
ignore	early	warning	symptoms,	and	evidence	is	found	
of	this,	it	will	affect	your	insurance,	and	the	NDLS	and	
Garda	will	take	action	to	remove	your	licence.
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How do I inform the NDLS?
If,	following	consultation	with	your	GP,	your	medical	
condition	is	one	that	needs	to	be	notified	to	the	NDLS,	
you	need	to	complete	forms	(1)	and	(2)	below	and	return	
in	person	to	any	NDLS	centre.
You need to bring:
1)		 a	completed	Driver	Licence	Application	Form;
2)		 a	Medical	Report	Form	(D501)	completed	by	your	
doctor	(a	letter	from	your	doctor	is	not	accepted);
3)		 proof	of	your	PPSN;	and
4)		 your	current	licence.	
You	will	then,	within	a	specified	time	frame,	be	issued	
with	a	new,	updated	licence.
Please	see	www.ndls.ie	for	locations/bookings		
and	forms.
If	you	have	more	questions,	please	email	
medicalfitness@rsa.ie	or	telephone	1890 40 60 40.
Please	note	if	you	have	supplied	a	medical	report	form	to	
obtain	your	existing	licence	or	permit	and	the	terms	of	
licence	or	permit	are	not	being	altered,	you	may	submit	
your	new	application	together	with	your	medical	report	
form	by	post	to:
National	Driver	Licence	Service
PO	Box	858
Southside	Delivery	Office
Co	Cork
Further information sources:
n	 Your	GP	or	nurse.
n	 Diabetes	Ireland	is	a	valuable	source	of	support		
and	information.
Web:		 www.diabetes.ie
Helpline:		1850	909	909
Email:		 info@diabetes.ie
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Anxiety or depression
(Without significant memory 
or concentration problems, 
agitation, behavioural 
disturbance or suicidal 
thoughts).
NDLS need not be notified and 
driving may continue. 
(See note about medication in 
Appendix at end of this Chapter). 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Very minor short-lived illnesses need 
not be notified to NDLS.
(See note about medication in 
Appendix at end of this Chapter). 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
More severe anxiety states or 
depressive illnesses
(With significant memory 
or concentration problems, 
agitation, behavioural 
disturbance or suicidal 
thoughts).
N.B. For cases which also 
involve persistent misuse of or 
dependence on alcohol/drugs, 
please refer to the appropriate 
section of the alcohol/drugs 
chapter (Chapter 6). Where 
psychiatric illness has been 
associated with substance 
misuse, continuing misuse is not 
acceptable for licensing.
Driving should cease pending 
the outcome of medical enquiry. 
A period of stability depending 
upon the circumstances will be 
required before driving can be 
resumed. Particularly dangerous 
are those who may attempt 
suicide at the wheel.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Driving should cease pending 
assessement by a consultant 
psychiatrist as being well and 
stable for a substantial period. 
Medication must not cause side 
effects which would interfere with 
alertness or concentration. Driving 
is usually permitted if the anxiety or 
depression is long-standing, but is 
controlled on doses of psychotropic 
medication which do not impair 
driving function. 
N.B. It is the illness rather than 
the medication, which is of prime 
importance, but see notes on 
medication. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Chapter 5
Psychiatric disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
See appendix at end of this chapter
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See appendix at end of this chapter
Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acute Psychotic disorders
of any type
N.B. For cases, which also
involve persistent misuse of or
dependence on alcohol/drugs,
please refer to the appropriate
section of the alcohol/drugs
chapter (Chapter 6). Where
psychiatric illness has been
associated with substance
misuse, continuing misuse is not
acceptable for licensing.
Driving must cease during the
acute illness. Return to driving
can be considered when all of
the following conditions can be
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In 
line with good practice, 
attempts should be made 
to achieve the minimum 
effective antipsychotic 
dose; tolerability should be 
optimal and not associated 
with any deficits (e.g. in 
alertness, concentration and 
motor performance) that 
might impair driving ability.
Driver must notify NDLS if
medical advice is to cease
driving for 6 months or longer.
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve the 
minimum effective antipsychotic 
dose; tolerability should be 
optimal and not associated with 
any deficits (e.g. in alertness, 
concentration and motor 
performance) that might impair 
driving ability. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Hypomania/Mania
N.B. For cases, which also 
involve persistent misuse of or 
dependence on alcohol/drugs, 
please refer to the appropriate 
section of Chapter 6. Where 
psychiatric illness has been 
associated with substance 
misuse, continuing misuse is not 
acceptable for licensing.
Driving must cease during the 
acute illness. Return to driving 
can be considered when all of 
the following conditions can be 
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In 
line with good practice, 
attempts should be made 
to achieve the minimum 
effective antipsychotic 
dose; tolerability should be 
optimal and not associated 
with any deficits (e.g. in 
alertness, concentration and 
motor performance) that 
might impair driving ability. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer. 
Repeated changes of mood: 
Hypomania or mania are 
particularly dangerous to 
driving when there are repeated 
changes of mood. In such cases 
a specialist opinion from a 
consultant psychiatrist is advised.
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve the 
minimum effective antipsychotic 
dose; tolerability should be 
optimal and not associated with 
any deficits (e.g. in alertness, 
concentration and motor 
performance) that might impair 
driving ability. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Relapsing/remitting 
Schizophrenia and Psychoses
N.B. For cases, which also
involve persistent misuse of
or dependence on
alcohol/drugs, please refer
to the appropriate section of
Chapter 6. Where
psychiatric illness has been
associated with substance
misuse, continuing misuse is
not acceptable for licensing.
Return to driving can be 
considered when all of the 
following conditions can be 
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve 
the minimum effective anti-
psychotic dose; tolerability 
should be optimal and 
not associated with any 
deficits (e.g. in alertness, 
concentration and motor 
performance) that might 
impair driving ability.
Continued on next page
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve 
the minimum effective anti-
psychotic dose; tolerability 
should be optimal and not 
associated with any deficits (e.g. 
in alertness, concentration and 
motor performance) that might 
impair driving ability. 
Continued on next page
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Relapsing/remitting 
Schizophrenia and Psychoses
Continued from previous page
Continuing symptoms:
Even with limited insight, these 
do not necessarily preclude 
licensing. Symptoms should 
be unlikely to cause significant 
concentration problems, 
memory impairment or 
distraction whilst driving. 
Particularly dangerous, are 
those drivers whose psychotic 
symptoms relate to other road 
users.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer. 
Due consideration should be 
given to specialist on-road 
assessment if doubt remains 
about fitness to drive.
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Developmental disorders
Includes Asperger’s Syndrome, 
autism, severe communication 
disorders and Attention Deficit 
Hyperactivity Disorder.
A diagnosis of any of these 
conditions is not in itself a bar 
to licensing. Factors such as 
impulsivity, lack of awareness of 
the impact of own behaviours 
on self or others need to be 
considered.
It is normally a requirement that the 
person is assessed by a consultant 
psychiatrist. Continuing minor 
symptomatology may be compatible 
with licensing. Cases will be 
considered on an individual basis.
Attention deficit hyperactivity 
disorder (ADHD)30 
 Compliance with medication is 
associated with reduced crash 
risk in ADHD. 
Compliance with medication is 
associated with reduced crash risk 
in ADHD.  
See appendix at end of this chapter
30.  Fuermaier AB, Tucha L, Evans BL, Koerts J, de Waard D, Brookhuis K,Aschenbrenner S, Thome J, Lange KW, Tucha O. Driving and attention deficit hyperactivity 
disorder. J Neural Transm. 2015 Sep 29. [Epub ahead of print] PubMed PMID: 26419597.
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Mild Cognitive Impairment (MCI) Where there is no objective 
impairment of function MCI 
does not need to be notified to 
NDLS. Where there is objective 
impairment of function or 
specific treatment is required 
then MCI will not be the cause 
and doctor should clarify the 
cause and apply the relevant 
section of Sláinte agus Tiomáint.
Given that a significant 
proportion of people with 
MCI progress to dementia 
over time, at least yearly 
review of diagnostic status is 
recommended to monitor for 
transition to dementia by the 
doctor31.
If MCI is suspected a specialist 
opinion is required and at least 
yearly review. If meets the medical 
standards a 1 year licence may be 
issued.
Where there is no objective 
impairment of function MCI 
does not need to be notified to 
NDLS. Where there is objective 
impairment of function or specific 
treatment is required then MCI will 
not be the cause and doctor (it is 
normally a requirement that the 
person is assessed by a consultant 
psychiatrist, geriatrician or 
neurologist) should clarify the cause 
and apply the relevant section of 
Sláinte agus Tiomáint.
See appendix at end of this chapter
31.  http://www.alzheimer.ie/Alzheimer/media/SiteMedia/Helpline%20and%20Information%20Resources/Info%20Pack%20PDF’s/Giving-Up-Driving_Section-D1_
web-view_1.pdf.
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Dementia or any Organic  
Brain Syndrome32
It can be difficult to assess 
driving ability in those with 
dementia. Those who have 
poor short-term memory, 
disorientation, lack of insight 
and judgement are almost 
certainly not fit to drive.
The variable presentations 
and rates of progression are 
acknowledged. Disorders 
of attention will also cause 
impairment. A decision 
regarding fitness to drive is 
usually based on consultant 
medical assessment, further 
assessment by occupational 
therapy and/or neuropsychology, 
with a low threshold for an on-
road driving assessment33.
In early dementia when 
sufficient skills are retained and 
progression is slow, a licence 
may be issued subject to annual 
review or sooner if a significant 
medical or functional decline 
is noted. A formal driving 
assessment is generally an 
integral part of assessment and 
review but the overall decision 
rests with the treating doctor 
(see section 3.6).
Driver must notify NDLS.
See Section: 2.3.1 Chapter 1.
Not fit to Drive.
Driver must notify NDLS. 
See Section: 2.3.1 Chapter 1.
32.  Carr DB, O’Neill D. Mobility and safety issues in drivers with dementia. Int, Psychogeriatr. 2015 Jun 26:1-10.
33.  http://www.alzheimer.ie/Alzheimer/media/SiteMedia/Helpline%20and%20Information%20Resources/Info%20Pack%20PDF’s/Giving-Up-Driving_Section-D1_
web-view_1.pdf.
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Learning disability
Severely below average general 
intellectual functioning 
accompanied by significant 
limitations in adaptive 
functioning in at least two of the 
following areas: communication, 
self-care, home-living, social/
interpersonal skills, use of 
community resources, self-
direction, functional academic 
skills, work, leisure, health and 
safety.
Severe learning disability is not 
compatible with driving and 
the licence application must 
be refused. In milder forms, 
provided there are no other 
relevant problems, it may be 
possible to hold a licence.
Moderate and severe learning 
disability is not compatible with 
driving and the licence application 
must be refused. Minor degrees 
of learning disability when the 
condition is stable with no medical 
or psychiatric complications may be 
compatible with the holding of a 
licence.
Behaviour disorders 
Includes post head injury 
syndrome and Non-Epileptic 
Seizure Disorder.
If seriously disturbed e.g. violent 
behaviour or alcohol abuse and 
likely to be a source of danger 
at the wheel, driving must 
cease. After medical assessment 
confirms that behavioural 
disturbances have been 
satisfactorily controlled, driving 
can resume. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Not compatible with driving and 
the licence application must be 
refused if associated with serious 
behaviour disturbance likely to 
make the individual be a source of 
danger at the wheel. If assessment 
by consultant psychiatric confirms 
enduring stability, then return to 
driving can be considered. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Personality disorders If likely to be a source of 
danger at the wheel cessation 
of driving is required or the 
application refused. Licensing 
may be permitted providing 
medical enquiry confirms that 
any behaviour disturbance is 
not related to driving or not 
likely to adversely affect driving 
or road safety.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Cessation of driving is required or 
refusal of application if associated 
with serious behaviour disturbance 
likely to make the individual be 
a source of danger at the wheel. 
In such cases licensing can be 
considered if assessment by 
consultant psychiatrist confirms 
stability. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
See appendix at end of this chapter
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Appendix — Chapter 5
Psychiatric notes
Important Notes
Other psychiatric conditions, which do not fit neatly into the aforementioned classification, will need to be reported to 
the National Driver Licence Service (NDLS) if causing or felt likely to cause symptoms affecting driving safety. These would 
include for example any impairment of consciousness or awareness, any increased liability to distraction or symptoms 
affecting the safe operation of vehicle controls. The driver should be advised to declare both the condition and symptoms 
of concern.
It is the relationship of symptoms to driving that is of importance.
• Directive (91/439/EEC) as amended by Directive 2009/112/113/EC requires member states to set minimum medical 
standards of fitness to drive and sets out the requirements for mental health in broad terms.
• These Directives make a clear distinction between the standards needed for Group 1 (car and motorcycles) and Group 2 
(lorries and buses) licences. The standards for the latter being more stringent due to the size of vehicle and the greater 
time spent at the wheel during the course of the occupation.
• Severe mental disorder for the purposes of these Guidelines is defined as including mental illness, arrested or 
incomplete development of the mind, psychopathic disorder or severe impairment of intelligence or social functioning. 
The standards must reflect, not only the need for an improvement in the mental state, but also a period of stability, 
such that the risk of relapse can be assessed should the driver fail to recognise any deterioration, this is especially 
pertinent in the assessment of Group 2 licence.
• Misuse of or dependence on alcohol or drugs will require the standards in this chapter to be considered in conjunction 
with those of Chapter 6 of this publication.
Medication
• Any person who drives, attempts to drive or is in charge of a vehicle in a public place whilst under the influence of 
an intoxicant (including a drug or drugs) to such an extent as to be incapable of having proper control of the vehicle 
is liable to prosecution, as set out in the Road Traffic Acts. 
• All drugs acting on the central nervous system can impair alertness, concentration and driving performance. This 
is particularly so at initiation of treatment, or soon after and when dosage is being increased. Driving must cease if 
adversely affected until the patient is unimpaired.
• The older tricyclic antidepressants can have pronounced anticholinergic and antihistaminic effects, which may impair 
driving. The more modern antidepressants may have fewer adverse effects. These considerations need to be taken 
into account when planning the treatment of a patient who is a professional driver.
• Antipsychotic drugs, including the depot preparations, can cause motor or extrapyramidal effects as well as sedation 
or poor concentration, which may, either alone or in combination, be sufficient to impair driving. Careful clinical 
assessment is required.
• The epileptogenic potential of psychotropic medication should be considered particularly when drivers are professional 
drivers.
• Benzodiazepines are the most likely psychotropic medication to impair driving performance, particularly the long 
acting compounds. Alcohol will potentiate the effects.
• Doctors and pharmacists have a duty of care to advise drivers of the potential dangers of adverse effects from medication 
and interactions with other substances, especially alcohol.
• Drivers with psychiatric illnesses are often safer when well and on regular psychotropic medication than when they 
are ill. Inadequate treatment or irregular compliance may render a driver impaired by both the illness and medication.
Confidentiality
See Part A, Introduction Chapter 1, Section 2.3.1
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Alcohol Problems Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol misuse
There is no single definition 
which embraces all the variables 
in this condition but the 
following is offered as a guide:
“A state which, because of 
consumption of alcohol, causes 
disturbance of behaviour, related 
disease or other consequences, 
likely to cause the patient, his/
her family or society harm now, 
or in the future, and which may 
or may not be associated with 
dependence”. 
Reference to ICD10 F10.1 is 
relevant.
Persistent alcohol misuse, 
confirmed by medical enquiry 
with or without evidence 
of otherwise unexplained 
abnormal blood biomarkers, 
requires cessation from driving 
until a minimum 3 month 
period of controlled drinking 
or abstinence has been 
attained, with normalisation of 
biomarkers, if relevant. 
Driver to seek advice from 
medical or other sources during 
the period off the road. 
Driver must notify NDLS.
Persistent alcohol misuse, 
confirmed by medical enquiry with 
or without evidence of otherwise 
unexplained abnormal blood 
biomarkers, requires cessation from 
driving until a minimum 1 year 
period of abstinence or controlled 
drinking has been attained, with 
normalisation of biomarkers, if 
relevant. 
 
Driver to seek advice from medical 
or other sources during the period 
off the road. 
Driver must notify NDLS.
Chapter 6: Part 1
Alcohol misuse and dependence
The presence of any of the conditions listed below requires the applicant or licence holder to inform the National Driver 
Licence Service (NDLS) unless stated otherwise in the text. Group 2 standards are minimum standards and do not preclude 
employers setting higher standards in terms of the demands of the driving tasks encountered in the course of employment.
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Alcohol Problems Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol dependence
“A cluster of behavioural, 
cognitive and physiological 
phenomena that develop after 
•  repeated alcohol use and 
which include a strong 
desire to take alcohol, 
• difficulties in controlling 
its use, 
• persistence in its 
use despite harmful 
consequences, with 
evidence of increased 
tolerance and sometimes a 
physical withdrawal state.” 
Indicators may include a history 
of withdrawal symptoms, of 
tolerance, of detoxification(s) 
and/or alcohol related fits.
Alcohol dependence, confirmed 
by medical enquiry, requires 
cessation from driving until 
a 6 month period free from 
alcohol has been attained with 
normalisation of biomarkers, if 
relevant. 
Driver must notify NDLS.
Return to Driving 
Will require satisfactory 
medical assessment from own 
doctor(s) and management of 
blood biomarkers if relevant. 
Consultant support/referral may 
be necessary.
See also under “Alcohol related 
seizures”.
Group 2 licence will not be granted 
where there is a history of alcohol 
dependence within the past 3 years. 
Driver must notify NDLS. 
Return to Driving
Will require satisfactory medical 
assessment from own doctor(s) and 
management of blood biomarkers 
if relevant. Consultant support/
referral may be necessary.
See also under “Alcohol related 
seizures”.
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car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol related seizures
Seizures associated with alcohol 
are not considered provoked for 
licensing purposes. 
Following a solitary alcohol-
related seizure, cessation 
from driving for a minimum 6 
month period from the date 
of the event. Should however 
the seizure have occurred on 
a background of alcohol, the 
standards for such conditions 
will need to be satisfied before 
a new application can be 
considered. Where more than 
one seizure has occurred, the 
epilepsy standards will apply 
(See Appendix to Neurology 
Chapter 2 for full details). Return 
to driving should only occur 
after an appropriate period 
free from persistent alcohol 
misuse and/or dependence. 
Independent medical 
assessment with management 
of blood biomarkers if relevant 
and consultant reports will 
normally be necessary.
Driver must notify NDLS.
Following a solitary alcohol-related 
seizure, a cessation from driving for 
a minimum 5 year period from the 
date of the event. 
Return to driving thereafter requires: 
• No underlying cerebral 
structural abnormality. 
• Off antiepileptic medication for 
at least 5 years. 
• Maintained abstinence from 
alcohol if previously dependent. 
• Review by an addiction specialist 
and neurological opinion. 
Where more than one seizure has 
occurred or there is an underlying 
cerebral structural abnormality, the 
Group 2 epilepsy standards apply. 
(See Appendix to Neurology Chapter 
for full details). 
Driver must notify NDLS.
Alcohol related disorders
E.g. Hepatic cirrhosis with 
neuro-psychiatric impairment, 
psychosis.
Driving should cease until there 
is satisfactory recovery and is 
able to satisfy all other relevant 
medical standards. 
Driver must notify NDLS.
Driving should cease. 
Driver must notify NDLS.
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To view or download information advice leaflets visit www.rsa.ie or www.ndls.ie
NDLS
Alcohol	and	Driving
This	is	an	overview	of	the	driving	risks	for	drivers	who	
misuse	alcohol	and	have	alcohol-dependence	issues.	
Full	guidelines	are	published	in	Sláinte	agus	Tiomáint:	
Medical	Fitness	to	Drive	(MFTD)	Guidelines.
Alcohol	and	speed	are	two	leading	factors	in	fatal	collisions.	
Alcohol	was	shown	to	be	a	factor	in	over	15%	of	fatal	collisions	
in	2007	(Review of Pre-crash Behaviour in Fatal Road Collisions 
Report 1:	Alcohol,	RSA	Research	Department,	2011.)
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Be a responsible driver
It is your responsibility as a driver to:
n	 take	any	prescribed	medication	and	manage	your	
condition(s);
n	 tell	the	National	Driver	Licence	Service	(NDLS)	
and	your	insurance	provider	of	any	long-term	or	
permanent	injury	or	illness	that	may	affect	your	
ability	to	drive	safely;
n	 comply	with	requirements	of	your	licence	as	
appropriate,	including	periodic	medical	reviews;
n	 get	medical	advice	on	your	medical	fitness	to	drive	if	
you	develop	a	medical	condition	during	the	term	of	
your	licence.
Effects of alcohol use on driving
As	a	driver,	you	should	be	aware	that	alcohol	can	impair	
your	driving.	For	example,	using	alcohol	can	make	you	
tired	and	affect	your	concentration,	which	reduces	your	
ability	to	drive	safely.	You	also	need	to	be	aware	of	how	
long	it	takes	for	alcohol	to	leave	the	body.	Many	people	
underestimate	how	long	it	takes	and,	as	a	result,	their	
driving	may	be	impaired	and/or	they	may	be	over	the	
legal	limit.	
As	a	general	rule,	you	should	allow	at	least	one	hour	
for	each	unit	of	alcohol	(for	example,	a	glass	of	beer)	to	
leave	the	body.	However,	it	may	take	longer	than	that,	as	
other	factors	–	such	as	body	size,	or	how	recently	you’ve	
eaten	–	can	also	have	an	effect.
Never ever drink and drive. Any amount of alcohol 
impairs your driving.
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For further advice and information 
on alcohol and your health visit:
Health Service Executive: 
http://www.hse.ie/go/alcohol	and	or
Alcohol Action Ireland: 
http://alcoholireland.ie
Road Safety Authority 
http://www.rsa.ie
Alcohol Misuse
If	you	misuse	alcohol,	you	may	drift	into	addiction.	There	
is	no	clear	line	between	misuse	and	addiction	–	one	fades	
into	the	other.	If	you	experience	any	of	the	following,	
then	you	may	be	misusing	alcohol:
n	 disturbances	of	behaviour;
n	 alcohol-related	diseases	(liver,	stomach,	mental	
health	problems,	and	so	on);
n	 actions	that	cause	you,	your	family	or	society	harm,	
now	or	in	the	future.
Alcohol Misuse –  
Driver Responsibilities
Group 1 - Driving a car, motor cycle or 
tractor
If you are a Group 1 driver, you must inform NDLS if:
n	 your	doctor	or	other	health	professional	advises	you	
to	stop	driving	because	of	your	persistent	alcohol	
misuse.	You	must	do	so	until	they	confirm	that	
you	have	achieved	a	minimum	period	of	3	months	
controlled	drinking	or	abstinence.	This	assessment	
may	also	include	blood	tests.
6378_RSA Alcohol and Driving.indd   3 20/04/2017   16:57
Group 2 - Driving a bus or truck
If you are a Group 2 driver, you must inform NDLS	if	your	
doctor	or	other	health	professional	advises	you	to	stop	
driving	because	of	your	persistent	alcohol	misuse.
You	must	do	so	until	they	confirm	that	you	have	achieved	
a	minimum	period	of	1 year	controlled	drinking	or	
abstinence.	This	assessment	may	also	include	blood	
tests.
Alcohol dependence
Alcohol	dependence	is	a	condition	that	develops	after	
repeated	alcohol	use.	People	who	are	alcohol-dependent	
will	have	experienced	three	or	more	of	the	following	
symptoms	during	the	past	year:
n	 have	a	strong	desire	to	drink	alcohol,
n	 have	difficulty	controlling	their	use	of	alcohol,
n	 persist	in	using	alcohol	despite	the	harmful	
consequences,
n	 have	an	increased	tolerance	for	high	levels	of	alcohol,
n	 have	neglected	other	pleasures	or	interests.
Other	indicators	of	alcohol	dependence	may	include	a	
history	of	tolerance,	of	detoxification(s)	and	or	alcohol-
related	fits.
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Alcohol Dependence –  
Driver Responsibilities
Group 1 – Driving a car, motor cycle or 
tractor
If you are a Group 1 driver, you must inform NDLS if:
n	 a	doctor	or	other	health	professional	confirms	that	
you	have	an	alcohol	dependence.	In	this	case,	you	
must	stop	driving	until	your	doctor	confirms	that	
you	have	achieved	6	months	free	from	alcohol.	This	
assessment	may	also	include	blood	tests.
Group 2 – Driving a bus or truck
If you are a Group 2 driver, you must inform NDLS if:
n	 a	doctor	or	other	health	professional	confirms	that	
you	have	an	alcohol	dependence.	In	this	case,	you	
must	stop	driving	until	your	doctor	confirms	that	
you	have	achieved	3	years	free	from	alcohol.	This	
assessment	may	also	include	blood	tests.	Specialist	
support	may	be	necessary.
What if I don’t feel that my 
alcohol intake is a problem?
If	you	disagree	with	medical	opinion,	and	don’t	believe	
you	have	an	alcohol	misuse	or	dependence	condition,	
you	can	get	a	second	opinion.	You	must	stop	driving	until	
this	second	opinion	has	been	completed.
What will happen if I still drive?
It	is	important	to	strike	a	balance	between	mobility	and	
safety.	If	you	continue	to	drive	against	medical	advice,	
and	evidence	is	found	of	this,	it	will	affect	your	insurance,	
and	the	NDLS	and	An	Garda	Síochána	will	take	action	to	
remove	your	licence.	It	is	important	to	remember	that	
driving	over	the	limit	is	a	statutory	offence	and	you	will	
be	prosecuted.
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How do I inform the NDLS?
If,	following	consultation	with	your	GP,	your	medical	
condition	is	one	that	needs	to	be	notified	to	the	NDLS,	
you	need	to	complete	forms	(1)	and	(2)	below	and	return	
in	person	to	any	NDLS	centre.
You need to bring:
1)		 a	completed	Driver	Licence	Application	Form;
2)		 a	Medical	Report	Form	(D501)	completed	by	your	
doctor	(a	letter	from	your	doctor	is	not	accepted);
3)		 proof	of	your	PPSN;	and
4)		 your	current	licence.	
You	will	then,	within	a	specified	time	frame,	be	issued	
with	a	new,	updated	licence.
Please	see	www.ndls.ie	for	locations/bookings		
and	forms.
If	you	have	more	questions,	please	email	
medicalfitness@rsa.ie	or	telephone	1890 40 60 40.
Please	note	if	you	have	supplied	a	medical	report	form	to	
obtain	your	existing	licence	or	permit	and	the	terms	of	
licence	or	permit	are	not	being	altered,	you	may	submit	
your	new	application	together	with	your	medical	report	
form	by	post	to:
National	Driver	Licence	Service
PO	Box	858
Southside	Delivery	Office
Co	Cork.
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Further information sources:
n	 Your GP or nurse or counsellor	–	will	advise	you	on	
the	next	steps,	and	direct	you	on	how	to	seek	help.
n	 HSE Alcohol & Drugs Helpline 1800 459 459		
This	helpline	is	open	Mon	–	Fri	10am-5pm.
Email:	drugshiv@hse.ie		
(You	will	receive	a	reply	within	3	working	days.)
Web: www.drugs.ie
Everyone can choose never to drink and drive. You can 
help yourself and others by remembering the following 
advice:
n	 Before	drinking	in	a	group,	choose	a	designated	
driver	–	a	non-drinking	driver.
n	 If	you’re	out	drinking,	get	a	lift	home	with	a		
non-drinking	driver,	or	call	a	taxi.
n	 Don’t	let	friends	drink	and	drive.
n	 Choose	not	to	binge	drink	yourself,	and	help	others	
not	to	do	it.
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Drug Misuse and Dependence
Reference to ICD10 F10.1-F10.7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Cannabis
The non-prescribed use of this 
drug and/or the use of supra- 
therapeutic dosage constitutes 
misuse/ dependence for 
licensing purposes. 
The prescribed use of medicinal 
cannabis at therapeutic doses 
(MIMS/BNF/PIL), without 
evidence of impairment, 
does not amount to misuse/
dependence for licensing 
purposes (although clinically 
dependence may exist). 
See also Chapter 1, s3.9.2 The 
effects of specific medicine 
classes
Persistent use of or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 3 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of 
illicit substances. 
Driver must notify NDLS.
Persistent use of or dependence 
on these substances, confirmed by 
medical enquiry, requires cessation 
from driving until a minimum 
1 year period free of such use has 
been attained. Specialist medical 
assessment (including accredited 
Level 2 trained GP) and drug screen 
may be required. There should be no 
evidence of continuing use of illicit 
substances.
Driver must notify NDLS.
Cocaine, Amphetamines, 
Methamphetamine
Ecstasy, ketamine & other 
psychoactive substances, 
including LSD and hallucinogens, 
psychoactive substances (Head 
shop products).
Persistent use of or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 6 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of 
illicit substances.
Driver must notify NDLS.
Persistent use of or dependence 
on these substances, confirmed by 
medical enquiry, requires cessation 
from driving until a minimum 
1 year period free of such use has 
been attained. Specialist medical 
assessment (including accredited 
Level 2 trained GP) and drug screen 
may be required. There should be no 
evidence of continuing use of illicit 
substances.
Driver must notify NDLS.
Chapter 6: Part 2
Drug misuse and dependence
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Drug Misuse and Dependence
Reference to ICD10 F10.1-F10.7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Heroin, Methadone* and other 
opiates including Codeine
The prescribed use of these 
drugs at therapeutic doses 
(MIMS/BNF), without evidence 
of impairment, does not amount 
to misuse/dependence for 
licensing purposes (although 
clinically dependence may exist).
Persistent use of, or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 6 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing illicit use 
of such substances.
*Applicants or drivers who are 
complying fully and are stable 
on a supervised oral methadone 
substitution programme may 
continue to drive, subject 
to favourable assessment 
and annual medical review. 
Applicants or drivers on an oral 
buprenorphine programme may 
be considered applying the same 
criteria. There should be no 
evidence of continuing illicit use 
of such substances.
Driver must notify NDLS.
Persistent use of, or dependence 
on these substances, confirmed by 
medical enquiry requires cessation 
from driving until a minimum 3 
year period free of such use has 
been attained. Specialist medical 
assessment (including accredited 
Level 2 trained GP) and drug screen 
will normally be required. 
*Applicants or drivers complying 
fully with a consultant supervised 
oral methadone maintenance 
programme may be considered for 
an annual review licence once a 
minimum 3 year period of stability 
on the maintenance programme 
has been established, with 
favourable random drug tests and 
assessment. There should be no 
evidence of continuing illicit use of 
such substances and no evidence of 
disorders of cognition, attention or 
insight.
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10.1-F10.7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Benzodiazepines
The non-prescribed use of these 
drugs and/or the use of supra-
therapeutic dosage, whether 
in a substance withdrawal/
maintenance programme or 
otherwise, constitutes misuse/
dependence for licensing 
purposes.
The prescribed use of these 
drugs at therapeutic doses 
(MIMS/BNF), without evidence 
of impairment, does not amount 
to misuse/dependence for 
licensing purposes (although 
clinically dependence may exist).
Persistent misuse of, or 
dependence on these 
substances, confirmed by 
medical enquiry, requires driving 
cessation until a minimum 
6 month period free of such use 
has been attained. Independent 
medical assessment and drug 
screen may be required. In 
addition favourable consultant 
or specialist report may be 
required.
Driver must notify NDLS.
Persistent misuse of, or dependence 
on these substances, confirmed 
by medical enquiry, requires 
driving cessation until a minimum 
3 year period free of such use has 
been attained. Specialist medical 
assessment (including accredited 
Level 2 trained GP) and drug screen 
may be required. 
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10.1-F10.7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Seizure(s) associated with drug 
misuse/dependence 
Seizures associated with 
drug misuse/dependence are 
not considered provoked for 
licensing purposes.
Following a solitary seizure 
associated with drug misuse or 
dependence, driving must cease 
for a minimum 6 month period 
from the date of the event. 
Should however, the seizure 
have occurred on a background 
of substance misuse or 
dependence, the standards for 
such conditions will also need 
to be satisfied before return 
to driving. Where more than 
one seizure has occurred, the 
epilepsy standards will apply 
(See Appendix Neurology 
Chapter 2 for full details). 
Medical enquiry will be required 
before driving to confirm 
appropriate period free from 
persistent drug misuse and/
or dependence. Independent 
medical assessment with urine 
analysis and consultant reports 
will normally be necessary. 
Driver must notify NDLS.
Following a solitary seizure 
associated with drug misuse or 
dependence, driving must cease for 
a minimum 5 year period from the 
date of the event.
Return to driving thereafter requires:
• No underlying cerebral 
structural abnormality.
• Off antiepileptic medication for 
at least 5 years.
• Maintained abstinence from 
drugs if previously dependent.
• Review by an addiction specialist 
and neurological opinion.
Where more than one seizure has 
occurred, the epilepsy standards 
will apply (See Appendix Neurology 
Chapter 2 for full details). 
Driver must notify NDLS.
N.B. A person who has resumed driving following persistent drug misuse or dependence must be advised as 
part of their after-care that if their condition recurs they should cease driving and notify the NDLS.
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acuity Must have binocular visual 
acuity, with corrective lens as 
necessary, of at least 6/12 (0.5 
decimal) on a Snellen chart.
If the driver has an illness likely 
to cause progressive loss of 
visual acuity the NDLS must be 
notified and on the advice of a 
competent medical authority, 
a 1 or 3 year licence may be 
appropriate.
Drivers must have a visual acuity, 
using corrective lenses if necessary, 
of at least 6/7.5 (0.8 decimal) in the 
better eye and at least 6/60 Snellen 
(0.1 decimal) in the other eye.
Where glasses are worn to meet  
the minimum standards, they 
should have a corrective power  
≤ +8 dioptres. 
It is also necessary for all drivers of 
Group 2 vehicles to be able to meet 
the prescribed and relevant Group 1 
visual acuity requirements.
Cataract
Includes severe bilateral 
cataracts, failed bilateral 
cataract extractions and post 
cataract surgery where these are 
affecting the eyesight.
Must be able to meet the acuity 
and visual field requirements, 
and more detailed specialist 
examination (see Appendix to 
this chapter, Item A) is indicated 
if there is concern that these are 
not adequately met. 
Must be able to meet the above 
prescribed acuity requirement. 
In the presence of cataract, glare 
may affect acuity and visual field 
requirements, and more detailed 
specialist examination (see Appendix 
to this chapter, Item A) is indicated 
if there is concern that these are not 
adequately met.
Chapter 7
Visual disorders
A licence holder or applicant must meet the standards for visual acuity and fields (assessed by a confrontation visual field test 
in the first instance) as outlined below, and if there is reason to doubt that these are adequate, the applicant or licence holder 
should undergo a more detailed examination by a specialist (an ophthalmologist or orthoptist or other medical practitioner 
with a special interest in defects of eyesight or optometrist) - see Appendix to this chapter, Item A, elements which should be 
assessed in more detailed assessment.
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
Bioptic telescope devices are not accepted for driving by the NDLS.
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Monocular vision
(Includes the use of one eye only 
for driving)
Complete loss of vision in 
one eye (i.e. if there is any 
light perception, driver is not 
considered monocular). Must 
notify NDLS but may drive when 
clinically advised by a competent 
medical authority that driver 
has adapted to the disability and 
the prescribed eyesight standard 
in the remaining eye can be 
satisfied and there is a normal 
monocular visual field in the 
remaining eye, i.e. there is no 
area of defect which is caused by 
pathology. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Complete loss of vision in one eye 
or corrected acuity of less than 6/60 
(0.1 decimal) applicants may not 
hold a Group 2 licence.
Driver must notify NDLS if medical 
advice is to cease driving. 
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Visual field defects
Disorders such as severe 
bilateral glaucoma, severe 
bilateral retinopathy, retinitis 
pigmentosa and other disorders 
producing significant field defect 
including partial or complete 
homonymous hemianopia/
quadrantanopia or complete 
bitemporal hemianopia.
Driving must cease unless 
confirmed that the horizontal 
visual field is at least 120 
degrees, the extension is at 
least 50 degrees left and right 
and 20 degrees up and down. 
No defects should be present 
within a radius of the central 
20 degrees. If the driver has an 
illness likely to cause progressive 
loss of visual field, NDLS must 
be notified and on advice by a 
competent medical authority, 
a 1 or 3 year licence may be 
appropriate.
See item B of Appendix at end 
of this chapter for guidance on 
more detailed assessment of 
visual fields. 
See item C of Appendix at end 
of this chapter for consideration 
as an exceptional case if not 
meeting these standards.
The horizontal visual field should be 
at least 160 degrees, the extension 
should be at least 70 degrees left 
and right and 30 degrees up and 
down. No defects should be present 
within a radius of the central 30 
degrees. 
It is recommended that formal 
perimetry is undertaken for  
Group 2 drivers.
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Diplopia Cease driving on detection. 
Resume driving on confirmation 
to the NDLS that the diplopia 
is controlled by glasses (with 
or without a prism) or by 
a patch which the licence 
holder undertakes to wear 
while driving. (If patching, 
note requirements above for 
monocularity). 
Exceptionally a stable 
uncorrected diplopia of 
appropriate duration (for 
example, 6 months or more) 
may be compatible with 
driving if there is support 
from a competent medical 
authority indicating satisfactory 
functional adaptation. For 
treated decompensated phoria, 
driving can resume without 
informing the NDLS.
Cease driving on detection. 
Cease driving if permanent 
intractable diplopia. Patching is  
not acceptable.
Night blindness Acuity and field standards 
must be met. Cases should be 
considered on an individual basis 
by an appropriately qualified 
medical authority.
Group 2 acuity and field standards 
must be met and cases will then be 
considered on an individual basis.
Colour blindness Need not notify NDLS. Driving 
may continue with no restriction 
on licence.
Need not notify NDLS. Driving may 
continue with no restriction on 
licence.
See appendix at end of this chapter
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Appendix — Chapter 7
Visual notes
VISION REQUIREMENTS FOR HOLDING OF GROUP 1 LICENCE ENTITLEMENT
A) Elements which should be assessed in a more detailed assessment
Visual acuity, field of vision, twilight vision, glare and contrast sensitivity, diplopia and other visual functions that can 
compromise driving safety with no elevated risk: adjudication determined by clinical judgement. 
B) Guidance on formal field of vision testing
The minimum field of vision for driving safety is defined as “a field of at least 120° on the horizontal, measured using a 
target equivalent to the white Goldmann III4e settings. In addition, there should be no significant defect in the binocular 
field which encroaches within 20° of fixation above or below the horizontal meridian”.
This means that homonymous or bitemporal defects which come close to fixation, whether hemianopic or quadrantanopic, 
are not normally accepted as safe for driving.
If a visual field assessment is necessary to determine fitness to drive, a number of tests are possible: in the UK and 
Australia, for example, a binocular Esterman field is recommended. Monocular full field charts may also be requested in 
specific conditions. Exceptionally, Goldmann perimetry, carried out to strict criteria, will be considered. For an Esterman 
binocular chart to be considered reliable for licensing, the false positive score must be no more than 20%. When assessing 
monocular charts and Goldmann perimetry, fixation accuracy will also be considered.
Defect affecting central area ONLY
Pending the outcome of current research, the following are generally regarded as acceptable central loss as measured 
by the Esterman field method:
• Scattered single missed points.
• A single cluster of up to 3 adjoining points.
The following are generally regarded as unacceptable (i.e. ‘significant’) central loss as measured by the Esterman field 
method:
• A cluster of 4 or more adjoining points that is either wholly or partly within the central 20 degree area.
• Loss consisting of both a single cluster of 3 adjoining missed points up to and including 20 degrees from fixation, and 
any additional separate missed point(s) within the central 20 degree area.
• Any central loss that is an extension of a hemianopia or quadrantanopia of size greater than 3 missed points.
Defect affecting the peripheral areas – width assessment
The following will be disregarded when assessing the width of field:
• A cluster of up to 3 adjoining missed points, unattached to any other area of defect, lying on or across the horizontal 
meridian.
• A vertical defect of only single point width but of any length, unattached to any other area of defect, which touches 
or cuts through the horizontal meridian.
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C) Exceptional cases which can be considered for Group 1 drivers only
Drivers who have previously held full driving entitlement, removed because of a field defect which does not satisfy the 
standard, may be eligible to be considered as exceptional cases on an individual basis by a medical eye doctor,subject 
to strict criteria:
• The defect must have been present for at least 12 months.
• The defect must have been caused by an isolated event or a non-progressive condition. 
• There must be no other condition or pathology present which is regarded as progressive and likely to be affecting the 
visual fields. 
• The applicant has sight in both eyes.
• There is no uncontrolled diplopia.
• There is no other impairment of visual function, including glare sensitivity, contrast sensitivity or impairment of 
twilight vision. 
In order to meet the requirements of European law, to provide a driving licence for 1, 3 or 10 years the NDLS will, in 
addition, require: 
• Clinical assessment of full satisfactory functional adaptation.
• A satisfactory practical driving assessment, carried out by an appropriately qualified driving assessor, must subsequently 
be completed.
Note: 
• An individual who is monocular cannot be considered under exceptional case criteria.
• D501 (Medical Report) or D502 (Eyesight Report) are only accepted by the NDLS if printed and signed as double-sided 
documents. 
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Renal Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Renal Failure +CAPD 
(Continuous ambulatory 
peritoneal dialysis) 
Haemodialysis
No restriction on holding a 
10 year licence, or if over 60 
a licence that expires at age 
70 unless subject to severe 
electrolyte disturbance or 
significant symptoms, e.g. 
sudden disabling attacks of 
dizziness or fainting or impaired 
psychomotor or cognitive 
function when driving should 
cease until the symptoms are 
controlled.
Hemodialysis patients should 
not travel distances more than 
1—2 days driving time from 
their home without making 
arrangements for dialysis at 
another centre. 
They should not drive for at least 
24 hours after missing a dialysis 
treatment, and resume driving 
when dialysis resumed and 
condition stabilised.
Driver must notify the NDLS.
Drivers with these disabilities will 
be assessed individually by their 
treating specialist (consultant 
nephrologist) against the criteria as 
shown in the Group 1 entitlement.
Driver must notify the NDLS.
All other Renal Disorders Need not notify NDLS unless 
associated with a relevant 
disability.
Need not notify NDLS unless 
associated with significant 
symptoms or a relevant disability.
Chapter 8
Renal disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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Respiratory and  
Sleep Disorders
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Sleep Disorders
Including moderate or severe 
Obstructive Sleep Apnoea 
Syndrome causing excessive 
daytime/awake time sleepiness 
(while driving). 
A moderate obstructive sleep 
apnoea syndrome corresponds 
to a number of apnoeas and 
hypopnoeas per hour (Apnoea-
Hypopnoea Index) between 15 
and 29 and a severe obstructive 
sleep apnoea syndrome 
corresponds to an Apnoea-
Hypopnoea Index of 30 or more, 
both associated with excessive 
daytime sleepiness 
Refer to Chapter 2 Neurology re 
Narcolepsy
Driving must cease until 
satisfactory control of symptoms 
has been attained with ongoing 
compliance with treatment, 
confirmed by medical opinion. 
Periodic Medical review, 1-3 year 
licence may be granted.
Driver must notify NDLS.
Driving must cease until satisfactory 
control of symptoms has been 
attained, with ongoing compliance 
with treatment, confirmed by 
specialist medical opinion. 
Regular, normally annual, licensing 
review required.
Driver must notify NDLS.
Primary/Central Hypersomnias
Including Narcoleptic syndromes
See Chapter 2 Neurology. See Chapter 2 Neurology.
Respiratory Disorders
Including asthma, COPD (Chronic 
Obstructive Pulmonary Disease) 
and Cough Syncope.
NDLS need not be notified unless 
attacks are associated with 
disabling dizziness, fainting or 
loss of consciousness.
NDLS need not be notified unless 
attacks are associated with disabling 
dizziness, fainting or loss of 
consciousness.
Carcinoma of Lung NDLS need not be notified unless 
cerebral secondaries are present.
(See Chapter 2 for Malignant 
Brain Tumour).
Those drivers with non small cell 
lung cancer classified as T1N0M0 
can be considered on an individual 
basis. In other cases, driving must 
cease until 2 years has elapsed from 
the time of definitive treatment. 
Fit to drive providing treatment 
satisfactory and no brain scan 
evidence of intracranial metastases.
Chapter 9
Respiratory and sleep disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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To view or download driver information leaflets visit www.rsa.ie or www.ndls.ie
Obstructive Sleep 
Apnoea Syndrome 
(OSAS) and Driving
This is an overview of the driving risks for drivers 
with Obstructive Sleep Apnoea Syndrome (OSAS). 
The complete standards are published in Sláinte agus 
Tiomáint: Medical Fitness to Drive (MFTD) Guidelines.
NDLS
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Why does OSAS affect driving?
Although you may not realise it, OSAS interrupts your 
sleep and may result in daytime sleepiness, which could 
cause you to fall asleep at the wheel. Signs of sleep 
apnoea include loud snoring, disturbed sleep, fighting for 
breath during sleep and falling asleep in the daytime.
Drivers with OSAS are three times more likely to have a 
road traffic crash than the general population, but this 
increased risk is avoided with effective treatment.
What are the actual rules about 
OSAS, and do I need to stop 
driving?
Drivers with moderate or severe OSAS which causes 
excessive daytime (awake-time) sleepiness, and who do 
not follow the rules below (while driving), are driving 
while unsafe to do so and are breaking the law.
Group 1 drivers – driving a car, 
motor cycle or tractor
n	 You must not drive until your symptoms are under 
control and can be kept under control with ongoing 
treatment. This must be confirmed by a medical 
professional. Also, you will need to have regular 
medical reviews.
n	 You must also notify the NDLS.
n	 After that, a 1-3 year licence may be granted.
Group 2 drivers – driving a bus  
or truck
n	 You must not drive until your symptoms are under 
control and can be kept under control with ongoing 
treatment. This must be confirmed by a medical 
professional.
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Be a responsible driver
It is your responsibility as a driver to:
n	 follow your doctor’s advice, take your prescribed 
medication, and monitor and manage your medical 
condition(s);
n	 tell the National Driver Licence Service (NDLS) and 
your insurance provider if you have any long-term 
or permanent injury or illness that may affect your 
ability to drive safely;
n	 comply with the requirements of your licence, 
including periodic medical reviews; and
n	 get professional advice on your medical fitness to 
drive if you develop a medical condition, or your 
condition changes, during the term of your licence.
Sleepiness and driving
Driving is a complex task that can be impaired by 
a driver’s physical, mental and emotional health, 
including fatigue (tiredness). There is good evidence that 
sleepiness and fatigue account for 15 – 20% of all road 
traffic crashes. Many of these sleep-related crashes are 
as a result of lifestyle issues – such as driving without 
adequate sleep. However, some are due to medical 
conditions.
What is Obstructive Sleep Apnoea 
Syndrome (OSAS)?
OSAS, is believed to affect at least 100,000 people in 
Ireland. Those affected stop breathing briefly on repeated 
occasions while they are asleep.
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n	 You must also notify the NDLS.
n	 You will have your licence reviewed regularly – 
usually every year.
How is OSAS diagnosed?
OSAS is diagnosed by combining the results of a sleep 
study and an assessment of how sleepy the patient is.
What is the treatment for OSAS?
Continuous Positive Airway Pressure (CPAP) is often the 
treatment of choice for people who have been diagnosed 
with OSAS.
This treatment works by preventing the upper air passage 
from narrowing or collapsing during sleep. The patient 
will be fitted with a comfortable, close-fitting nasal 
mask, which is connected by tubing to the CPAP machine. 
CPAP is usually very effective in controlling the sleepiness 
associated with OSAS, and the benefits are usually 
evident within the first few weeks of treatment.
Be aware of these warning signs:
n	 Trouble keeping your eyes open or focused
n	 Continual yawning
n	 Not being able to remember driving parts of  
your journey.
Should I keep a Sleep Diary?
It may be helpful to keep a record of:
n	 how many hours you sleep each night,
n	 how often you awaken during the night and for how 
long,
n	 how long it takes you to fall asleep,
n	 how well rested you feel upon awakening, and
n	 how sleepy you feel during the day.
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As you may not be aware of some symptoms, ask your 
sleeping partner if you snore loudly, snort or gasp 
for breath, or have jerking movements. You may also 
perspire at night or have morning headaches.
If you have the above symptoms, your doctor may refer 
you to a sleep specialist for further investigation and 
help.
Ultimately, the onus is on you – the driver – and your 
sense of social responsibility not to drive if you are 
sleepy. OSAS is included in the Irish driving licence 
regulations (as required by Directive 2014/85/EU) and the 
regulations are set out in Sláinte agus Tiomáint: Medical 
Fitness to Drive Guidelines available on www.ndls.ie.
Do OSAS and sleep-related crashes 
have any particular distinguishing 
features?
Yes. Usually, OSAS and sleep-related crashes have the 
following features in common:
n	 They are single-vehicle collisions.
n	 The driver is alone in the vehicle and does not 
attempt to avoid the crash.
n	 The crash is likely to be serious and occur on a  
high-speed road.
n	 The crash occurs either late at night, early in the 
morning, or mid-afternoon.
What if I disagree that my sleep 
patterns are a problem?
You can get a second opinion. You must not drive until 
this opinion agrees that your sleep problems are not 
problematic.
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Then, within a specified time frame, you will be issued 
with a new, updated licence.
Please see www.ndls.ie for locations/bookings and 
forms.
If you have more questions, please email 
medicalfitness@rsa.ie or telephone 1890 40 60 40.
Please note that if you have supplied a medical report 
form to obtain your existing licence or permit and the 
terms of licence or permit are not being changed, you 
may submit your new application together with your 
medical report form by post to:
National Driver Licence Service 
PO Box 858 
Southside Delivery Office 
Co Cork
Further information sources:
n	 Your doctor or nurse 
Your doctor or nurse will advise you on your condition 
and where and how to seek help.
n	 Web 
Irish Sleep Apnoea Trust: 
http://www.isat.ie/ 
Tel: (086) 605 3891
n	 Sláinte agus Tiomáint: Medical Fitness to Drive 
Guidelines is available on www.ndls.ie
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Why is it important that I’m fully fit to 
drive?
n	 If you continue to drive against advice, and evidence 
is found of this, it will affect your insurance. Also, 
the NDLS and the Gardaí will take action to revoke 
(cancel) your licence.
n	 If you are involved in an accident or stopped by a 
member of An Garda Síochána, you may be asked to 
prove you are in full control. A charge can be brought 
against you even if you don’t have an incident, but, 
if you cause harm to a person or property, the charge 
will be more serious
The NDLS aims to maximise drivers’ mobility and to 
encourage patients with OSAS to seek diagnosis and 
effective treatment. Treated patients no longer pose an 
increased crash risk. However, it is important to ensure 
that an appropriate balance is found between mobility 
and safety.
If I need to, how do I inform the 
NDLS?
If, following consultation with your doctor, your OSAS is 
causing excessive sleepiness and your medical condition 
is one that needs to be noted on your driver record (but 
does not change your licence entitlement), or if your 
licence needs to be changed – for example, valid for a 
shorter period – you must notify the NDLS. You need to 
complete forms (1) and (2) listed below and return them 
in person to any NDLS centre along with your current 
licence and proof of your PPS number. These forms are 
available on www.ndls.ie.
Checklist of what you need to bring:
1) a complete Driver Licence Application Form;
2) a Medical Report Form (D501) completed by your 
doctor (a letter from your doctor is not accepted);
3) proof of PPSN; and
4) your current licence.
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Miscellaneous Conditions Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Deafness (Profound) Need not notify NDLS. Of paramount importance is 
the proven ability to be able to 
communicate in the event of an 
emergency by speech or by using a 
device e.g. a MINICOM. If unable to 
do so likely to be unfit to drive. 
Driver must notify NDLS.
All Cancers not already  
covered in earlier sections
For all tumours, fitness to drive 
depends upon:
• The prospective risk of a 
seizure:
NDLS does not need to be 
notified unless there are cerebral 
metastases or significant 
complications of relevance 
(see subsequent bullet points for 
guidance).
• Specific limb impairment, 
e.g. from bone primary or 
secondary cancer.
• General state of health. 
Advanced malignancies 
causing symptoms such 
as general weakness or 
cachexia to such an extent 
that driving would be 
comprised.
For all tumours, fitness to drive 
depends upon:
• The prospective risk of a seizure:
Specific attention is paid to the risk 
of cerebral metastasis.
• Specific limb impairment, e.g. 
from bone primary or secondary 
cancer.
• General state of health. 
Advanced malignancies causing 
symptoms such as general 
weakness or cachexia to such 
an extent that driving would be 
comprised.
For Group 2 entitlement (ODL), 
specific attention is paid to the 
risk of cerebral metastasis. For eye 
cancers, the vision requirements 
must be met as well as the above.
AIDS Syndrome Driving may continue providing 
medical enquiries confirm no 
relevant associated disability 
(e.g. neurological or vision 
disorders) likely to affect driving. 
1 or 3 year licence with medical 
review. Need not notify NDLS.
Cases will be assessed on an 
individual basis by the supervising 
consultant.
Need not notify NDLS.
Chapter 10
Miscellaneous Conditions
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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Miscellaneous Conditions Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
HIV Positive Need not notify NDLS. 
See Section 3.5: Multiple 
Conditions.
Need not notify NDLS. 
See Section 3.5: Multiple  
Conditions.
Age (Older Drivers) Age is no bar to the holding of a 
licence and physical frailty is not 
per se a bar to the holding of a 
licence.
See Section 3.5 on multiple 
morbidity, and relevant specific 
section for relevant diseases 
which are more common later 
in life, such as stroke and 
dementia.
See Chapter 1: Table 4.
Age is no bar to the holding of a 
licence and physical frailty is not per 
se a bar to the holding of a licence.
See Section 3.5 on multiple 
morbidity, and relevant specific 
section for relevant diseases which 
are more common later in life, such 
as stroke and dementia.
See Chapter 1: Table 4.
Hypoglycaemia
From any cause other than the 
treatment of diabetes
If suffering episodes of severe 
hypoglycaemia should cease 
driving while liable to these 
episodes. Examples would 
include after bariatric surgery 
or in association with eating 
disorders.
If suffering episodes of severe 
hypoglycaemia should cease driving 
while liable to these episodes. 
Examples would include after 
bariatric surgery or in association 
with eating disorders.
See appendix at end of this chapter
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To view or download driver information leaflets visit www.rsa.ie or www.ndls.ie
Emergency Department 
(ED): getting back to 
driving after injury
This is an overview of returning to driving after an injury. 
The complete standards are published in Sláinte agus 
Tiomáint: Medical Fitness to Drive (MFTD) Guidelines.
NDLS
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Practical self-assessment
The following sections give you some guidance and 
practical steps you can take to assess your injury and 
how it affects your driving.
How do I assess lower leg 
strength, range of motion  
and balance?
Walk three metres (10 feet), turn around and walk back 
to where you started. If it takes you more than nine 
seconds to do this, your legs may be too weak for you  
to drive safely.
How can I assess my ability  
to control and manoeuvre  
my vehicle?
n	 Neck rotation – Can you look over either shoulder to 
look behind you or to reverse your car? Would you be 
sure to see a child behind you? If not, do not drive.
n	 Finger curl – Can you make fists with both hands 
strong enough to allow you to hold a steering wheel 
or handle grips safely?
n	 Shoulder and elbow flexion – Pretend you are holding 
a steering wheel. Can you turn the imaginary wheel 
all the way to the right and then all the way to the 
left? Could you avoid a child if they ran out in front of 
you? If not, do not drive.
n	 Ankle flexion – pretend you are doing an emergency 
stop and you are pressing a car brake pedal quickly 
and hard. Now bring your toes back towards you. 
Could you brake in time and without hesitation to 
avoid a child who has run out in front of you? If not, 
or if you are in any doubt, do not drive.
If your movement is hesitant, causes pain, or is limited, 
your ability to drive safely will be impaired.
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Be a responsible driver
It is your responsibility as a driver to:
n	 follow your doctor’s advice, take your prescribed 
medication, and monitor and manage your medical 
condition(s);
n	 stop driving if any of the medications you are taking, 
or treatments you are receiving for your injury 
affect your ability to drive safely. Medications and 
treatments include– plaster casts, splints, slings, 
patches, medicines, injections and so on;
n	 inform the National Driver Licence Service (NDLS) if 
your doctor or health professional advises you to stop 
driving;
n	 comply with the requirements of your licence, 
including having medical reviews;
n	 get professional advice on medical fitness to drive 
if you develop a sudden, serious and/or ongoing 
medical condition during the term of your licence.
Note: You are committing an offence if you continue 
to drive after you become aware that you are not fit 
to do so. ‘Awareness’ can be your own awareness – for 
example, noticing that you are having dizzy spells or 
fainting, or knowing that your ability to drive is reduced 
because of an injury. Or, your doctor might make you 
aware by warning you not to drive.
When can I get back to driving 
after an injury?
It depends. After you are discharged from the emergency 
department (ED) with an injury, determining when you 
are fit to get back to driving depends on several things. 
For example:
n	 Are you putting yourself at risk of undoing the benefit 
of a recent surgery or treatment?
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n	 If you are protecting a body part with 
‘immobilisation’ – for example, a splint, a plaster 
cast or heavy bandage – or if you cannot bend or 
move the joint or limb normally, then you should  
not drive.
n	 You need to be sure that you can drive a vehicle 
safely, and respond to unpredictable situations 
appropriately. Studies have shown that even wearing 
a simple wrist splint while driving can significantly 
affect your ability to safely control the vehicle.
n	 If you have (or suspect you have) a fracture, wait until 
you get advice at your fracture clinic or ED follow-up 
appointment before you drive.
n	 If you have any numbness or loss of sensation in 
your arms or legs, your ability to use the vehicle 
controls safely and effectively could be impaired – for 
example, missing the brake pedal, losing your grip on 
the gear stick, and so on.
n	 If you have a ‘soft tissue’ injury – for example, 
damage to muscles, tendons and so on – it may 
become stiff and uncomfortable and may affect your 
driving ability.
n	 If you have had surgery, your doctor will advise you 
when it’s safe for you to drive. Be sure to ask him/
her.
Remember that any pain or stiffness may affect your 
speed of movement. It is essential that when you drive 
that you can react quickly and effectively to ensure safety 
on the road. While you may have adequate movement 
to drive ‘normally’, you need to be aware if any pain or 
stiffness associated with your injury is likely to slow down 
your speed of movement and your ability to react quickly 
enough if you have to avoid a sudden danger.
If you are still not sure about your physical condition and 
medical fitness to drive, ask the doctor treating you in 
the Emergency Department.
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To assess your strength, ask someone to fi rmly push 
against you when you do the movements below. You 
may be unable to drive safely if you cannot do them:
1. Lift each arm in turn in the air
2. Extend and fl ex your wrist
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3. Clench your fists
4. Extend and flex your ankle
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6 7
What if I have been treated with  
a sedative?
If you have been sedated in the ED:
n	 you must have a responsible adult to take you home 
and stay with you for 12 hours after your discharge;
n	 you must not drive for a minimum of 24 hours, or 
longer as advised by the medical team;
n	 for a surgical procedure, your doctor or other treating 
health professional will advise you when you can 
drive.
What about other medications?
You must follow your doctor’s and the medication 
manufacturer’s instructions on the correct dose of any 
medication you take. You must also understand the 
possible side effects of the medication, including advice 
about whether or not it may affect your ability to drive.
If you are aware or suspect that the pain relief or other 
medications you are taking for the injury affects your 
ability to think clearly, or affects your reaction time, you 
should not drive.
What if my injury affects my sleep?
It is important to be aware that not being able to sleep 
at night due to your injury can affect your co-ordination 
response times and, therefore, your ability to drive safety. 
Ultimately, the responsibility is on you – the driver – not 
to drive if you are sleepy or think you will become sleepy 
on the road.
What if I have suffered a  
head injury?
You should not drive for a minimum of 24 hours or as 
advised by your doctor, depending on severity of the 
head injury.
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Further information sources:
Head Injuries
Brí: Independent brain injury support, advocacy and 
information.
Web: www.briireland.ie
Phone: 01 482 4802
Email :  info@briirelnd.ie
Insurance: If a member of the public who holds a valid 
licence is deemed not fit to drive by a doctor or health 
professional, they must share this information with their 
insurance provider straight away.
Web: www.insuranceireland.eu
Phone:  01 6761820
Email:  feedback@insuranceireland.eu
Sláinte agus Tiomáint: Medical Fitness to Drive Guidelines 
is available on www.ndls.ie
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Group 2 – bus and truck drivers 
What do I do if I drive a bus or truck  
as my job?
If you drive for work, you should inform your employer 
of your injury. The rules are stricter for you, and you 
must ask for advice about your medical fitness to drive 
from your treating doctor. You must let them know 
your driving duties. If possible, ask your company’s 
occupational health doctor.
Why is it important that I’m fully fit to 
drive?
n	 The safety of you and the safety of your passengers 
and other road users depends on your ability to safely 
operate your vehicle.
n	 If you are involved in an accident or stopped by a 
member of An Garda Síochána, you may be asked 
to prove you are in full control. If you have not 
fully recovered from an injury and this is found 
to be affecting your driving, you may be charged 
with an offence and prosecuted in court. A charge 
can be brought against you even if you don’t have 
an incident, but, if you cause harm to a person or 
property, the charge will be more serious.
n	 Reduced movement in your limbs (arms or legs), 
or pain as a result of an injury may invalidate 
your insurance. It is illegal to drive without valid 
insurance, so you must declare any change in your 
health to your insurer if you continue to drive.
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If I need to, how do I inform  
the NDLS?
If, following consultation with your doctor, your medical 
condition is one that needs to be notified to the NDLS 
and your licence needs to be changed – for example, 
valid for a shorter period – you must notify the NDLS. 
You need to complete forms (1) and (2) listed below and 
return them in person to any NDLS centre along with 
your current licence and proof of your PPS number. These 
forms are available on www.ndls.ie.
Checklist of what you need to bring:
1) a complete Driver Licence Application Form;
2) a Medical Report Form (D501) completed by your 
doctor (a letter from your doctor is not accepted);
3) proof of PPSN; and
4) your current licence.
Then, within a specified time frame, you will be issued 
with a new, updated licence.
Please see www.ndls.ie for locations/bookings and 
forms.
If you have more questions, please email 
medicalfitness@rsa.ie or telephone 1890 40 60 40.
Please note if you have supplied a medical report form to 
obtain your existing licence or permit and the terms of 
licence or permit are not being changed, you may submit 
your new application together with your medical report 
form by post to:
National Driver Licence Service 
PO Box 858 
Southside Delivery Office 
Co Cork
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Drivers with disabilities
Group 1 Car and Motorcycles
Driving is possible in both static and progressive or relapsing disorders but vehicle modification may be needed.
1. Permanent Limb Disabilities/Spinal Disabilities.
 e.g. amputation, hemiplegia/cerebral palsy, ankylosing spondylitis, severe arthritis, especially with pain.
2. Neurological Disorders:
 e.g. multiple sclerosis, Parkinson’s disease, motor neurone disease, peripheral neuropathy34.
Sophisticated vehicle adaptation is now possible and varies from automatic transmission to joy sticks and infra red controls 
for people with severe disabilities.
The NDLS requires notification of which, if any, of the controls required to be modified. The driving licence will then be 
coded to reflect the modifications. 
Group 2 Entitlement ODL truck and bus (with or without trailer)
Some disabilities may be compatible with the driving of large vehicles if mild and non-progressive. Individual assessment 
will be required.
The National Office for Traffic Medicine is reviewing the current situation of assessments of driving and adaptation of 
vehicles in Ireland. 
34.  Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly 
population. Neurology. 2016 Nov 1;87(18):1892-1898
Useful resources
Location Available
RSA and NDLS web resources and email
www.rsa.ie/ie 
medicalfitness@rsa.ie
and 
www.ndls.ie
• D501 Medical Report
• D502 Eyesight Report
• Driver Advisory Form
• RSA Medical Pages – RSA only
• Road safety statistics – RSA only
NOTM web resources at
www.rcpi.ie/traffic-medicine/ 
• Certificate in Traffic Medicine (14 CPD) Online and 
one day workshop
• Links to other international Guidelines
• Online Multiple Choice Exam on Guidelines (3 CPD)
• Traffic Medicine Ezine
• Upcoming Education Events
• Traffic Medicine Research
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Driver Advisory Form 
Dear 
Following your assessment today, _____ /_____ /_____, I am advising you that you need to contact your National Driver Licence 
Service to let them know that you have a condition _____________________ which may impact on your fitness to drive: 
I am also advising that: 
The philosophy of the NDLS is an enabling one, aiming to maximise mobility of drivers to the greatest extent possible. However, 
it is important to ensure that an appropriate balance is found between mobility and safety and the NDLS is likely to request you to 
provide a medical report clarifying your medical fitness to drive once you have notified them. The conditions that require reporting 
to your NDLS are outlined in the declaration made by you when you applied for, or renewed, your driving licence (see below) and 
also in the official RSA guidelines for medical fitness to drive, Sláinte agus Tiomáint. You should also clarify with your insurer as to 
whether or not this condition needs to be reported to them as well. A record of  
this notification will be held in your medical file here.
Yours sincerely
1. Diabetes treated by insulin and or sulphonylurea tablets (doctor 
to advise whether patient is on these or not) no need to tell us if 
managed by other tablets and or diet 
2. Epilepsy
3. Stroke or TIAs with any associated symptoms lasting longer than 
one month
4. Fits or blackouts
5. Any type of brain surgery, brain abscess or severe head injury 
involving in-patient treatment or brain tumour or spinal injury or 
spinal tumour
6. An implanted cardiac pacemaker
7. An implanted cardiac defibrillator (ICD)
8. Repeated attacks of sudden disabling dizziness 
9. Any other chronic neurological condition such as multiple sclerosis,  
motor neurone disease, Parkinson disease and Huntington’s 
disease 
10. A serious problem with memory or periods of confusion.
11. Persistent alcohol misuse or dependency
12. Persistent drug misuse or dependency
13.  Serious psychiatric illness or mental health problems
14. Parkinson’s Disease
15.  Sleep Apnoea Syndrome
16.  Narcolepsy
17.  Any condition affecting the drivers peripheral vision 
18.  Total loss of sight in one eye
19.  Any condition affecting both eyes, or the remaining eye if driver only 
has one eye (Not including colour blindness or short or long sight) 
20.  A serious hearing deficiency
21.  Any persisting problem with arm(s) or leg(s) which needs driving to 
be  
restricted to certain types of vehicle or those with adapted controls 
22.  Is the driver’s vehicle adapted because of a physical disability to 
enable 
 you to drive 
23.  Severe learning disability
The above list is not exhaustive.
Please note if you are the holder of an EU licence from a country other than Ireland, or hold a licence from a recognised country for licence exchange  
purposes, you should contact the NDLS to arrange for a licence exchange and medical report.
     This is a discretionary form. Doctors may prefer to use other notation methods for the patient file.
Medical conditions requiring declaration at application for and renewal of driving licence
And recommend a further specialist opinion                   Yes                            No

Sláinte agus Tiomáint
Medical Fitness To Drive Guidelines
 (Group 1 and Group 2 Drivers)
(6th Ed) April 2017,  
replaces previous editions  
and the document  
Medical Aspects of Driver Licensing:  
A Guide for Medical Practitioners 2010.
Summary of Medical Amendments
Edition April 2016 V April 2017 
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1 .0
Acknowledgements
Some changes in Working Group 
member representation
Ms Caroline Byrne added to 
Irish Association of Orthoptists 
representation and Mr Steven Young 
added to Neurosurgeons representation, 
Ms Ruth Hoban added to Nursing 
and Midwifery Board of Ireland, Dr. 
Doreen Fagan added to Health Products 
Regulatory Authority and Mr Martin 
McNulty added to RSA representation.
2.3 Roles and 
Responsibilities of 
health professionals
Restrictions which may be indicated on 
the driver https://www.ndls.ie/medical-
reports.html” D501 Medical Report
will be:-
 •  Needs driving to be restricted to 
certain types of vehicle
 •  Needs vehicle adaptation(s) 
fitted to the vehicle
 •  Limited to day-time driving (one 
hour after sunrise and one hour 
before sunset)
 •  Limited to journeys within a 
radius 
Restrictions which are indicated on the 
driver https://www.ndls.ie/medical-
reports.html” D501 Medical Report
are:-
 •  Needs driving to be restricted to 
certain types of vehicle
 •  Needs vehicle adaptation(s) 
fitted to the vehicle
 •  Limited to day-time driving (one 
hour after sunrise and one hour 
before sunset)
 •  Limited to journeys within a 
radius of 30km from holder’s 
place of residence
 •  Limited to journeys with a speed 
not greater than 80 km/h
3.6 Multiple 
conditions and age 
related change
On-road driving 
assessment 
(paragraph 7)
In the near future it is anticipated that 
it will be possible to recommend a 
restricted licence in terms of daylight 
driving, driving within a specific 
distance from home, etc, and this may 
be a useful aid in maintaining safe 
driving16.
A new driver licence Medical Report 
Form (D501) has been introduced where 
it will be possible to recommend a 
restricted licence in terms of daylight 
driving, driving within a specific 
distance from home, etc., and this may 
be a useful aid in maintaining safe 
driving16.
SUMMARY OF AMENDMENTS 2017 Edition 
Medical Changes throughout document
Chapter 1 Introduction
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3.9 Medications
and driving
Any medication that acts on the central 
nervous system has the potential to 
adversely affect driving skills, although 
it must be also recognised that many 
medications, such as medications for 
attention-deficit and hyperactivity 
disorder17, antiparkinsonian 
medications, anti-inflammatory agents 
and antidepressants, may actually make 
driving safer and more comfortable.
Conversely, many medications 
improve driving safety and comfort, 
including antiparkinsonian, anti-
inflammatory agents and medications 
for the treatment of ADHD17, and due 
compliance is an important aspect of 
MFTD in such cases18.
Any medication that acts on the central 
nervous system has the potential 
to adversely affect driving skills.  
Conversely, it is recognised that many 
medications, such as medications for 
attention-deficit and hyperactivity 
disorder17, antiparkinsonian 
medications, anti-inflammatory agents 
and antidepressants, may actually make 
driving safer and more comfortable and 
due compliance is an important aspect 
of MFTD in such cases18. 
3.9.2 The effects of 
specific medicine 
classes
For the following psychoactive 
medications, the driver should be 
advised about concerns over sedation 
while initiating and changing treatment, 
and that driving should cease if such 
signs are noted: resumption should only 
recommence when such sedating side-
effects have ceased.
For the following psychoactive 
medications, the driver should be advised 
about concerns over sedation while 
initiating and changing treatment, and 
that driving should cease if such signs 
are noted: resumption should only 
recommence when such sedating side-
effects have ceased. Helpful background 
information can be obtained from the 
deliberations of the EU-FP6 funded project 
“Driving under the Influence of Drugs, 
Alcohol and Medicines” (DRUID)19,20.
New accompanying footnotes
19Rudisill TM, Zhu M, Kelley GA, Pilkerton 
C, Rudisill BR. Medication use and the 
risk of motor vehicle collisions among 
licensed drivers: A systematic review. 
Accid. Anal. Prev. 2016 Nov;96:255-70
20http://www.druid-project.
eu/Druid/EN/deliverales-list/
downloads/Deliverable_4_4_1.pdf?__
blob=publicationFile&v=1
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3.9.2 The effects of 
specific medicine 
classes Sub-section 
“Benzodiasepines”
Additional text Benzodiazepines, particularly long-
acting benzodiazepines, increase the 
risk of a crash. In many of these studies, 
benzodiazepines were used without 
prescription, at supra-therapeutic 
doses, or in combination with other 
impairing and/or illicit substances. If 
a hypnotic is needed, a shorter-acting 
medicine is preferred. Tolerance to the 
sedative effects of the longer-acting 
benzodiazepines used in the treatment of 
anxiety gradually reduces their adverse 
impact on driving skills. Particular 
caution should be exercised with Group 
2 drivers and benzodiazepines, avoiding 
benzodiazepines to the greatest extent 
possible21, and if any doubt persists about 
their impact on driving, a second opinion 
from a psychiatrist or occupational 
physician should be sought.
New accompanying footnote
21Federal Motor Carrier Safety 
Administration.
https://www.fmcsa.dot.gov/sites/fmcsa.
dot.gov/files/docs/Medical-Expert-Panel-
Psychiatric-Psychiatric-MEP-Panel-Opin.
pdf 
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Primary/Central 
Hypersomnias
(including 
Narcoleptic 
syndromes)1
1 Change the 
contents of this 
paragraph for both 
Group 1 &  Group 2 
drivers
Fit to drive when there has been a 
period of between 3 and 6 months 
satisfactory control of symptoms 
with appropriate treatment. If not on 
appropriate treatment, dririving may 
be allowed subject to a satisfactory 
objective assessment of maintained 
wakefullness.
Fit to drive when there has been a 
period of between 3 and 6 months 
satisfactory control of symptoms 
with appropriate treatment. If not 
requiring treatment, relicensing may be 
considered after satisfactory objective 
assessment of maintained wakefulness, 
such as the Osler test26.  
New accompanying footnote: 
26 Pizza F, Jaussent I, Lopez R, Pesenti C, 
Plazzi G, Drouot X, Leu-Semenescu S, 
Beziat S, Arnulf I, Dauvilliers Y. Car 
Crashes and Central Disorders of
Hypersomnolence: A French Study. PLoS 
One. 2015 Jun 8;10(6):e0129386.
Chronic Subdural
(Treated surgically)
Chronic Subdural
(Treated surgically)
Chronic Subdural Haematoma
(Treated surgically)
Mild Cognitive 
Impairment (MCI)
Where there is no objective impairment 
of function MCI does not need to be 
notified to   NDLS. Where there is 
objective impairment of function or 
specific treatment is required then MCI 
will not be the cause and doctor should 
clarify the cause and apply the relevant 
section of Sláinte agus Tiomáint.
Given that a significant proportion of 
people with MCI progress to dementia 
over time, at least yearly review of 
diagnostic status is recommended to 
monitor for transition to dementia by 
the treating doctor.
The following footnote added to 
accompany the original text 
http://www.alzheimer.ie/Alzheimer/
media/SiteMedia/Helpline%20and%20
Information%20Resources/Info%20
Pack%20PDF’s/Giving-Up-Driving_
Section-D1_web-view_1.pdf
Chapter 3 Cardiovascular disorders
No change to existing text.
Chapter 4 Diabetes Mellitus
No change to existing text.
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Dementia or any 
Organic Brain 
Syndrome27
It can be difficult to assess driving ability 
in those with dementia. Those who have 
poor short-term memory, disorientation, 
lack of insight and judgement are almost 
certainly not fit to drive.
The variable presentations and rates 
of progression are acknowledged. 
Disorders of attention will also cause 
impairment. A decision regarding 
fitness to drive is usually based on 
consultant medical assessment, further 
assessment by occupational therapy 
and/or neuropsychology31., with a 
low threshold for an on- road driving 
assessment.
In early dementia when sufficient skills 
are retained and progression is slow, a 
licence may be issued subject to annual 
review or sooner if a significant medical 
or functional decline
is noted. A formal driving assessment is 
generally an integral part of assessment 
and review but the overall decision rests 
with the treating doctor (see section 3.6).
The following footnote added to 
accompany the original text 
http://www.alzheimer.ie/Alzheimer/
media/SiteMedia/Helpline%20and%20
Information%20Resources/Info%20
Pack%20PDF’s/Giving-Up-Driving_
Section-D1_web-view_1.pdf
Chapter 5 Psychiatric disorders
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Drivers with 
disabilities Group 1 
Car and Motorcycles 
Item 2. Chronic 
Neurological 
Disorders:
(p. 97)
2. Chronic Neurological Disorders:e.g. 
multiple sclerosis, parkinson’s disease, 
motor neurone disease, peripheral 
neuropathy.
2. Chronic Neurological Disorders:
e.g. multiple sclerosis, Parkinson’s 
disease, motor neurone disease, 
peripheral neuropathy34.
The following footnote added to 
accompany the above text
34Hanewinckel R, Drenthen J, van Oijen 
M, Hofman A, van Doorn PA, Ikram MA.
Prevalence of polyneuropathy in the 
general middle-aged and elderly 
population. Neurology. 2016 Nov 
1;87(18):1892-1898. 
Chapter 10 Miscellaneous Conditions  
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Location in Text Original text Replacement or additional text
Summary of Medical 
Amendments 2017
Update tables on pages 106 - 115 Update tables on pages 106 - 115
Summary of Medical 
Amendments
Page 105
Edition March 2015 v April 2016 Edition April 2016 – April 2017
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